
<html lang="en"     class="pb-page"  data-request-id="5e65bf1e-f1fa-455d-909f-67f0d947f5dd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00527;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-12;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors" /></meta><meta name="dc.Creator" content="Joana  Reis" /></meta><meta name="dc.Creator" content="Fernando  Cagide" /></meta><meta name="dc.Creator" content="Daniel  Chavarria" /></meta><meta name="dc.Creator" content="Tiago  Silva" /></meta><meta name="dc.Creator" content="Carlos  Fernandes" /></meta><meta name="dc.Creator" content="Alexandra  Gaspar" /></meta><meta name="dc.Creator" content="Eugenio  Uriarte" /></meta><meta name="dc.Creator" content="Fernando  Remião" /></meta><meta name="dc.Creator" content="Stefano  Alcaro" /></meta><meta name="dc.Creator" content="Francesco  Ortuso" /></meta><meta name="dc.Creator" content="Fernanda  Borges" /></meta><meta name="dc.Description" content="The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small library of chromon..." /></meta><meta name="Description" content="The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small library of chromon..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 10, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00527" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00527" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00527" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00527" /></link>
        
    
    

<title>Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00527" /></meta><meta property="og:title" content="Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0013.jpeg" /></meta><meta property="og:description" content="The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small library of chromone derivatives was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B). The structure–activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring. The most potent MAO-B inhibitors were N-(3′-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3′,4′-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, respectively. Computational docking studies provided insights into enzyme–inhibitor interactions and a rationale for the observed selectivity and potency. Compound 27 stands out due to its favorable toxicological profile and physicochemical properties, which pointed toward blood–brain barrier permeability, thus being a valid candidate for subsequent animal studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00527"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00527">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00527&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00527&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00527&amp;href=/doi/10.1021/acs.jmedchem.6b00527" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5879-5893</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00489" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00600" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b00600"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joana++Reis">Joana Reis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Cagide">Fernando Cagide</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Chavarria">Daniel Chavarria</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tiago++Silva">Tiago Silva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Fernandes">Carlos Fernandes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra++Gaspar">Alexandra Gaspar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugenio++Uriarte">Eugenio Uriarte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Remi%C3%A3o">Fernando Remião</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Alcaro">Stefano Alcaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Ortuso">Francesco Ortuso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fernanda++Borges">Fernanda Borges</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of “Scienze della Vita”, University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy</span></div><div class="corresp-info"><strong>*</strong>Phone: +351 220402560. E-mail: <a href="/cdn-cgi/l/email-protection#4325212c312426300325206d36336d3337"><span class="__cf_email__" data-cfemail="086e6a677a6f6d7b486e6b267d7826787c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00527&amp;href=/doi/10.1021%2Facs.jmedchem.6b00527" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5879–5893</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 31, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 April 2016</li><li><span class="item_label"><b>Published</b> online</span>10 June 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 June 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00527" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00527</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5879%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJoana%2BReis%252C%2BFernando%2BCagide%252C%2BDaniel%2BChavarria%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D12%26contentID%3Dacs.jmedchem.6b00527%26title%3DDiscovery%2Bof%2BNew%2BChemical%2BEntities%2Bfor%2BOld%2BTargets%253A%2BInsights%2Bon%2Bthe%2BLead%2BOptimization%2Bof%2BChromone-Based%2BMonoamine%2BOxidase%2BB%2B%2528MAO-B%2529%2BInhibitors%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5893%26publicationDate%3DJune%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00527"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1860</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">49</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00527" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Joana&quot;,&quot;last_name&quot;:&quot;Reis&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Cagide&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Chavarria&quot;},{&quot;first_name&quot;:&quot;Tiago&quot;,&quot;last_name&quot;:&quot;Silva&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Fernandes&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;Gaspar&quot;},{&quot;first_name&quot;:&quot;Eugenio&quot;,&quot;last_name&quot;:&quot;Uriarte&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Remião&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Alcaro&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Ortuso&quot;},{&quot;first_name&quot;:&quot;Fernanda&quot;,&quot;last_name&quot;:&quot;Borges&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;5879-5893&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00527&quot;},&quot;abstract&quot;:&quot;The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small library of chromone derivatives was synthesized and screened toward human monoamine oxidase isoforms (hMAO-A and hMAO-B). The structure–activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring. The most potent MAO-B inhibitors were N-(3′-chlorophenyl)-4-oxo-4H-chromene-3-carboxamide (20) (IC50 = 403 pM) and N-(3′,4′-dimethylphenyl)-4-oxo-4H-chromene-3-carboxamide (27) (IC50 = 669 pM), acting as competitive and noncompetitive reversible inhibitors, respectively. Computational docking studies provided insights into enzyme–inhibitor interactions and a rationale for the observed selectivity and potency. Compound 27 stands out due to its favorable toxicological profile and physicoch&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00527" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00527&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00527" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00527&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00527" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00527&amp;href=/doi/10.1021/acs.jmedchem.6b00527" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00527" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00527" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00527%26sid%3Dliteratum%253Aachs%26pmid%3D27244485%26genre%3Darticle%26aulast%3DReis%26date%3D2016%26atitle%3DDiscovery%2Bof%2BNew%2BChemical%2BEntities%2Bfor%2BOld%2BTargets%253A%2BInsights%2Bon%2Bthe%2BLead%2BOptimization%2Bof%2BChromone-Based%2BMonoamine%2BOxidase%2BB%2B%2528MAO-B%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D12%26spage%3D5879%26epage%3D5893%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/jmcmar.2016.59.issue-12/20160623/jmcmar.2016.59.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery of new chemical entities endowed with potent, selective, and reversible monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small library of chromone derivatives was synthesized and screened toward human monoamine oxidase isoforms (<i>h</i>MAO-A and <i>h</i>MAO-B). The structure–activity relationships studies strengthen the importance of the amide spacer and the direct linkage of carbonyl group to the γ-pyrone ring, along with the presence of meta and para substituents in the exocyclic ring. The most potent MAO-B inhibitors were <i>N</i>-(3′-chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>20</b>) (IC<sub>50</sub> = 403 pM) and <i>N</i>-(3′,4′-dimethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>27</b>) (IC<sub>50</sub> = 669 pM), acting as competitive and noncompetitive reversible inhibitors, respectively. Computational docking studies provided insights into enzyme–inhibitor interactions and a rationale for the observed selectivity and potency. Compound <b>27</b> stands out due to its favorable toxicological profile and physicochemical properties, which pointed toward blood–brain barrier permeability, thus being a valid candidate for subsequent animal studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disorders, affecting up to 10 million people worldwide. Its current pharmacological therapy is mainly focused on improving the motor symptomatology and the patients’ quality of life by slowing down the progression of symptoms and reducing morbidity. In spite of all the research performed in the field, there are only a few classes of drugs approved for the treatment of the motor related symptoms of PD, namely, those acting primarily on the dopaminergic system, such as L-dopa, dopamine agonists, monoamine oxidase B (MAO-B), and catechol-<i>O</i>-methyltransferase inhibitors.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a></div><div class="NLM_p">Monoamine oxidases (MAOs) are intracellular flavine-containing enzymes that play a major role in the in vivo inactivation of biogenic amines, in both peripheral and central neuronal tissues. MAO-A and MAO-B are two isoforms of MAOs expressed in mammals, which can be distinguished based on their substrate preference and their interaction with specific inhibitors.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> The primary substrates of MAOs in the human brain are neurotransmitters, and albeit dopamine can be metabolized by both isoforms, it has a higher affinity for MAO-B. The expression of MAO-B in neuronal tissues enhances 4-fold with aging, resulting in an increased level of dopamine metabolism and higher production of hydrogen peroxide, which are thought to play a relevant role in the etiology of neurodegenerative diseases. Accordingly, the use of selective MAO-B inhibitors (IMAO-B), alone or combined with dopamine or its precursors, is an important therapeutic approach for neurodegenerative disorders, such as PD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Currently, there are two IMAO-B in the market, selegiline (<i>R</i>-(−)-deprenyl) and rasagiline, which are selective but irreversible (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> More recently, safinamide has been developed as a multitarget drug based on the enhancement of the dopaminergic function (through reversible inhibition of MAO-B and of dopamine reuptake) and inhibition of the excessive release of glutamate in patients with early or mid- to late-stage PD (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known MAO-B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, due the lack of significant disease modifying properties, a pressing need for new chemical entities endowed with selective and reversible IMAO-B still exists. Chromones, a class of heterocyclic compounds widely distributed in nature, have attracted attention in the field of drug discovery and development due to their interesting biological activities.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Several lines of evidence reported by our research group have shown that chromone (4<i>H</i>-benzopyran-4-one) is a privileged structure for the rational discovery and development of new IMAO-B.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11-15)</a> In this context, it was shown that the structural modification of the chromone scaffold with the insertion of a phenylcarboxamide moitey at position C3 of the γ-pyrone ring yielded selective IMAO-B.<a onclick="showRef(event, 'ref11 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref14">(11, 14)</a> Focusing on the lead optimization of chromone-3-phenylcarboxamide as IMAO-B and guided by the rational design strategy shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, the work herein reports the synthesis of a novel chromone library and the establishment of new structure–activity relationships (SARs). The evaluation of druglike properties, kinetics, and mechanism of enzymatic inhibition and cytotoxicity studies of the best chromone-based IMAO-B was also performed. Finally, in order to rationalize our results, docking experiments were performed using models built on the basis of the crystal structures of human MAO-A and MAO-B.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of the lead compound described in previous work<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and rational design strategy followed for lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">A lead optimization process of chromone-3-phenylcarboxamide was performed to improve its IMAO-B potency and selectivity. The rational design strategy described in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> was mainly focused on the study of (i) the effect of different substituents (type, number, and position) located on the aromatic exocyclic ring C and (ii) the importance of the amide linker located between the γ-pyrone nucleus (ring B) and the exocyclic aromatic ring (ring C) by the insertion of different spacers (amide, inverse amide, ester, thioester, amine, and vinyl). As a result, a library of new chromone-based compounds was obtained (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The first chromone series (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, compounds <b>2</b>–<b>31</b>) incorporated carboxamide, thioester, or ester spacers directly attached to C-3 and an aromatic exocyclic ring with different electron donating or withdrawing substituents, variable in type, number, and position. The chromone-based compounds were synthesized in moderate yields through a reaction that encompassed the in situ generation of an acyl chloride intermediate, using phosphoryl chloride (POCl<sub>3</sub>) in <i>N</i>,<i>N</i>-dimethylformamide (DMF), and the subsequent addition of the appropriate arylamine, 4-methylphenol, or 4-methylbenzenethiol.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Compound <b>10</b> was obtained from compound <b>12</b> by cleavage of the <i>tert</i>-butoxycarbonyl protecting group with trifuoroacetic acid (TFA).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Strategy Followed for the Synthesis of Chromone-3-phenylcarboxamide Derivatives (<b>2</b>–<b>31</b>) from Chromone-3-carboxylic Acid (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, appropriate arylamine (a<sub>1</sub>), <i>N</i>-methylaniline (a<sub>2</sub>), 4-methylphenol (a<sub>3</sub>), or 4-methylbenzenethiol (a<sub>4</sub>), rt, 1–5 h; (b) TFA, rt, 2 h.</p></p></figure><div class="NLM_p">Compound <b>34</b>, bearing an inverted carboxamide linker at C-3, was obtained by a two-step synthetic strategy. Initially, an intramolecular cyclization between aldehyde and nitrile of compound <b>32</b> was performed in the presence of 5-(2-hydroxyethyl)-3,4-dimethylthiazolium iodide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), leading to the chromone amine <b>33</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Subsequently, chromone <b>34</b> was synthesized by an in situ amidation reaction using 4-methylbenzoic acid, POCl<sub>3</sub>, and DMF. In turn, compound <b>36</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was obtained by a reductive amination, in the presence of sodium triacetoxyborohydride, of the imine intermediate formed from the reaction of 3-formylchromone (<b>35</b>) with 4-methylaniline.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Strategy Followed for the Synthesis of Chromone Derivative <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5-(2-hydroxyethyl)-3,4-dimethylthiazolium iodide, DBU, rt, 5 h; (b) POCl<sub>3</sub>, DMF, DIPEA, 4-methylbenzoic acid, rt, 2 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Strategy Followed for the Synthesis of Chromone Derivatives (<b>36</b>–<b>41</b>) from 3-Formylchromone (<b>35</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylaniline, Na(AcO)<sub>3</sub>BH, rt, 15 min; (b) malonic acid, pyridine, rt, 1.5 h; (c) PyBOP, appropriate arylamine, DMF, DIPEA, rt, 6 h.</p></p></figure><div class="NLM_p last">The synthetic procedure followed to obtain the chromone derivatives bearing a vinyl spacer linked to the γ-pyrone ring involved two steps (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). First, the 3-(4-oxo-4<i>H</i>-chromen-3-yl)acrylic acid (compound <b>37</b>) was obtained from the reaction between 3-formylchromone (<b>35</b>) and malonic acid through a Knoevenagel–Doebner condensation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The corresponding chromone carboxamides (compounds <b>38</b>–<b>41</b>) were then synthesized by a one-pot condensation reaction. Briefly, this amidation was performed using compound <b>37</b> and aniline or its ring-substituted derivatives as starting materials, using as coupling agent (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) in basic medium (<i>N</i>,<i>N</i>-diisopropylethylamine, DIPEA).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Monoamine Oxidase Inhibition Studies</h3><div class="NLM_p">The evaluation of <i>h</i>MAO inhibitory activity of the chromones under study was performed by a fluorescence-based assay measuring their effect on the production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) from <i>p</i>-tyramine (a common substrate for both <i>h</i>MAO-A and <i>h</i>MAO-B), using the Amplex Red MAO assay kit and microsomal MAO isoforms prepared from insect cells (BTI-TN-5B1-4) infected with recombinant baculovirus containing cDNA inserts for <i>h</i>MAO-A or <i>h</i>MAO-B.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The production of H<sub>2</sub>O<sub>2</sub> catalyzed by MAO isoforms was detected using 10-acetyl-3,7-dihydroxyphenoxazine, a nonfluorescent and highly sensitive probe that reacts with H<sub>2</sub>O<sub>2</sub> in the presence of horseradish peroxidase to produce a fluorescent product (resorufin).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The chromone derivatives under study and standard inhibitors did not react directly with the Amplex Red reagent, which indicated that they did not interfere with the measurements.</div><div class="NLM_p">The results of the in vitro evaluation of inhibitory potency (IC<sub>50</sub> values) and selectivity expressed as SI ([IC<sub>50</sub>(MAO-A)]/[IC<sub>50</sub>(MAO-B)]) toward <i>h</i>MAO-A and <i>h</i>MAO-B of the chromones under study and standard inhibitors (clorgyline for MAO-A and (<i>R</i>)-(−)-deprenyl, rasagiline, safinamide for MAO-B, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MAO Inhibitory Activities of Chromone-3-phenylcarboxamides <b>6</b>–<b>28</b> and Standard Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Asterisks indicate the following: (∗) inactive at 10 μM; (∗∗) inactive at 100 μM (highest concentration tested); (∗∗∗) not soluble in DMSO. SI: <i>h</i>MAO-B selectivity index = IC<sub>50</sub>(<i>h</i>MAO-A)/IC<sub>50</sub>(<i>h</i>MAO-B).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Values obtained under the assumption that the corresponding IC<sub>50</sub> against MAO-A or MAO-B is the highest concentration tested (10 μM).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Values obtained under the assumption that the corresponding IC<sub>50</sub> against MAO-A or MAO-B is the highest concentration tested (100 μM).</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. MAO Inhibitory Activities of Chromone Derivatives (<b>29</b>–<b>31</b>, <b>34</b>, <b>36</b>, and <b>38</b>–<b>41</b>)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Asterisk indicates the following: (∗) inactive at 10 μM (highest concentration tested). SI: <i>h</i>MAO-B selectivity index = IC<sub>50</sub>(<i>h</i>MAO-A)/IC<sub>50</sub>(<i>h</i>MAO-B).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Values obtained under the assumption that the corresponding IC<sub>50</sub> against MAO-A or MAO-B is the highest concentration tested (10 μM).</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationship Studies</h3><div class="NLM_p">Following the previous results obtained for chromone-3-phenylcarboxamides (compounds <b>2</b>–<b>4</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and in order to establish SAR, the MAO inhibitory activity of the newly developed chromone library (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was evaluated and the results are depicted in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Effect of Ring C Substituents on MAO Inhibitory Activity</h4><div class="NLM_p">The introduction of halogens at the para position of the exocyclic ring yielded different results: iodine (compound <b>7</b>) and fluorine (compound <b>8</b>) caused a decrease in activity when compared with the chlorine (compound <b>3</b>, IC<sub>50</sub> = 2.90 nM), while bromine (compound <b>6</b>) led to a more potent compound (IC<sub>50</sub> = 1.15 nM). Properties like atomic radius and/or electronegativity may thus play a significant role on the ligand–enzyme interaction. The evaluation of the effect of the introduction of a <i>p</i>-thiol substituent in compound <b>9</b> was not performed due to its poor solubility. The introduction of a <i>p-</i>amine substituent (compound <b>10</b>) was unfavorable, leading to a ∼500-fold activity decrease when compared to the halogenated or methyl substituted derivatives (compounds <b>3</b>, <b>4</b>, <b>6</b>–<b>8</b>). This result is in accordance with recently published data, which showed that the introduction of a strong electron donating group (<i>p</i>-OH, compound <b>5</b>) decreased MAO-B inhibitory capacity (IC<sub>50</sub> = 1382 nM).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Additionally, the presence of bulky para substituents led to a dramatic decrease (compound <b>11</b>) or complete loss (compound <b>12</b>) of MAO-B inhibitory activity. These observations also provided valuable data concerning the volume restrictions of the substituents on the exocyclic ring, since only small substituents seemed to favor an appropriate accommodation of the ligand on the enzyme’s active site. The presence of the <i>p</i>-ethynyl (compound <b>13</b>, IC<sub>50</sub> = 24.00 nM) and <i>p</i>-vinyl (compound <b>14</b>, IC<sub>50</sub> = 26.45 nM) substituents yielded compounds with a remarkable inhibitory potency, although a superior activity was obtained for the saturated <i>p-</i>ethyl derivative (compound <b>15</b>, IC<sub>50</sub> = 3.31 nM). The data showed that the presence of an unsaturated system in the mentioned position is not crucial for the IMAO-B activity of chromone-3-phenylcarboxamide based ligands. Overall, SAR studies indicated that the type of substituents on the exocyclic aromatic ring of chromone-3-phenylcarboxamide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) exerted a noteworthy influence on MAO-B inhibitory activity.</div><div class="NLM_p">Subsequently, the effect of the most interesting substituents (Cl, Br, OH, and CH<sub>3</sub>) located at the ortho and meta positions of the exocyclic ring was evaluated. With the exception of the bromine group (compound <b>17</b>), the insertion of <i>o-</i>substituents (compounds <b>16</b> (Cl), <b>18</b> (OH), and <b>19</b> (CH<sub>3</sub>)) resulted in a noticeable decrease on MAO-B inhibitory activity when compared to the corresponding para derivatives (compounds <b>3</b>–<b>5</b>). However, when these substituents were located at the meta position (compounds <b>20</b> (Cl), <b>22</b> (OH), and <b>23</b> (CH<sub>3</sub>)), a significant enhancement of IMAO-B potency was observed, with the exception of the <i>m</i>-bromine derivative (<b>21</b>), for which no potency change was observed. The type and position of substituents had a noteworthy effect on MAO-B inhibitory activity. In particular, the presence of a <i>m</i>-chlorine substituent at the aromatic exocyclic ring remarkably enhanced IMAO-B potency, with chromone <b>20</b> (IC<sub>50</sub> = 0.40 nM and SI > 250 000) emerging as the most potent and selective derivative.</div><div class="NLM_p">Additional studies were performed with chromone carboxamides in which the exocyclic ring was derivatized with two or three chlorine or methyl substituents. However, the low solubility of the corresponding derivatives (compounds <b>24</b> and <b>25</b>) precluded their biological evaluation. Thus, the biological screening was only performed with the dimethyl (compounds <b>26</b> and <b>27</b>) and trimethyl (compound <b>28</b>) derivatives. Compound <b>27</b> (IC<sub>50</sub> = 0.67 nM and SI > 149 254) displayed a notorious increase of MAO-B potency and selectivity when compared with compound <b>4</b> (IC<sub>50</sub> = 8.00 nM and SI > 1250), due to the introduction of a <i>m</i>-methyl substituent. However, when the same substituents were located at ortho and meta positions (compound <b>26</b>), a significant decrease of potency and selectivity (IC<sub>50</sub> = 579 nM and a SI of 17) was observed. For compound <b>28</b>, with a third 5′-methyl group, a decrease on IMAO-B activity was also observed (IC<sub>50</sub> = 31.61 nM).</div><div class="NLM_p last">SAR studies pointed that chromone-3-phenylcarboxamides with a <i>m</i>-chlorine substituent (<b>20</b>) or a 3′,4′-dimethyl substituent (compound <b>27</b>) presented IMAO-B IC<sub>50</sub> values within the picomolar range. Both compounds <b>20</b> (IC<sub>50</sub> = 0.40 nM, SI > 250 000) and <b>27 (</b>IC<sub>50</sub> = 0.67 <i>p</i>M, SI > 149 254) showed respectively a 42- and 25-fold increase in inhibitory potency when compared to (<i>R</i>)-(−)-deprenyl, a 123- and 74-fold increase compared to rasagiline, and finally, a 57- and 34-fold increase compared to safinamide.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effect of the Spacer between the Chromone and Exocyclic Aromatic Ring</h4><div class="NLM_p last">The insertion of a methyl group in the amide spacer completely abolished MAO inhibitory activity (compound <b>2</b> vs <b>29</b>). Similarly, the replacement of the amide nitrogen with oxygen (compound <b>4</b> vs <b>30</b>) caused a marked decrease of IMAO-B activity from 8.00 nM (compound <b>4</b>) to 2038 nM (compound <b>30</b>). A comparable outcome was observed when the nitrogen was replaced by sulfur (compound <b>4</b> vs <b>31</b>), with 67-fold decrease on IMAO-B activity observed for compound <b>31</b> (IC<sub>50</sub> = 538 nM). This outcome suggests the inexorable significance of hydrogen bonding with the residues in the enzyme’s active pocket. The importance of the carbonyl moiety was then subsequently explored. First, an exchange on the carbonyl and nitrogen group position (compound <b>4</b> vs <b>34</b>) was performed and the IMAO activity evaluated: although the compound was still active, a 12-fold decrease on IMAO-B activity (IC<sub>50</sub> = 102 nM) was observed. As the results obtained so far indicated the importance of the spatial position of the amide group for the observed IMAO activity, a subsequent structural modification was performed in which the carbonyl group was removed (compound <b>36</b>). Biological screening of <b>36</b> showed that the presence of the amine yielded an active IMAO-B. A 71-fold decrease in inhibitory potency was observed (IC<sub>50</sub> = 568 nM), suggesting that the carbonyl moiety is also a very important structural requirement to establish the appropriate interactions with the target residues. To further characterize the importance of the location of the carboxamide spacer, a vinylic spacer between the pyrone ring and the carboxamide function of the chromone-3-phenylcarboxamide was introduced (compound <b>38</b>), leading to complete loss of MAO inhibitory activity. The same effect was observed when <i>p</i>-chlorine (compound <b>39</b>) or <i>p</i>-methyl (compound <b>40</b>) substituents were placed in the exocyclic aromatic ring and with the introduction of a 3′,4′-dimethyl substituent (compound <b>41</b>). The existence of a vinylic spacer may lead to steric constraints in the MAO-B pocket and, consequently, an unfavorable effect on activity. Moreover, the data reinforce the hypothesis established in our previous work, in which the carboxamide function linked directly to the pyrone ring ensured a key role in the ligand–enzyme complex.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The vinylic spacer present in compounds <b>38</b>–<b>41</b> may displace the carboxamide function from the appropriate binding site, leading to complete loss of MAO inhibitory activity.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Evaluation of Druglike Properties</h3><div class="NLM_p">The 10 most potent and selective IMAO-B (compounds <b>3</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>15</b>, <b>17</b>, <b>20</b>, <b>21</b>, <b>22</b>, and <b>27</b>) were selected and their druglike properties calculated (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The selection criteria was an IC<sub>50</sub> toward human MAO-B of <12 nM and selectivity higher than 1000-fold for MAO-B over MAO-A. Remarkably, all the selected compounds were more potent <i>h</i>MAO-B inhibitors than the standard inhibitors. The calculated physicochemical parameters include molecular weight (MW), number of heavy atoms (<i>N</i>), partition coefficient (clogP), topological polar surface area (tPSA in Å<sup>2</sup>), number of hydrogen acceptors (HBA), number of hydrogen donors (HBD), and number of rotatable bonds (<i>n</i><sub>rotb</sub>) (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In addition, the following multiparameter scores were also calculated: ligand-lipophilicity efficiency<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (LLE), blood (plasma)–brain partitioning<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (log BB), and absorption, distribution, metabolism, excretion, and toxicity (ADMET) efficiency index<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (AEI) (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The same parameters were calculated for the MAO-B standard inhibitors selegiline, safinamide, and rasagiline (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Druglike Properties of Selected Chromones and MAO-B Standard Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MW<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>N</i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">clogP<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA (Å<sup>2</sup>)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HBA<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HBD<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i><sub>rotb</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LLE</th><th class="colsep0 rowsep0" align="center" char=".">log BB</th><th class="colsep0 rowsep0" align="center" char=".">AEI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">299.71</td><td class="colsep0 rowsep0" align="char" char=".">8.54</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.23</td><td class="colsep0 rowsep0" align="char" char=".">–0.236</td><td class="colsep0 rowsep0" align="char" char=".">8.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">279.30</td><td class="colsep0 rowsep0" align="char" char=".">8.10</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.08</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.02</td><td class="colsep0 rowsep0" align="char" char=".">–0.271</td><td class="colsep0 rowsep0" align="char" char=".">8.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">344.16</td><td class="colsep0 rowsep0" align="char" char=".">8.94</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.45</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.49</td><td class="colsep0 rowsep0" align="char" char=".">–0.214</td><td class="colsep0 rowsep0" align="char" char=".">9.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">391.16</td><td class="colsep0 rowsep0" align="char" char=".">7.94</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.72</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4.22</td><td class="colsep0 rowsep0" align="char" char=".">–0.173</td><td class="colsep0 rowsep0" align="char" char=".">7.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">293.32</td><td class="colsep0 rowsep0" align="char" char=".">8.48</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">3.55</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4.93</td><td class="colsep0 rowsep0" align="char" char=".">–0.199</td><td class="colsep0 rowsep0" align="char" char=".">8.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">344.16</td><td class="colsep0 rowsep0" align="char" char=".">8.99</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.40</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.59</td><td class="colsep0 rowsep0" align="char" char=".">–0.222</td><td class="colsep0 rowsep0" align="char" char=".">9.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">299.71</td><td class="colsep0 rowsep0" align="char" char=".">9.39</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.29</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6.10</td><td class="colsep0 rowsep0" align="char" char=".">–0.239</td><td class="colsep0 rowsep0" align="char" char=".">10.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">344.16</td><td class="colsep0 rowsep0" align="char" char=".">8.88</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.42</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.46</td><td class="colsep0 rowsep0" align="char" char=".">–0.219</td><td class="colsep0 rowsep0" align="char" char=".">9.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">281.27</td><td class="colsep0 rowsep0" align="char" char=".">8.76</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">2.13</td><td class="colsep0 rowsep0" align="char" char=".">79.54</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6.63</td><td class="colsep0 rowsep0" align="char" char=".">–0.714</td><td class="colsep0 rowsep0" align="char" char=".">8.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">293.32</td><td class="colsep0 rowsep0" align="char" char=".">9.17</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">3.46</td><td class="colsep0 rowsep0" align="char" char=".">59.31</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.71</td><td class="colsep0 rowsep0" align="char" char=".">–0.213</td><td class="colsep0 rowsep0" align="char" char=".">9.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rasagiline</td><td class="colsep0 rowsep0" align="char" char=".">171.24</td><td class="colsep0 rowsep0" align="char" char=".">7.30</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">2.10</td><td class="colsep0 rowsep0" align="char" char=".">12.03</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">5.20</td><td class="colsep0 rowsep0" align="char" char=".">0.280</td><td class="colsep0 rowsep0" align="char" char=".">43.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">safinamide</td><td class="colsep0 rowsep0" align="char" char=".">302.35</td><td class="colsep0 rowsep0" align="char" char=".">7.64</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">2.91</td><td class="colsep0 rowsep0" align="char" char=".">64.36</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">4.73</td><td class="colsep0 rowsep0" align="char" char=".">–0.371</td><td class="colsep0 rowsep0" align="char" char=".">7.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-(−)-deprenyl</td><td class="colsep0 rowsep0" align="char" char=".">187.29</td><td class="colsep0 rowsep0" align="char" char=".">7.77</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">2.64</td><td class="colsep0 rowsep0" align="char" char=".">3.24</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">5.13</td><td class="colsep0 rowsep0" align="char" char=".">0.492</td><td class="colsep0 rowsep0" align="char" char=".">158.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CNS<sup>+</sup> drugs<a onclick="showRef(event, 'ref21 ref22 ref23 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref26">(21-23, 26)</a></td><td class="colsep0 rowsep0" align="char" char="."><450</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."><60–70</td><td class="colsep0 rowsep0" align="char" char="."><7</td><td class="colsep0 rowsep0" align="char" char="."><3</td><td class="colsep0 rowsep0" align="char" char="."><8</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">≥−1</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">MW, molecular weight; <i>N</i>, number of heavy atoms; clog P, calculated logarithm of the octanol–water partition coefficient; HBA, number of hydrogen acceptors; HBD, number of hydrogen donors; <i>n</i><sub>rotb</sub>, number of rotatable bonds; LLE, ligand-lipophilicity efficiency; log BB, logarithm of the ratio of the concentration of a drug in the brain and in the blood; AEI, ADMET efficiency index.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Properties calculated using Cheminformatics software [<a href="http://www.molinspiration.com" class="extLink">http://www.molinspiration.com</a>].</p></div></div></div><div class="NLM_p">Overall, the selected chromones were in line with general druglikeness requirements, namely, concerning the well-known rule-of-5.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Additionally, they exhibited clogP and tPSA values within the optimal range for oral bioavailability and blood–brain barrier (BBB) permeability (log <i>P</i> = 2–4, MW < 400, and tPSA = 50–90 Å<sup>2</sup>).<a onclick="showRef(event, 'ref21 ref22 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref24 ref25">(21, 22, 24, 25)</a> With the exception of compounds <b>7</b> and <b>15</b>, the multiparameter score LLE<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> obtained for all derivatives was within the optimal range for suitable drug candidates (5 < LLE < 7).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Chromones <b>20</b>, <b>22</b>, and <b>27</b> (LLE ≥ 6) may be suitable candidates for in vivo studies. Another key measurement is the prediction of BBB permeability properties, as determined by the log BB, which is the ratio of the steady-state concentrations of the drug in the brain and in the blood. Compounds with log BB below −1 are poorly distributed to the brain and are unlikely to function as effective CNS drugs.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> All chromone derivatives depicted on <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> displayed log BB > −1, pointing toward potential BBB permeability. Incorporating the contribution of drug-transporters, the AEI score links lipophilic efficiency and ADMET properties. It has been suggested that AEI values over 7 identify compounds with improved ADMET properties.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In line with the AEI score calculated for the new chiral IMAO-B safinamide, all the selected chromones displayed AEI > 7.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">Overall, the selected chromones presented druglike properties similar to those of the standard inhibitor safinamide. Moreover, rasagiline and (<i>R</i>)-(−)-deprenyl have outlier behavior for a significant number of parameters, including <i>N</i>, tPSA, log BB, and AEI (see <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Evaluation of Enzyme-Inhibition Mechanism</h3><div class="NLM_p">To examine the inhibition mechanism of the most promising <i>h</i>MAO-B inhibitors (compounds <b>20</b> and <b>27</b>), kinetic experiments were performed. For this purpose, the initial rates of the MAO-B-catalyzed oxidation of <i>p</i>-tyramine at five different substrate concentrations, in the absence or presence of the selected chromone inhibitors at different concentrations, were measured. The results are depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Graphical analyses of the reciprocal Lineweaver–Burk plots allowed the determination of Michaelis–Menten reaction kinetic parameters (Michaelis constant <i>K</i><sub>m</sub> and maximum velocity <i>V</i><sub>max</sub>). Concerning compound <b>20</b>, it was found that the <i>V</i><sub>max</sub> remained unchanged while <i>K</i><sub>m</sub> increased. The Lineweaver–Burk plots for different concentrations of <b>20</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) were linear and intersected at the <i>y</i>-axis, indicating that this compound acted as a competitive IMAO-B. As for compound <b>27</b>, the <i>K</i><sub>m</sub> remained almost constant at different concentrations of the inhibitor whereas <i>V</i><sub>max</sub> decreased. The Lineweaver–Burk plots obtained for different concentrations of compound <b>27</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B) displayed a series of converging lines on the same point of the <i>x</i>-axis (1/[S]), profiling a noncompetitive inhibition mechanism.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic studies on the mechanism of <i>h</i>MAO-B inhibition by chromones <b>20</b> (A) and <b>27</b> (B). The effect of the inhibitors on the enzyme was determined from the double reciprocal plot of 1/rate (1/<i>V</i>) versus 1/substrate concentration in the presence of varying concentrations of the inhibitors. The <i>K</i><sub>i</sub> values were calculated by the intersection of the curves obtained by plotting 1/<i>V</i> versus the inhibitor concentration for each substrate concentration (Dixon plots insets in the top left).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From the Dixon plots, obtained from the replots of the slopes of the Lineweaver–Burk plots vs inhibitor concentrations (upper left corner), the <i>h</i>MAO-B inhibition binding affinities, determined as inhibition constants (<i>K</i><sub>i</sub>), were calculated. Chromones <b>20</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) and <b>27</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B) displayed <i>K</i><sub>i</sub> values of 0.79 and 0.67 nM, respectively. The estimated <i>K</i><sub>i</sub> values correlated well with the inhibition mechanism suggested by the kinetic experiments: compound <b>20</b> (IC<sub>50</sub> = 0.40 nM) displayed IC<sub>50</sub> and <i>K</i><sub>i</sub> values slightly different but within the picomolar range, and compound <b>27</b> (IC<sub>50</sub> = 0.67 nM), as a noncompetitive inhibitor, showed a <i>K</i><sub>i</sub> equal to its IC<sub>50</sub>. Compound <b>27</b> can bind to the allosteric site distorting the 3D tertiary structure of the enzyme.</div><div class="NLM_p">The reversibility of MAO-B inhibition by chromones <b>20</b> and <b>27</b> was then assessed by time-dependent inhibition studies. The behavior of standard irreversible ((<i>R</i>)-(−)-deprenyl and rasagiline) and reversible (safinamide) inhibitors was also evaluated under the same experimental conditions. <i>h</i>MAO-B activity (% of control) was measured along a 60 min incubation with the enzyme inhibitors (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent inhibition of recombinant human MAO-B by standard compounds (<i>R</i>)-(−)-deprenyl (50 nM), safinamide (40 nM), and rasagiline (200 nM) (A) and test compounds <b>20</b> (0.7 nM) and compound <b>27</b> (2 nM) (B). The remaining activity was expressed as % of activity. Data are the mean ± SD of three different experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The analysis of time-dependent enzyme inhibition studies performed with the irreversible inhibitors (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) showed that the enzyme residual activity decayed continuously after the first 15 min of incubation, which is consistent with irreversible enzymatic inhibition. In the case of the reversible inhibitor safinamide (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) an enhancement on enzymatic activity was observed along the analysis time. The same behavior was observed for chromones <b>20</b> and <b>27</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B), which points toward reversible MAO-B inhibition.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Modeling Studies</h3><div class="NLM_p">For the <i>h</i>MAOs binding modes of the most potent inhibitors, molecular modeling studies were carried out. Docking experiments were performed for compounds <b>20</b> and <b>27</b> with respect to <i>h</i>MAO-A and <i>h</i>MAO-B theoretical receptor models (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Both targets were recognized by the chromone based inhibitors by means of two opposite binding modes: (a) with the chromone scaffold directed to the flavin adenine dinucleotide (FAD) cofactor (BMA) or (b) toward the entrance gorge (BMB). Excluding <b>27</b> into the <i>h</i>MAO-A, whose BMB was predicted as best pose, all best ranked complexes reported a BMA ligand accommodation. The graphical inspection of all sampled poses revealed BMA and BMB of <b>20</b> and <b>27</b> in both <i>h</i>MAOs (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">Table S1</a>, <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). All available docking score functions were in agreement with the experimentally observed <i>h</i>MAO-B selectivity. However, no correlation was observed comparing the different affinities of compounds <b>20</b> and <b>27</b> . Actually, even if docking simulation suggested for both compounds a similar affinity with respect to the same target, <b>27</b> was predicted as more active than <b>20</b>. With the aim to progress in our analysis, ligand free targets (LF), the best poses (TC) of <b>20</b> and <b>27</b> in both targets, and the top ranked configuration opposite (SC) the corresponding TC were submitted to explicit water solvent molecular dynamics simulation (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">Table S1, Figure S1</a>, <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). First, the number of solvent water molecules available into the LF active sites and displaced by ligands TC and SC recognition was evaluated taking into account the molecular dynamics (MD) starting structures (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Number of <i>h</i>MAOs Active Sites Water Molecules Displaced by Compounds <b>20</b> and <b>27</b> Recognition in MD Starting Structures</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">recognition</th><th class="colsep0 rowsep0" align="center" char=".">displaced waters</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h</i>MAO-A</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">TC</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">TC</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h</i>MAO-B</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">TC</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">TC</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr></tbody></table></div></div><div class="NLM_p">Such a preliminary analysis, and according to experimental selectivity data, addressed a desolvation penalty to <i>h</i>MAO-A recognition. Actually, both inhibitor binding modes always required the displacement of a larger number of water molecules in <i>h</i>MAO-A with respect to <i>h</i>MAO-B. Then, the perturbations of <i>h</i>MAOs conformational properties were investigated by comparing MD generated trajectories of the targets-inhibitors complexes with respect to the corresponding target ligand free (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). The resulting rmsd matrix (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">Figure S2, Supporting Information</a>) attained for both inhibitors clearly showed wider <i>h</i>MAO-A than <i>h</i>MAO-B distortions. Taking into account that previous observation did not appear strictly dependent from the binding mode, an involvement of ligand steric hindrance in the isoform selectivity could be suggested. In fact, <i>h</i>MAO-A and <i>h</i>MAO-B active sites show similar primary structure but the former exhibits a monopartite substrate cavity, whereas the second one has a larger and bipartite binding cleft. The differences in terms of shape and volume could reduce the <i>h</i>MAO-B perturbation induced by our ligands recognition. With the aim to understand the role of the chromone inhibitors exocyclic aromatic nucleous substituents and their contribution to the target binding, a graphical inspection of MD trajectories was performed (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). This approach disclosed the favorable effect of the solvent in target recognition. In all trajectories, compounds <b>20</b> and <b>27</b> established stable water bridged hydrogen bonds to the <i>h</i>MAOs. In the case of compound <b>20</b> the water bridges involved also chlorine atom located on the exocyclic aromatic substituent. Such an atom also revealed target direct halogen bonds. Moreover, the MD frames graphical inspection highlighted a key role of stacking in complexes stabilization. In <i>h</i>MAO-A, Tyr407 established a π–π interaction with both TC and SC ligand orientation. The same contribution was also observed for <i>h</i>MAO-A Phe208 and, with lower frequency, for Tyr444. In <i>h</i>MAO-B, solvent molecules improved the ligands recognition more remarkably than in <i>h</i>MAO-A: water bridges between chromone moiety and Tyr435 or Phe102 or between amide sp<sup>2</sup> oxygen and Thr201 were observed in <b>20</b> TC and <b>27</b> SC, respectively. Notably, the compound <b>20</b> SC binding mode in <i>h</i>MAO-B showed a wide interaction network involving isoform exclusive residues: the ligand established hydrogen bond to Cys172 and stacking contacts to Tyr326 and Phe208 that in <i>h</i>MAO-A are replaced by Asn181, Ile335, and Ile199 respectively. Moreover during the MD simulation a water bridge was underlined between compound <b>20</b> chlorine atom and Tyr188 side chain.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Last MD trajectory frames of <b>20</b> and <b>27</b> interacting with <i>h</i>MAO-A and <i>h</i>MAO-B. Ligands are depicted in polytube. FAD cofactor is depicted in spacefill, and ligand interacting residues are in wireframe and water molecules in ball and sticks notation. Chemical structures are CPK color compliant. Cyan, purple, or yellow dotted lines represent stacking contacts, halogen bonds, or hydrogen bonds, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>27</b> reported similar interactions with respect to <b>20</b>: stacking contacts were observed with <i>h</i>MAO-B Tyr326 and Ile199. Probably due to its steric hindrance, larger than <b>20</b>, and due to the lack of the halogen atom, its <i>h</i>MAO-B recognition was less stable and its location within the active site was less deep preventing the hydrogen bond to Cys172.</div><div class="NLM_p last">Overall, the acquired data pointed out that chromone-3-phenylcarboxamides should not be considered as pan-assay interference compounds.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In fact, they are not MAO promiscuous ligands, as they behaved as selective MAO-B inhibitors with absent or negligible MAO-A activity. Furthermore, as shown for the most promising chromones, they did not behave as covalent inhibitors, since MAO-B inhibition was a reversible process. Furthermore, a good correlation between biological data and molecular docking experiences was attained.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Evaluation of the Cytotoxicity</h3><div class="NLM_p">The cytotoxicity of the most promising compounds <b>20</b> and <b>27</b> was evaluated by the determination of the cellular viability in human neuroblastoma cells (SH-SY5Y cell line), after 24 h incubation period and at two different concentrations (1 μM and 10 μM). Cellular viability was estimated using the methylthiazolyldiphenyltetrazolium bromide (MTT) reduction and the neutral red (NR) uptake assays. Metabolically active cells reduce MTT to formazan, which can be spectrophotometrically quantified, providing a direct measure of mitochondrial function.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The NR uptake assay is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes, thus providing a quantitative estimation of the number of viable cells in culture. Control experiments were performed for both viability end points by adding vehicle (serum free medium with 0.1% DMSO) instead of the compound solution. The results obtained are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. In the MTT reduction assay, compound <b>20</b> caused a significant decrease on cellular viability, when compared to control groups (101.6 ± 11.7%), for both concentrations (43.70 ± 5.98% at 10 μM and 64.31 ± 5.96% at 1 μM, <i>p</i> < 0.001) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). For compound <b>27</b> no significant decrease on cellular viability was detected at 1 μM and only a slight decrease on the cellular viability was observed at 10 μM (74.55 ± 7.08%, <i>p</i> < 0.01) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). However, no significant decrease of the cellular viability for both compoundś concentrations was observed when considering the NR uptake end point (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0007.jpeg" id="GRAPHIC-d656e2303-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell viability of human neuroblastoma SH-SY5Y cells after a 24 h exposure to chromones <b>20</b> and <b>27</b> at 1 and 10 μM as determined in the MTT reduction (A) and the NR uptake (B) assays. Untreated cells were used as control: (∗∗) <i>p</i> < 0.01 and (∗∗∗) <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the main effects were observed in the MTT reduction assay, the preliminary toxicological screening under the current experimental conditions points toward potential effects of <b>20</b> on mitochondrial function even at low concentrations (1 μM), which may be indicative of a potential drug-induced toxicity. Compound <b>27</b> showed only a mild mitochondrial effect at the highest concentration, suggesting a wider safety window.</div><div class="NLM_p last">Overall, the pharmacological and toxicological data acquired so far sustain the project progression wherein additional preclinical studies will be performed.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We successfully reported the optimization of the <i>N</i>-phenylchromone-3-carboxamide scaffold for the development of selective and reversible MAO-B inhibitors with subnanomolar potency. Structural optimization and SAR studies strengthen the importance of the amide spacer and the direct linkage of the carbonyl group to the γ-pyrone ring. While <i>o</i>-subsituents in the exocyclic ring generally led to a decrease on inhibitory potency, the presence of substituents in meta and para positions significantly enhanced MAO-B inhibition. The most potent and selective derivatives were <i>N</i>-(3′-chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>20</b>) (MAO-B IC<sub>50</sub> = 0.40 nM), a competitive IMAO-B, and <i>N</i>-(3′,4′-dimethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>27</b>) (MAO-B IC<sub>5</sub>0 = 0.67 nM), a noncompetitive IMAO-B. Both acted as reversible MAO-B inhibitors with remarkable potency within the subnanomolar range and showed a druglike profile similar to that of standard inhibitor safinamide. Computational docking studies provided insights into the inhibitors’ interaction with the enzyme binding site and a rationale for their high potency. Compound <b>27</b> can be highlighted due to its wide safety range, as determined by preliminary cytotoxicity screenings in human neuroblastoma SH-SY5Y cells. Due to its appropriate physicochemical profile, which points toward BBB permeability, compound <b>27</b> is a valid candidate for subsequent animal studies and for the development of promising drug candidates for the therapy of neurodegenerative diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry. Reagents and General Conditions</h3><div class="NLM_p">Chromone-3-carboxylic acid, 3-formylchromone, benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP), pyridine, malonic acid, potassium carbonate, sodium sulfate, <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), dimethylformamide (DMF), 1,8-diazabicycloundec-7-ene (DBU), phosphorus oxychloride (POCl<sub>3</sub>), and aniline and its derivatives were purchased from Sigma-Aldrich Química S.A. (Sintra, Portugal). All other reagents and solvents were pro analysis grade and were acquired from Carlo Erba Reagents and Scharlab and were used without additional purification.</div><div class="NLM_p">Thin-layer chromatography (TLC) was carried out on precoated silica gel 60 F254 (Merck) with layer thickness of 0.2 mm. For analytical control the following systems were used: ethyl acetate/petroleum ether, ethyl acetate/methanol, chloroform/methanol, diethyl acetate in several proportions. The spots were visualized under UV detection (254 and 366 nm) and iodine vapor. Flash chromatography was performed using silica gel 60, 0.2–0.5 or 0.040–0.063 mm (Carlo Erba Reagents). Following the workup, the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>. Solutions were decolorized with activated charcoal, when necessary. The recrystallization solvents were ethyl acetate, dichloromethane, or ethyl ether/<i>n</i>-hexane. Solvents were evaporated in a Buchi rotavapor.</div><div class="NLM_p last">The purity of the final products (>97% purity) was verified by high-performance liquid chromatography (HPLC) equipped with a UV detector. Chromatograms were obtained in an HPLC/DAD system, a Jasco instrument (pumps model 880-PU and solvent mixing model 880-30, Tokyo, Japan), equipped with a commercially prepacked Nucleosil RP-18 analytical column (250 mm × 4.6 mm, 5 μm, Macherey-Nagel, Duren, Germany) and UV detection (Jasco model 875-UV) at the maximum wavelength of 254 nm. The mobile phase consisted of a methanol/water or acetonitrile/water (gradient mode, room temperature) at a flow rate of 1 mL/min. The chromatographic data were processed with a Compaq computer, fitted with CSW 1.7 software (DataApex, Czech Republic).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Apparatus</h3><div class="NLM_p last">NMR data were acquired, at room temperature, on a Brüker AMX 400 spectrometer operating at 400.15 MHz for <sup>1</sup>H and 100.62 MHz for <sup>13</sup>C. Chemical shifts were expressed in δ (ppm) values relative to tetramethylsilane (TMS) as internal reference; coupling constants (<i>J</i>) were given in Hz. Assignments were also made from DEPT (distortionless enhancement by polarization transfer) (underlined values). Electron impact mass spectrometry (EI-MS) was carried out on a VG AutoSpec instrument; the data were reported as <i>m</i>/<i>z</i> (% of relative intensity of the most important fragments). Microwave-assisted synthesis was performed in a Biotage initiator microwave synthesizer. Melting point data were obtained with Stuart Scientific melting point SMP1.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (A) Synthesis of Chromone Carboxamides (<b>2</b>–<b>9</b>, <b>11</b>–<b>29</b>), Ester (<b>30</b>), and Thioester (<b>31</b>)</h3><div class="NLM_p last">To a solution of chromone-3-carboxylic acid (<b>1</b>, 2.6 mmol) in DMF (4 mL) POCl<sub>3</sub> (2.6 mmol) was added. The mixture was stirred at room temperature for 30 min for the in situ formation of the acyl chloride. Then, an aromatic amine with the desired aromatic pattern (for compounds <b>2</b>–<b>9</b>, <b>11</b>–<b>29</b>), 4-methylphenol (for compound <b>30</b>), 4-methylbenzenethiol (for compound <b>31</b>) were added to the reaction. After 1–5 h, the mixture was diluted with dichloromethane (20 mL), washed with H<sub>2</sub>O (2 × 10 mL) and with saturated NaHCO<sub>3</sub> solution (2 × 10 mL). The organic phase was dried, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography and/or crystallization.</div></div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(4′-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>6</b>)</h3><div class="NLM_p last">The compound was obtained in 45% yield and recrystallized from DMF: mp 278–280 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.50–7.45 (2H, m, H3′, H5′), 7.55 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.0 Hz, H6), 7.61 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.68–7.63 (2H, m, H2′, H6′), 7.81 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.07 (1H, s, H2), 11.47 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 115.8 (C3), 117.1 (C4′), <u class="uu">118.6</u> (C8), <u class="uu">122.1</u> (C2′, C6′), 124.0 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">132.0</u> (C3′, C5′), <u class="uu">135.0</u> (C7), 137.1 (C1′), 156.2 (C8a), 160.8 (CONH), <u class="uu">162.9</u> (C2), 177.4 (C4). MS/EI <i>m</i>/<i>z</i> (%): 345 (M<sup>+</sup> + 2, 31), 343 (M<sup>+</sup>, 29), 173 (100), 121 (23).</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(4′-Iodophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>7</b>)</h3><div class="NLM_p last">The compound was obtained in 16% yield and recrystallized from DMF: mp 277–280 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.60–7.53 (3H, m, H6, H3′, H5′), 7.63 (1H, d, <i>J</i> = 8.5 Hz, H8), 7.72–7.66 (2H, m, H2′, H6′), 7.83 (1H, ddd, <i>J</i> = 8.6, 7.2, 1.6 Hz, H7), 8.36 (1H, dd, <i>J</i> = 8.0, 1.5 Hz, H5), 9.09 (1H, s, H2), 11.48 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 87.9 (C4′), 116.0 (C3), <u class="uu">118.7</u> (C8), <u class="uu">122.5</u> (C2′, C6′), <u class="uu">124.2</u> (C6), <u class="uu">126.4</u> (C5), 126.8 (C4a), <u class="uu">135.2</u> (C7), 137.2 (C1′), <u class="uu">138.1</u> (C3′, C5′), 156.3 (C8a), 161.0 (CONH), <u class="uu">163.1</u> (C2), 177.6 (C4). MS/EI <i>m</i>/<i>z</i> (%): 390 (M<sup>+</sup>, 93), 173 (100), 121 (25).</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(4′-Fluorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>8</b>)</h3><div class="NLM_p last">The compound was obtained in 23% yield and recrystallized from DMF: mp 254–257°C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.11–7.02 (2H, m, H3′, H5′), 7.55 (1H, ddd, <i>J</i> = 8.1, 7.3, 1.0 Hz, H6), 7.61 (1H, dd, <i>J</i> = 8.5, 0.5 Hz, H8), 7.75–7.67 (2H, m, H2′, H6′), 7.80 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.08 (1H, s, H2), 11.40 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">115.7</u> (d, <i>J</i><sub>FC</sub> = 22.5 Hz, C3′, C5′), 115.9 (C3), <u class="uu">118.6</u> (C8), <u class="uu">122.2</u> (d, <i>J</i><sub>FC</sub> = 7.8.5 Hz, C2′, C6′), 124.1 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.6</u> (C5), 134.1 (d, <i>J</i><sub>FC</sub> = 2.8 Hz, C1′), <u class="uu">135.0</u> (C7), 156.2(C8a), 159.5 (d, <i>J</i><sub>FC</sub> = 244.7 Hz, C4′), 160.7 (CONH), <u class="uu">162.9</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 384 (M<sup>+</sup> + 1, 31), 383 (M<sup>+</sup>, 94), 174 (43), 173 (100), 121 (81).</div></div><div id="sec4_2_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(4′-Mercaptophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>9</b>)</h3><div class="NLM_p last">The compound was obtained in 8% yield and recrystallized from AcOEt/<i>n</i>-hexane: mp >300 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 3.45 (1H, s, <i>J</i> = 8.8 Hz, SH), 7.30 (2H, d, <i>J</i> = 8.6 Hz, H3′, H5′), 7.58–7.52 (1H, m, H6), 7.60 (1H, d, <i>J</i> = 8.4 Hz, H8), 7.64 (2H, d, <i>J</i> = 8.6 Hz, H2′, H6′), 7.80 (1H, ddd, <i>J</i> = 8.6, 7.2, 1.6 Hz, H7), 8.33 (1H, dd, <i>J</i> = 8.0, 1.5 Hz, H5), 9.06 (1H, s, H2), 11.40 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 115.9 (C3), <u class="uu">118.6</u> (C8), <u class="uu">121.2</u> (C2′, C6′), 124.1 (C4a), 125.5 (C4′), <u class="uu">126.3</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">130.7</u> (C7), <u class="uu">134.9</u> (C3′, C5′), 136.3 (C1′), 156.2 (C8a), 160.7 (CONH), <u class="uu">162.9</u> (C2), 177.4 (C4). MS/EI <i>m</i>/<i>z</i> (%): 297 (M<sup>+</sup>, 100), 173 (97), 121 (64).</div></div><div id="sec4_2_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(4′-(Dimethylamino)phenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>11</b>)</h3><div class="NLM_p last">The compound was obtained in 47% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 244–246 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.95 (6H, s, 2xCH<sub>3</sub>), 6.76 (2H, d, <i>J</i> = 8.9 Hz, H3′, H5′), 7.53 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, Hz, H6), 7.64–7.57 (3H, m, H2′, H6′, H8), 7.78 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 9.07 (1H, s, H2), 11.17 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">41.0</u> (2 × CH<sub>3</sub>), <u class="uu">113.1</u> (C3′, C5′), 116.3 (C3), <u class="uu">118.5</u> (C8), <u class="uu">121.9</u> (C2′, C6′), 124.2 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.4</u> (C5, C1′), <u class="uu">134.7</u>, 156.2 (C8a, C4′), 160.1 (CONH), <u class="uu">162.5</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 309 (M<sup>+</sup> + 1, 26), 308 (M<sup>+</sup>, 100), 135 (59), 120 (20).</div></div><div id="sec4_2_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl (4-(4-Oxo-4<i>H</i>-chromene-3-carboxamide)phenyl)carbamate (<b>12</b>)</h3><div class="NLM_p last">The compound was obtained in 51% yield and recrystallized from AcOEt/<i>n</i>-hexane: mp 230–232 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 1.52 (9H, s, 3 × CH<sub>3</sub>), 6.47 (1H, s, OCONH), 7.41–7.33 (2H, m, H3′, H5′), 7.54 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.60 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.70–7.65 (2H, m, H2′, H6′), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.07 (1H, s, H2), 11.34 (1H, s, CONH). <sup>13</sup>C NMR(CDCl<sub>3</sub>) δ = <u class="uu">28.4</u> (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 80.5 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 116.1 (C3), <u class="uu">118.5</u> (C8), <u class="uu">119.1</u> (C3′,C5′), <u class="uu">121.2</u> (C2′,C6′), 124.1 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.5</u> (C5), 133.4 (C1′, C4′), <u class="uu">134.9</u> (C7), 152.8 (OCONH), 156.2 (C8a), 160.5 (CONH), <u class="uu">162.7</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 380 (M<sup>+</sup>, 45), 325 (87), 324 (98), 306 (60), 280 (100), 173 (98), 121 (98).</div></div><div id="sec4_2_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(4′-Ethynylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>13</b>)</h3><div class="NLM_p last">The compound was obtained in 28% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 240–242 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 3.06 (1H, s, CCH), 7.52–7.46 (2H, m, H3′, H5′), 7.55 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.0 Hz, H6), 7.60 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.75–7.69 (2H, m, H2′, H6′), 7.80 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.6 Hz, H5), 9.07 (1H, s, H2), 11.52 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 76.8 (C<u class="uu">C</u>H), 83.5 (<u class="uu">C</u>CH), 115.9 (C3), 117.8 (C4′), <u class="uu">118.6</u> (C8), <u class="uu">120.2</u> (C2′,C6′), 124.1 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">133.0</u> (C3′,C5′), <u class="uu">135.0</u> (C7), 138.5 (C1′), 156.2 (C8a), 160.8 (CONH), <u class="uu">163.0</u> (C2), 177.4 (C4). EI/ME <i>m</i>/<i>z</i> (%): 290 (M<sup>+</sup> + 1, 62), 289 (M<sup>+</sup>, 95), 174 (55), 173 (100), 121 (83).</div></div><div id="sec4_2_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(4′-Vinylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>14</b>)</h3><div class="NLM_p last">The compound was obtained in 33% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 238–241 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 5.21 (1H, dd, <i>J</i> = 10.9, 0.8 Hz, CHC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 5.71 (1H, dd, <i>J</i> = 17.6, 0.9 Hz, CHC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 6.70 (1H, dd, <i>J</i> = 17.6, 10.9 Hz, C<u class="uu">H</u>CH<sub>2</sub>), 7.46–7.38 (2H, m, H2′, H6′), 7.55 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.60 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.75–7.69 (2H, m, H3′, H5′), 7.80 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 9.08 (1H, s, H2), 11.44 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">113.2</u> (CH<u class="uu">C</u>H<sub>2</sub>), 116.1 (C3), <u class="uu">118.7</u> (C8), <u class="uu">120.6</u> (C2′,C6′), 124.2 (C4a), <u class="uu">126.4</u> (C6), <u class="uu">126.7</u> (C5), <u class="uu">127.0</u> (C3′,C5′), 134.8 (C4′), <u class="uu">135.1</u> (C7), <u class="uu">136.4</u> (<u class="uu">C</u>HCH<sub>2</sub>), 137.7 (C1′), 156.3 (C8a), 160.8 (CONH), <u class="uu">163.0</u> (C2), 177.6 (C4). MS/EI <i>m</i>/<i>z</i> (%): 291 (M<sup>+</sup>, 78), 173 (100), 121 (30).</div></div><div id="sec4_2_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(4′-Ethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>15</b>)</h3><div class="NLM_p last">The compound was obtained in 45% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 199–202 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 1.24 (3H, <i>t</i>, <i>J</i> = 7.6 Hz,CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">3</u></sub>), 2.64 (2H, <i>q</i>, <i>J</i> = 7.6 Hz, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 7.24–7.16 (2H, m, H3′, H5′), 7.54 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.60 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.68–7.62 (2H, m, H2′, H6′), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H8), 9.08 (1H, s, H2), 11.33 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">15.8</u> (CH<sub>2</sub><u class="uu">C</u>H<sub>3</sub>), <u class="uu">28.5</u> (<u class="uu">C</u>H<sub>2</sub>CH<sub>3</sub>), 116.3 (C3), <u class="uu">118.7</u> (C8), <u class="uu">120.8</u> (C2′,C6′), 124.3 (C4a), <u class="uu">126.4</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">128.5</u> (C3′,C5′), <u class="uu">135.0</u> (C7), 135.8 (C1′), 140.7 (C4′), 156.4 (C8a), 160.7 (CONH), <u class="uu">162.9</u> (C2), 177.6 (C4). MS/EI <i>m</i>/<i>z</i> (%): 293 (M<sup>+</sup>, 74), 278 (37), 173 (100), 121 (31).</div></div><div id="sec4_2_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(2′-Chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>16</b>)</h3><div class="NLM_p last">The compound was obtained in 53% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 240–242 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.08 (1H, ddd, <i>J</i> = 8.0, 7.5, 1.6 Hz, H4′), 7.30 (1H, ddd, <i>J</i> = 8.7, 1.5, 0.7 Hz, H5′), 7.44 (1H, dd, <i>J</i> = 8.0, 1.5 Hz, H3′), 7.53 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.59 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.78 (1H, ddd, <i>J</i> = 8.6, 7.2, 1.7 Hz, H7), 8.39 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 8.56 (1H, dd, <i>J</i> = 8.3, 1.5 Hz, H5′), 9.08 (1H, s, H2), 11.81 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 116.2 (C3), <u class="uu">118.6</u> (C8), <u class="uu">122.6</u> (C6), 124.1 (C4a), 124.2 (C2′), <u class="uu">125.0</u> (C5′), <u class="uu">126.6</u> (C5), <u class="uu">126.7</u> (C6′), <u class="uu">127.6</u> (C3′), <u class="uu">129.5</u> (C4′), <u class="uu">135.0</u> (C7′), 135.5 (C1′), 156.3 (C8a), 161.2 (CONH), <u class="uu">163.2</u> (C2), 177.4 (C4). MS/EI <i>m</i>/<i>z</i> (%): 301 (M<sup>+</sup>+2, 24), 299 (M<sup>+</sup>, 69), 265 (83), 264 (95), 265 (83), 174 (54), 173 (97), 121 (100).</div></div><div id="sec4_2_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(2′-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>17</b>)</h3><div class="NLM_p last">The compound was obtained in 36% yield and recrystallized from DMF: mp 186–189 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.02 (1H, ddd, <i>J</i> = 8.0, 7.4, 1.6 Hz, H4′), 7.39–7.29 (1H, m, H5′), 7.54 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.0 Hz, H6), 7.65–7.58 (2H, m, H8, H6′), 7.79 (1H, ddd, <i>J</i> = 8.6, 7.2, 1.7 Hz, H7), 8.40 (1H, dd, <i>J</i> = 8.0, 1.6 Hz, H5), 8.51 (1H, dd, <i>J</i> = 8.3, 1.5 Hz, H3′), 9.08 (1H, s, H2), 11.70 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = 114.4 (C3), 116.2 (C2′), <u class="uu">118.6</u> (C8), <u class="uu">123.2</u> (C6′), 124.3 (C2a), <u class="uu">125.6</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">126.7</u> (C5′), <u class="uu">128.2</u> (C4′), <u class="uu">132.8</u> (C3′), <u class="uu">135.0</u> (C7), 136.8 (C1′), 156.3 (C8a), 161.3 (CONH), <u class="uu">163.2</u> (C2), 177.3 (C4). MS/EI <i>m</i>/<i>z</i> (%): 345 (M<sup>+</sup> + 2, 26), 343 (M<sup>+</sup>, 27), 265 (58), 264 (100), 173 (69), 121 (38).</div></div><div id="sec4_2_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(2′-Hydroxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>18</b>)</h3><div class="NLM_p last">The compound was obtained in 31% yield and recrystallized from MeOH/CH<sub>2</sub>Cl<sub>2</sub>: mp 252–255 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 6.90–6.74 (1H, m, H5′), 7.02–6.90 (2H, m, H3′, H4′), 7.64 (1H, dd, <i>J</i> = 7.5, 7.5 Hz, H6), 7.82 (1H, d, <i>J</i> = 8.4 Hz, H8), 8.00–7.88 (1H, m, H7), 8.27 (1H, dd, <i>J</i> = 8.0, 1.6 Hz, H5), 8.44–8.31 (1H, m, H6′), 9.19 (1H, s, H2), 10.16 (1H, s, OH), 11.58 (1H, s, NH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ = <u class="uu">114.7</u> (C3′), 115.6 (C3), <u class="uu">118.8</u> (C8), <u class="uu">119.1</u> (C5′), <u class="uu">120.2</u> (C6), 123.6 (C4a), <u class="uu">124.1</u> (C4′), <u class="uu">125.7</u> (C6), 126.7 (C1′), <u class="uu">126.8</u> (C5), <u class="uu">135.4</u> (C7), 146.6 (C2′), 155.7 (C8a), 160.1 (CONH), <u class="uu">163.6</u> (C2), 176.6 (C4). MS/EI <i>m</i>/<i>z</i> (%): 281 (M<sup>+</sup>, 100), 173 (100), 121 (42).</div></div><div id="sec4_2_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(<i>o</i>-Tolyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>19</b>)</h3><div class="NLM_p last">The compound was obtained in 61% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 179–182 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.48 (3H, s, CH<sub>3</sub>), 7.08 (1H, ddd, <i>J</i> = 7.5, 7.5, 1.2 Hz, H4′), 7.28–7.21 (2H, m, H5′, H6′), 7.54 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.60 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.27 (1H, d, <i>J</i> = 8.1 Hz, H3′), 8.36 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 9.10 (1H, s, H2), 11.29 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): <u class="uu">18.4</u> (CH<sub>3</sub>), 116.4 (C3), <u class="uu">118.7</u> (C8), <u class="uu">122.1</u> (C6′), 124.3 (C4a), <u class="uu">124.7</u> (C5′), <u class="uu">126.5</u> (C6), <u class="uu">126.6</u> (C5), <u class="uu">126.8</u> (C4′), 128.5 (C2′), <u class="uu">130.5</u> (C3′), <u class="uu">135.0</u> (C7), 136.6 (C1′), 156.3 (C8a), 160.9 (CONH), <u class="uu">163.1</u> (C2), 177.7 (C4). MS/EI <i>m</i>/<i>z</i> (%): 279 (M<sup>+</sup>, 61) 260 (44), 173 (100), 121 (61).</div></div><div id="sec4_2_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(3′-Chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>20</b>)</h3><div class="NLM_p last">The compound was obtained in 40% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 239–242 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.21 (1H, ddd, <i>J</i> = 8.0, 2.1, 0.9 Hz, H4′), 7.42 (1H, dd, <i>J</i> = 8.1, 8.1 Hz, H5′), 7.57 (1H, ddd, <i>J</i> = 8.2, 2.0, 0.9 Hz, H6′), 7.66 (1H, ddd, <i>J</i> = 8.1, 7.1, 1.1 Hz, H6), 7.84 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.96 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 8.00 (1H, dd, <i>J</i> = 2.0, 2.0 Hz, H2′), 8.25 (1H, dd, <i>J</i> = 8.0, 1.3 Hz, H5), 9.20 (1H, s, H2), 11.40 (1H, s, NH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ = 115.5 (C3), <u class="uu">118.5</u> (C8), <u class="uu">118.8</u> (C6′), <u class="uu">119.5</u> (C2′), <u class="uu">123.4</u> (C6), 123.9 (C4a), <u class="uu">125.6</u> (C5), <u class="uu">126.8</u> (C4′), <u class="uu">130.7</u> (C5′), 133.3 (C3′), <u class="uu">135.5</u> (C7), 139.4 (C1′), 156.7 (C8a), 160.8 (CONH), <u class="uu">163.6</u> (C2), 176.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 301 (M<sup>+</sup> + 2, 42), 299 (M<sup>+</sup>, 85), 174 (29), 173 (100), 121 (70).</div></div><div id="sec4_2_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(3′-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>21</b>)</h3><div class="NLM_p last">The compound was obtained in 42% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 249–252 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.40–7.32 (2H, m, H4′, H5′), 7.63–7.59 (1H, m, H6′), 7.66 (1H, ddd, <i>J</i> = 8.1, 7.1, 1.1 Hz, H6), 7.84 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.96 (1H, ddd, <i>J</i> = 8.6, 7.1, 1.7 Hz, H7), 8.14 (1H, dd, <i>J</i> = 2.4, 1.4 Hz, H2′), 8.25 (1H, dd, <i>J</i> = 8.0, 1.3 Hz, H5), 9.19 (1H, s, H2), 11.38 (1H, s, NH). MS/EI <i>m</i>/<i>z</i> (%): 345 (M<sup>+</sup> + 2, 51), 343 (M<sup>+</sup>, 51), 173 (100), 121 (43).</div></div><div id="sec4_2_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(3′-Hydroxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>22</b>)</h3><div class="NLM_p last">The compound was obtained in 42% yield and recrystallized from DMF: mp 284–287 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 6.55 (1H, ddd, <i>J</i> = 8.1, 2.3, 0.7 Hz, H4′), 7.02 (1H, d, <i>J</i> = 8.2 Hz, H6′), 7.16 (1H, dd, <i>J</i> = 8.0, 8.0 Hz, H5′), 7.32 (1H, dd, <i>J</i> = 2.1, 2.1 Hz, H2′), 7.65 (1H, dd, <i>J</i> = 7.6 Hz, H6), 7.82 (1H d, <i>J</i> = 8.5 Hz, H8), 7.95 (1H, dd, <i>J</i> = 7.8, 7.8 Hz, H7), 8.25 (1H, d, <i>J</i> = 7.9 Hz, H5), 9.17 (1H, s, H2), 9.53 (1H, s, OH), 11.22 (1H, s, NH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ = <u class="uu">106.9</u> (C2′), <u class="uu">110.5</u> (C6′), <u class="uu">111.3</u> (C4′), 115.7 (C3), <u class="uu">118.8</u> (C8), 123.4 (C4a), <u class="uu">125.6</u> (C6), <u class="uu">126.7</u> (C5), <u class="uu">129.8</u> (C5′), <u class="uu">135.5</u> (C7), 139.0 (C1′), 155.7 (C8a), 157.9 (C3′), 160.2 (CONH), <u class="uu">163.4</u> (C2), 176.8 (C4). MS/EI <i>m</i>/<i>z</i> (%): 281 (M<sup>+</sup>, 100), 173 (98), 121 (47).</div></div><div id="sec4_2_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(<i>m</i>-Tolyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>23</b>)</h3><div class="NLM_p last">The compound was obtained in 45% yield and recrystallized from MeOH/CH<sub>2</sub>Cl<sub>2</sub>: mp 214–215 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.38 (3H, s, CH<sub>3</sub>), 6.98–6.94 (1H, m, H4′), 7.25 (1H, dd, <i>J</i> = 7.8 7.8 Hz, H5′), 7.62–7.52 (4H, m, H2′, H6′, H6, H8), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 9.07 (1H, s, H2), 11.35 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): <u class="uu">21.5</u> (CH<sub>3</sub>), 116.1 (C3), <u class="uu">117.7</u> (C6′), <u class="uu">118.5</u> (C8), <u class="uu">121.2</u> (C4′), 124.1 (C4a), <u class="uu">125.3</u> (C2′), <u class="uu">126.3</u> (C6), <u class="uu">126.5</u> (C5), <u class="uu">128.9</u> (C5′), <u class="uu">134.9</u> (C7), 137.9 (C3′), 138.9 (C1′), 156.2 (C8a), 160.7 (CONH), <u class="uu">162.8</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 279 (M<sup>+</sup>, 66), 173 (100), 121 (35).</div></div><div id="sec4_2_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(3′,4′-Dichlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>24</b>)</h3><div class="NLM_p last">The compound was obtained in 59% yield and recrystallized from DMF: mp >300 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.44 (1H, d, <i>J</i> = 8.7 Hz, H5′), 7.70–7.54 (3H, m, H6, H8, H6′), 7.84 (1H, ddd, <i>J</i> = 8.6, 7.2, 1.7 Hz, H7), 8.04 (1H, d, <i>J</i> = 2.4 Hz, H2′), 8.36 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.09 (1H, s, H2), 11.57 (1H, s, NH). MS/EI <i>m</i>/<i>z</i> (%): 337 (M<sup>+</sup> + 4, 30), 336 (M<sup>+</sup>+3, 30), 335 (M<sup>+</sup> + 2, 88), 334 (M<sup>+</sup> + 1, 45), 333 (M<sup>+</sup>, 100), 174 (57), 173 (94), 121 (98).</div></div><div id="sec4_2_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(3′,4′,5′-Trichlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>25</b>)</h3><div class="NLM_p last">The compound was obtained in 88% yield and recrystallized from DMF: mp 300–303 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 7.57 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.0 Hz, H6), 7.62 (1H, dd, <i>J</i> = 8.5, 0.5 Hz, H8), 7.83 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 7.88 (2H, s, H2′, H6′), 8.34 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.06 (1H, s, H2), 11.61 (1H, s, NH). EI/ME <i>m</i>/<i>z</i> (%): 371 (M<sup>+</sup> + 4, 14), 370 (M<sup>+</sup>+3, 7), 369 (M<sup>+</sup> + 2, 43), 368 (M<sup>+</sup> + 1, 8), 367 (M<sup>+</sup>, 45), 174 (20), 173 (100), 121 (46).</div></div><div id="sec4_2_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(2′,3′-Dimethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>26</b>)</h3><div class="NLM_p last">The compound was obtained in 26% yield and recrystallized from MeOH/CH<sub>2</sub>Cl<sub>2</sub>: mp 197–200 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.33 (3H, s, CH<sub>3</sub>), 2.34 (3H, s, CH<sub>3</sub>), 7.00 (1H, d, <i>J</i> = 7.5 Hz, H4′), 7.14 (1H, dd, <i>J</i> = 7.8, 7.8 Hz, H5′), 7.53 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.59 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.78 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 7.97 (1H, d, <i>J</i> = 8.1 Hz, H6′), 8.35 (1H, dd, <i>J</i> = 8.0, 1.3 Hz, H5), 9.08 (1H, s, H2), 11.21 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">13.8</u> (CH<sub>3</sub>), <u class="uu">20.7</u> (CH<sub>3</sub>), 116.2 (C3), <u class="uu">118.4</u> (C8), <u class="uu">120.7</u> (C6′), 124.1 (C4a), <u class="uu">125.8</u> (C5′), <u class="uu">126.2</u> (C4′), <u class="uu">126.4</u> (C6), <u class="uu">126.6</u> (C5), 127.8 (C2′), <u class="uu">134.8</u> (C7), 136.0 (C1′), 137.1 (C3′), 156.1 (C8a), 160.8 (CONH), <u class="uu">162.8</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 295 (M<sup>+</sup> + 3, 39) 294 (M<sup>+</sup> + 2, 50), 293 (M<sup>+</sup>, 65), 174 (52), 173 (40), 121 (100).</div></div><div id="sec4_2_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(3′,4′-Dimethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>27</b>)</h3><div class="NLM_p last">The compound was obtained in 23% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 233–236 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.25 (3H, s, CH<sub>3</sub>), 2.28 (3H, s, CH<sub>3</sub>), 7.12 (1H, d, <i>J</i> = 8.1 Hz, H5′), 7.48 (1H, dd, <i>J</i> = 8.1, 2.2 Hz, H6′), 7.56–7.50 (2H, m, H2′, H6), 7.59 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.79 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 8.34 (1H, dd, <i>J</i> = 8.0, 1.7 Hz, H5), 9.07 (1H, s, H2), 11.28 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">19.2</u> (CH<sub>3</sub>), <u class="uu">19.9</u> (CH<sub>3</sub>), 116.2 (C3), <u class="uu">118.0</u> (C8), <u class="uu">118.5</u> (C6′), <u class="uu">121.8</u> (C2′), 124.1 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.5</u> (C5), <u class="uu">130.0</u> (C5′), 132.8 (C4′), <u class="uu">134.8</u> (C7), 135.7 (C3′), 137.2 (C1′), 156.2 (C8a), 160.5 (CONH), <u class="uu">162.7</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 294 (M<sup>+</sup> + 1, 34), 293 (M<sup>+</sup>, 88,), 173 (100), 121 (62).</div></div><div id="sec4_2_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(3′,4′,5′-Trimethylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>28</b>)</h3><div class="NLM_p last">The compound was obtained in 32% yield and recrystallized from MeOH: mp 251–253 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.15 (3H, s, <i>J</i> = 7.0 Hz, CH<sub>3</sub>), 2.30 (6H, s, 2 × CH<sub>3</sub>), 7.40 (2H, s, H2′, H6′), 7.53 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.0 Hz, H6), 7.59 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.78 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 8.33 (1H, dd, <i>J</i> = 8.0, 1.4 Hz, H5), 9.06 (1H, s, H2), 11.22 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">15.0</u> (CH<sub>3</sub>), <u class="uu">20.7</u> (2xCH<sub>3</sub>), 116.2 (C3), <u class="uu">118.5</u> (C8), <u class="uu">119.7</u> (C2′, C6′), 124.2 (C4a), <u class="uu">126.3</u> (C6), <u class="uu">126.4</u> (C5), 131.4 (C1′), <u class="uu">134.8</u> (C7), 135.0 (C5, 137.1 (C3′, C5′), 156.2 (C8a), 160.4 (CONH), <u class="uu">162.7</u> (C2), 177.5 (C4). MS/EI <i>m</i>/<i>z</i> (%): 307 (M<sup>+</sup>, 42,), 253 (100), 183 (51), 173 (55).</div></div><div id="sec4_2_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-Methyl-<i>N</i>-phenyl-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>29</b>)</h3><div class="NLM_p last">The compound was obtained in 75% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 182–185 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 3.34 (3H, s, CH<sub>3</sub>), 7.17 (1H, <i>bs</i>, H4′), 7.28 (4H, bs, H2′, H3′, H5′, H6′), 7.45 (2H, dd, <i>J</i> = 6.2, 6.2 Hz, H6′), 7.58 (1H, d, <i>J</i> = 6.4 Hz, H8), 7.77 (1H, dd, <i>J</i> = 6.9, 6.9 Hz, H7), 7.92 (1H, bs, H8), 8.47 (1H, s, H2). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">36.9</u> (CH<sub>3</sub>), <u class="uu">118.5</u> (C8), 123.1 (C3), 123.4 (C4a), <u class="uu">125.1</u> (C6), <u class="uu">125.9</u> (C5), <u class="uu">126.9</u> (C2′, C6′), <u class="uu">127.3</u> (C4′), <u class="uu">129.0</u> (C3′, C5′), <u class="uu">134.6</u> (C7), 143.3 (C1′), 155.4 (C4a), <u class="uu">156.1</u> (C2), 163.1 (COON), 172.9 (C4). MS/EI <i>m</i>/<i>z</i> (%): 279 (M<sup>+</sup>, 72), 185 (21), 173 (100), 121 (67), 106.0 (38).</div></div><div id="sec4_2_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>O</i>-(<i>p</i>-Tolyl)-4-oxo-4<i>H</i>-chromene-3-carboxylate (<b>30</b>)</h3><div class="NLM_p last">The compound was obtained in 14% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 165–168 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.37 (3H, s, CH<sub>3</sub>), 7.13–7.09 (2H, m, H3′, H5′), 7.24–7.18 (2H, m, H2′, H6′), 7.50 (1H, ddd, <i>J</i> = 8.1, 7.2, 1.1 Hz, H6), 7.54 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.77–7.71 (1H, m, H7), 8.33 (1H, dd, <i>J</i> = 8.1, 1.5 Hz, H5), 8.85 (1H, s, H2). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">29.9</u> (CH<sub>3</sub>), 115.8 (C3), <u class="uu">118.2</u> (C8), <u class="uu">121.4</u> (C2′, C6′), 125.2 (C4a), <u class="uu">126.5</u> (C6), <u class="uu">126.7</u> (C5), <u class="uu">130.0</u> (C3′, C5′), <u class="uu">134.4</u> (C7), 135.8 (C4′), 148.1 (C1′), 155.7 (C8a), 162.0 (COO), <u class="uu">162.6</u> (C2), 173.2 (C4). MS/EI <i>m</i>/<i>z</i> (%): 280 (M<sup>+</sup>, 44), 173 (100), 121 (70).</div></div><div id="sec4_2_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>S</i>-(<i>p</i>-Tolyl)-4-oxo-4<i>H</i>-chromene-3-carbothioate (<b>31</b>)</h3><div class="NLM_p last">The compound was obtained in 26% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>/<i>n</i>-hexane: mp 155–158 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.43 (3H, s, CH<sub>3</sub>), 7.32–7.27 (2H, m, H2′, H6), 7.45–7.40 (2H, m,′ H3′, H5′), 7.59–7.52 (2H, m, H6, H8), 7.78 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.39 (1H, dd, <i>J</i> = 8.0, 1.5 Hz, H5), 8.71 (1H, s, H2). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ = <u class="uu">21.5</u> (CH<sub>3</sub>), <u class="uu">118.4</u> (C8), 121.4 (C3), 124.7 (C4a), 125.0 (C1′), <u class="uu">126.70</u> (C6), <u class="uu">126.72</u> (C5), <u class="uu">130.2</u> (C2′, C6′), <u class="uu">134.7</u> (C7), <u class="uu">135.0</u> (C3′, C5′), 140.0 (C4′), 155.8 (C8a), <u class="uu">160.8</u> (C2), 174.8 (C4), 187.8 (COS). MS/EI <i>m</i>/<i>z</i> (%): 296 (M<sup>+</sup>, 7), 173 (100), 121 (25).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (B) Synthesis of <i>N</i>-(4′-Aminophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide (<b>10</b>)</h3><div class="NLM_p last">To a solution of compound <b>12</b> (296 mg, 0.77 mmol) in dichloromethane (12 mL), trifluoroacetic acid (TFA) (2 mL) was added. After stirred 2 h at room temperature, the mixture was neutralized and washed with saturated NaHCO<sub>3</sub> solution. The organic phase was dried, filtered, and evaporated. The compound was obtained in 80% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>/<i>n</i>-hexane: mp 222–225 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 3.62 (2H, s, NH<sub>2</sub>), 6.75–6.66 (2H, m, H3′, H5′), 7.56–7.47 (3H, m, H2′, H6′, H6), 7.59 (1H, dd, <i>J</i> = 8.5, 0.6 Hz, H8), 7.78 (1H, ddd, <i>J</i> = 8.7, 7.2, 1.7 Hz, H7), 8.33 (1H, dd, <i>J</i> = 8.0, 1.5 Hz, H5), 9.06 (1H, s, H2), 11.18 (1H, s, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ = <u class="uu">115.6</u> (C3′, C5′), 116.3 (C3), <u class="uu">118.7</u> (C8), <u class="uu">122.3</u> (C2′, C6′), 124.3 (C4a), <u class="uu">126.4</u> (C6), <u class="uu">126.5</u> (C5), 129.7 (C1′), <u class="uu">134.9</u> (C7), 143.5 (C4′), 156.3 (C8a), 160.3 (CONH), <u class="uu">162.7</u> (C2), 177.6 (C4). MS/EI <i>m</i>/<i>z</i> (%): 281 (M<sup>+</sup> + 1, 57), 280 (M<sup>+</sup>, 100), 173 (94), 121 (64), 107 (65).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (C) Synthesis of 4′-Methyl-<i>N</i>-(4-oxo-4<i>H</i>-chromen-3-yl)benzamide (<b>34</b>)</h3><div class="NLM_p last">5-(2-Hydroxyethyl)-3,4-dimethylthiazolium iodide (94 mg, 0.62 mmol) and DBU (174 μL, 0.62 mmol) were added to a solution of 2-(cyanomethoxy)benzaldehyde (500 mg, 3.1 mmol) in anhydrous dichloromethane (30 mL) and under inert atmosphere. The reaction was stirred for 5 h. Then, DIPEA (2.1 mL, 12.4 mmol) was added followed by a solution of 4-methylbenzoic acid (422 mg, 3.1 mmol) and POCl<sub>3</sub> (289 μL, 3.1 mmol) in DMF (5 mL). After 2 h, the solution was washed with H<sub>2</sub>O (2 × 20 mL) and saturated with a NaHCO<sub>3</sub> solution (2 × 20 mL). The organic phase was dried, filtered, and evaporated. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/<i>n</i>-hexane 8:2). The compound was obtained in 13% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>/<i>n</i>-hexane: mp 203–206 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.44 (3H, s, CH<sub>3</sub>), 7.34–7.28 (2H, m, C3′, C5′), 7.44 (1H, ddd, <i>J</i> = 8.1, 7.1, 1.0 Hz, H6), 7.55 (1H, dd, <i>J</i> = 8.5, 0.5 Hz, H8), 7.72 (1H, ddd, <i>J</i> = 8.7, 7.1, 1.7 Hz, H7), 7.88–7.79 (2H, m, H2′, H6′), 8.29 (1H, dd, <i>J</i> = 8.0, 1.6 Hz, H5), 8.84 (1H, s, NH), 9.58 (1H, s, H2). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ = <u class="uu">21.7</u> (CH<sub>3</sub>), <u class="uu">118.7</u> (C8), 122.0 (C3), 124.9 (C4a), <u class="uu">125.0</u> (C6), <u class="uu">126.0</u> (C5), <u class="uu">127.4</u> (C2′, C4′), <u class="uu">129.7</u> (C3′, C4′), 130.9 (C1′), <u class="uu">134.1</u> (C7), 143.0 (C4′), <u class="uu">145.2</u> (C2), 156.0 (C8a), 165.6 (CONH), 172.2 (C4). MS/EI <i>m</i>/<i>z</i> (%): 279 (M<sup>+</sup>, 59), 118 (100), 91 (25).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (D) Synthesis of 3-((<i>p</i>-Tolylamino)methyl)-4<i>H</i>-chromen-4-one (<b>36</b>)</h3><div class="NLM_p last">To a solution of 3-formylchromone (<b>35</b>, 250 mg, 1.4 mmol) in dichloromethane (5 mL), <i>p</i>-toluidine (154 mg, 1.4 mmol) and Na(AcO)<sub>3</sub>BH (426 mg, 2 mmol) were added under inert atmosphere at room temperature. After 15 min, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (40 mL) and washed with saturated NaHCO<sub>3</sub> solution (2 × 10 mL). The organic phase was dried, filtered, and evaporated. The residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>). The compound was obtained in 61% yield and recrystallized from CH<sub>2</sub>Cl<sub>2</sub>: mp 165–168 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ = 2.25 (3H, s, CH<sub>3</sub>), 4.28 (2H, d, <i>J</i> = 1.0 Hz, CH<sub>2</sub>), 6.71–6.64 (2H, m, H2′, H6′), 7.04–6.99 (2H, m, H3′, H5′), 7.47–7.40 (2H, m, H6, H8), 7.68 (1H, ddd, <i>J</i> = 8.6, 7.1, 1.7 Hz, H7), 7.96 (1H, <i>t</i>, <i>J</i> = 1.0 Hz, H2), 8.25 (1H, ddd, <i>J</i> = 8.0, 1.7, 0.4 Hz, H5). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ = <u class="uu">20.6</u> (CH<sub>3</sub>), <u class="uu">41.5</u> (CH<sub>2</sub>), <u class="uu">114.4</u> (C2′, C6′), <u class="uu">118.3</u> (C8), 121.0 (C3), 123.9 (C4a), <u class="uu">125.3</u> (C6), <u class="uu">125.8</u> (C5), 128.4 (C4′), <u class="uu">130.0</u> (C3′, C5′), <u class="uu">133.9</u> (C7), 144.4 (C1′), <u class="uu">153.6</u> (C2), 156.7 (C8a), 178.2 (C4). EI/ME <i>m</i>/<i>z</i> (%): 266 (M<sup>+</sup> + 1, 138), 265 (M<sup>+</sup>, 100), 160 (25), 120 (76), 106 (58).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (E) Synthesis of (<i>E</i>)-4-oxo-4<i>H</i>-chromen-3-acrylic Acid (<b>37</b>)</h3><div class="NLM_p last">A mixture of 3-formylchromone (<b>35</b>, 1 mmol) and malonic acid (2 mmol) in the presence of pyridine (5 mL) was refluxed for 45 min with vigorous stirring. Upon completion, the mixture was cooled to room temperature, the pH adjusted to 1.0 with concentrated HCl, and the reaction was stirred for additional 30 min. The yellow colored solid was filtered, washed with 1 M HCl (2 × 20 mL), and dried. The compound was obtained in 93% yield and recrystallized from MeOH: mp 156–158 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.13 (1H, d, <i>J</i> = 16 Hz, H<sub>α</sub>), 7.44 (1H, d, <i>J</i> = 16 Hz, H<sub>β</sub>), 7.56 (1H, ddd, <i>J</i> = 7.4, 7.2, 0.8 Hz, H6), 7.71 (1H, dd, <i>J</i> = 8.8, 0.4 Hz, H8), 7.85 (1H, ddd, <i>J</i> = 7.4, 7.2, 0.8 Hz, H7), 8.14 (1H, dd, <i>J</i> = 8.8, 0.4 Hz, H5), 8.88 (1H, s, H2). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: <u class="uu">118.2</u> (C8), 118.6 (C3), 121.4 (C4a), <u class="uu">123.6</u> (C<sub>α</sub>), <u class="uu">125.5</u> (C6), <u class="uu">126.2</u> (C5), <u class="uu">134.7</u> (C7), <u class="uu">136.0</u> (C<sub>β</sub>), 155.2 (C8a), <u class="uu">159.9</u> (C2), 167.8 (COOH), 175.3 (CO). MS/EI <i>m</i>/<i>z</i> (%): 266 (M<sup>+</sup>, 8), 171 (100).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (F) Synthesis of Chromone Carboxamides with a Vinylic Spacer (<b>38</b>–<b>41</b>)</h3><div class="NLM_p last">Compound <b>37</b> (250 mg, 1.31 mmol) was dissolved in DMF (6 mL) and DIPEA (0.190 mL). The solution was cooled at 0 °C, and a solution of PyBOP (580 mg, 1.31 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was added. The mixture was stirred during 30 min. Then, the amine with the desired aromatic pattern (phenylamine, 4-methylphenylamine, 4-chlorophenylamine, or 3,4-dimethylphenylamine) (1.31 mmol) was added. The temperature was gradually increased to room temperature and the reaction kept under stirring for another 6 h. The mixture was then diluted with ethyl acetate (20 mL), washed with H<sub>2</sub>O (2 × 20 mL) and HCl 1 M. The organic phase was dried, filtered, and evaporated. The residues were purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/diethyl ether) and/or crystallization from ethyl acetate.</div></div><div id="sec4_2_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)<i>-N</i>-Phenyl-4-oxo-4<i>H</i>-chromen-3-acrylamide (<b>38</b>)</h3><div class="NLM_p last">The compound was obtained in 11% yield and recrystallized from AcOEt: mp 235–238 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.09–7.03 (1H, m, H4′), 7.35–7.30 (2H, m, H3′, H5′), 7.40 (1H, dd, <i>J</i> = 15.6 Hz, H<sub>β</sub>), 7.56 (1H, m, H6), 7.66 (1H, d, <i>J</i> = 15.6 Hz, H<sub>α</sub>), 7.76–7.70 (3H, m, H8, H2′, H6′), 7.86 (1H, ddd, <i>J</i> = 7.8, 7.0, 1.6 Hz, H7), 8.18 (1H, dd, <i>J</i> = 8.0, 1.2 Hz, H5), 8.86 (1H, s, H2), 10.45 (1H, s, N<u class="uu">H</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: <u class="uu">118.9</u> (C8), 119.0 (C3), <u class="uu">119.7</u> (C2′, C6′), <u class="uu">123.8</u> (C<sub>α</sub>), 124.0 (C4a), <u class="uu">125.5</u> (C6), <u class="uu">125.9</u> (C5), <u class="uu">126.5</u> (C4′), <u class="uu">129.2</u> (C3′, C5′), <u class="uu">132.9</u> (C7), <u class="uu">134.9</u> (C<sub>β</sub>), 139.9 (C1′), 155.5 (C8a), <u class="uu">160.4</u> (C7′), 164.6 (C2), 176.0 (C4). MS/EI <i>m</i>/<i>z</i> (%): 291 (M<sup>+</sup>, 73), 199 (100), 172 (22), 171 (100), 115 (21), 93 (24), 51 (20).</div></div><div id="sec4_2_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)<i>-N</i>-(4′-Chlorophenyl)-4-oxo-4<i>H</i>-chromen-3-acrylamide (<b>39</b>)</h3><div class="NLM_p last">The compound was obtained in 15% yield and recrystallized from AcOEt: mp 260–263 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 7.43–7.36 (3H, m, H<sub>β</sub>, H3′, H5′), 7.56 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.6 Hz, H6), 7.66 (1H, d, <i>J</i> = 15.6 Hz, H<sub>α</sub>), 7.72 (1H, dd, <i>J</i> = 8.4, 0.4 Hz, H8), 7.76 (2H, <i>dt</i>, <i>J</i> = 9.2, 2.6, 2.4 Hz, H2′, H6′), 7.86 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.6 Hz, H7), 8.18 (1H, dd, <i>J</i> = 8.4, 0.4 Hz, H5), 8.86 (1H, s, H2), 10.45 (1H, s, N<u class="uu">H</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: 119.0 (C3), <u class="uu">119.9</u> (C8), <u class="uu">121.2</u> (C2′, C6′), 124.0 (C4a), <u class="uu">125.1</u> (C<sub>α</sub>), <u class="uu">125.9</u> (C6), <u class="uu">126.5</u> (C5), 127.3 (C4′), <u class="uu">129.1</u> (C3′, C5′), <u class="uu">133.3</u> (C7), <u class="uu">135.0</u> (C<sub>β</sub>), 138.8 (C1′), 155.5 (C8a), <u class="uu">160.6</u> (7′), 164.7 (C2), 176.0 (C4). MS/EI <i>m</i>/<i>z</i> (%): 327 (M<sup>+</sup> + 2, 26), 325 (M<sup>+</sup>, 69), 200 (68), 199 (100), 172 (33), 171 (100), 127 (21), 121 (20) 115 (35), 79 (28), 51 (30).</div></div><div id="sec4_2_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>E</i>)<i>-N</i>-(<i>p</i>-Tolyl)-4-oxo-4<i>H</i>-chromen-3-acrylamide (<b>40</b>)</h3><div class="NLM_p last">The compound was obtained in 26% yield and recrystallized from AcOEt: mp 193–197 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 2.26 (3H, s, C<u class="uu">H</u><sub>3</sub>), 7.12 (2H, d, <i>J</i> = 8.4 Hz, H3′, H5′), 7.37 (1H, dd, <i>J</i> = 0.4, 15.6 Hz, H<sub>β</sub>), 7.56 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.6 Hz H6), 7.67–7.59 (3H, m, H<sub>α</sub>, H2′, H6′), 7.64 7.72 (1H, dd, <i>J</i> = 8.4, 0.8 Hz, H8), 7.86 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.6 Hz Hz, H7), 8.17 (1H, dd, <i>J</i> = 8.0, 0.8 Hz, H5), 8.84 (1H, s, H2), 10.22 (1H, s, N<u class="uu">H</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: <u class="uu">119.0</u> (C8), 119.1 (C3), <u class="uu">119.7</u> (C2′, C6′), 124.0 (C4a), <u class="uu">125.6</u> (C<sub>α</sub>), <u class="uu">125.9</u> (C6), <u class="uu">126.4</u> (C5), <u class="uu">129.6</u> (C3′, C5′), <u class="uu">132.4</u> (C7), 132.6 (C4′), <u class="uu">134.9</u> (C<sub>β</sub>), 137.4 (C1′), 155.5 (C8a), <u class="uu">160.3</u> (C7′), 164.3 (C2), 175.9 (C4). MS/EI <i>m</i>/<i>z</i> (%): 306 (M<sup>+</sup>+1, 39), 305 (M<sup>+</sup>, 98), 200 (48), 199 (97), 172 (38), 171 (100), 115 (21), 107 (38).</div></div><div id="sec4_2_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>E</i>)-<i>N</i>-(3′,4′-Dimethylphenyl)-4-oxo-4<i>H</i>-chromen-3-acrylamide (<b>41</b>)</h3><div class="NLM_p last">The compound was obtained in 18% yield and recrystallized from AcOEt: mp 197–200 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 2.18 (3H, s, C<u class="uu">H</u><sub>3</sub>), 2.20 (3H, s, C<u class="uu">H</u><sub>3</sub>), 7.06 (1H, d, <i>J</i> = 8 Hz, H2′), 7.35 (1H, dd, <i>J</i> = 15.6 Hz, H<sub>β</sub>), 7.50–7.44 (2H, m, H5′, H6′), 7.55 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.2 Hz, H6), 7.63 (1H, d, <i>J</i> = 15.6 Hz, H<sub>α</sub>), 7.72 (1H, dd, <i>J</i> = 8.4, 0.8 Hz, H8), 7.85 (1H, ddd, <i>J</i> = 7.6, 7.2, 1.2 Hz, H7), 8.17 (1H, dd, <i>J</i> = 8.0, 0.8 Hz, H5), 8.83 (1H, s, H2), 10.14 (1H, s, N<u class="uu">H</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ: <u class="uu">19.3</u> (CH<sub>3</sub>), <u class="uu">20.1</u> (CH<sub>3</sub>), <u class="uu">117.3</u> (C8), <u class="uu">119.0</u> (C6′), 119.2 (C3), <u class="uu">120.9</u> (C2′), 124.0 (C4a), <u class="uu">125.7</u> (C<sub>α</sub>), <u class="uu">125.9</u> (C6), <u class="uu">126.4</u> (C5), <u class="uu">130.0</u> (C5′), 131.5 (C4′), <u class="uu">132.4</u> (C7), <u class="uu">134.9</u> (C<sub>β</sub>), 136.7 (C3′), 137.6 (C1′), 155.5 (C8a), <u class="uu">160.2</u> (C7′), 164.3 (C2), 175.9 (C4). MS/EI <i>m</i>/<i>z</i> (%): 319 (M<sup>+</sup>, 45), 199 (100), 171 (81), 121 (29).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Pharmacology. Evaluation of Monoamine Oxidase (hMAO) Inhibitiory Activity</h3><div class="NLM_p">The inhibitory activity of the chromones under study on both <i>h</i>MAO isoforms was assessed following a previously described method.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">Briefly, the inhibitory activity on <i>h</i>MAOs was evaluated by measuring the effects of the chromones on the production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) from <i>p</i>-tyramine, using the Amplex Red MAO assay kit (Molecular Probes, Inc., Eugene, OR, U.S.) and microsomal MAO isoforms prepared from insect cells (BTI-TN-5B1-4) infected with recombinant baculovirus containing cDNA inserts for <i>h</i>MAO-A or <i>h</i>MAO-B (Sigma-Aldrich Química S.A.). The test compounds/standard inhibitors and adequate amounts of recombinant <i>h</i>MAO-A or <i>h</i>MAO-B were incubated for 15 min at 37 °C in a flat-black-bottom 96-well microplate (BRANDplates, pureGrade, BRAND GMBH, Wertheim, Germany) with Amplex Red reagent, 1 U/mL horseradish peroxidase, and 1 mM <i>p</i>-tyramine. The production of H<sub>2</sub>O<sub>2</sub> and consequently of resorufin was quantified at 37 °C in a multimode microplate reader (Biotek Synergy HT), based on the fluorescence generated (excitation, 545 nm, emission, 590 nm) over a 15 min period, in which the fluorescence increased linearly. Control experiments were carried out simultaneously by replacing the test drugs (new compounds and standard inhibitors) with appropriate dilutions of the vehicles. The IC<sub>50</sub> values were determined in triplicate from the dose–response inhibition curves and are expressed as mean ± standard deviation (SD). All IC<sub>50</sub> values are the mean ± SD from three experiments.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Evaluation of hMAO-A and hMAO-B Kinetics</h3><div class="NLM_p last">To determine the steady-state kinetic parameters (<i>K</i><sub>m</sub>, Michaelis constant, and <i>V</i><sub>max</sub>, maximum rate) of <i>h</i>MAO-A and <i>h</i>MAO-B, the enzymatic activity of both isoforms was evaluated (under the experimental conditions described above) in the presence of different <i>p</i>-tyramine concentrations. Under our experimental conditions, hMAO-A displayed a <i>K</i><sub>m</sub> of 449.08 ± 28.42 μM and a <i>V</i><sub>max</sub> of 30.03 ± 0.6529 nmol/min whereas hMAO-B showed a <i>K</i><sub>m</sub> of 58.76 ± 11.67 μM and a <i>V</i><sub>max</sub> of 22.60 ± 1.018 nmol/min (<i>n</i> = 3).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Evaluation of hMAO-B-Inhibitor Kinetics</h3><div class="NLM_p last">To evaluate the mechanism of <i>h</i>MAO-B inhibition of the most promising chromones (<b>20</b> and <b>27</b>), substrate-dependent kinetic experiments were performed. The catalytic rates of <i>h</i>MAO-B were measured at five different concentrations of <i>p</i>-tyramine substrate (0.031–2 mM) in the absence or presence of the selected inhibitors (compounds <b>20</b> and <b>27</b>) and standard inhibitors, at concentrations between 0.5 and 1.0 nM. The results are presented as double reciprocal Lineweaver–Burk plots (1/<i>V</i> vs 1/[S]), and the kinetic data, namely, Michaelis–Menten constant (<i>K</i><sub>m</sub>) and maximum reaction rate (<i>V</i><sub>max</sub>), were acquired employing Michaelis–Menten equation. The <i>K</i><sub>i</sub> values were estimated using Dixon plots, by replotting the slope of each Lineweaver–Burk plot versus the inhibitor concentration. In the Dixon plots, the <i>K</i><sub>i</sub> values were obtained from the <i>x</i>-axis intercept (−<i>K</i><sub>i</sub>). The enzymatic reactions and measurements were performed using the same <i>h</i>MAO-B assay conditions as described above (<i>n</i> = 3). Linear regression analysis was performed using Prism 5.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Evaluation of hMAO-B-Inhibitior Type of Binding Affinity</h3><div class="NLM_p last">The analysis of the type of binding of chromones <b>20</b> and <b>27</b> and the standard inhibitors with <i>h</i>MAO-B was performed by a time-dependent inhibition assay. The enzyme was incubated for a 60 min period with the chromone based inhibitors as well as the standard inhibitors at their IC<sub>80</sub> values. The final well concentrations were the following: compound <b>20</b> (0.7 nM), compound <b>27</b> (2 nM), (<i>R</i>)-(−)-deprenyl (50 nM), safinamide (40 nM), rasagiline (200 nM), and MAO-B (6.4 μg/mL). Control experiments without inhibitors were run simultaneously. The enzymatic activity was determined as described above (see determination of <i>h</i>MAO isoform activity). The percentage of enzyme activity was plotted against the incubation time to determine time-dependent enzyme inhibition. Data are the mean ± SD of three independent experiments.</div></div><div id="sec4_3_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Evaluation of Cytotoxicity for the Most Active Compounds. Reagents</h3><div class="NLM_p last">(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide and Dulbecco’s modified Eagle medium (DMEM) with 4.5 g/L glucose were obtained from Sigma (St. Louis, MO, USA). Reagents used in cell culture, including nonessential amino acids (NEAA), heat inactivated fetal bovine serum (FBS), 0.05% trypsin/1 mM EDTA, antibiotic (10000 U/mL penicillin, 10 000 μg/mL streptomycin), phosphate-buffered saline solution (PBS), and Hank’s balanced salt solution (HBSS) were purchased from Gibco Laboratories (Lenexa, KS). Dimethylsulfoxide (DMSO-<i>d</i><sub>6</sub>), absolute ethanol, and acetic acid were obtained from Merck (Darmstadt, Germany). All reagents were of analytical grade or of the highest grade available.</div></div><div id="sec4_3_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Cell Culture</h3><div class="NLM_p last">SH-SY5Y cells (ATCC, Manassas, VA, USA), a neuroblastoma cell line, were routinely cultured in 75 cm<sup>2</sup> flasks (Corning Costar, Corning, NY, USA) using DMEM with 4.5 g/L glucose, supplemented with 10% heat-inactivated FBS (v/v), 1% NEAA (v/v), 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were maintained at 37 °C in a humidified atmosphere of 95% air/5% CO<sub>2</sub>, and the medium was changed every 2 days. The cells used for all the experiments were taken between the 25th and 34th passages, in order to avoid phenotypic changes. Cultures were passaged weekly by trypsinization (0.05% trypsin/1 mM EDTA). For the cytotoxicity experiments, undifferentiated SH-SY5Y cells were seeded onto 96-well plates (25 000 cells/cm<sup>2</sup>) in complete cell culture medium and cultured for 3 days at 37 °C. Three days after seeding, when confluence was reached, the cells were exposed to the test compounds (0, 1, and 50.0 μM) in cell culture medium without FBS for 24 h. Cytotoxicity was evaluated 24 h after exposure, by the MTT reduction and by the NR uptake assays.</div></div><div id="sec4_3_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> MTT Reduction Assay</h3><div class="NLM_p last">The MTT reduction assay was used to measure mitochondrial dysfunction (decrease in mitochondrial dehydrogenase activity) in cells exposed to the test compounds. The signal generated is dependent on the degree of reduction of the MTT tetrazolium salt (water-soluble) to MTT formazan (water insoluble) by cellular dehydrogenases within metabolically active cells. At the selected time point, the cell culture medium was removed, followed by the addition of fresh cell culture medium containing 0.5 mg/mL MTT and incubation at 37 °C in a humidified, 5% CO<sub>2</sub> atm for 2 h. After this incubation period, the cell culture medium was removed and the formed formazan crystals dissolved in 100% DMSO. The absorbance was measured at 550 nm in a multiwell plate reader (BioTek Instruments, VT, USA). The percentage of MTT reduction relative to that of the control cells was used as the cytotoxicity measure [MTT reduction (% of control)].</div></div><div id="sec4_3_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Neutral Red Uptake Assay</h3><div class="NLM_p last">The NR uptake assay is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes, thus providing a quantitative estimation of the number of viable cells in a culture. Twenty-four hours after exposure, the cell culture medium was removed and the cells were incubated with neutral red (50 μg/mL in cell culture medium) at 37 °C, in a humidified 5% CO<sub>2</sub>–95% air atmosphere, for 2 h. After this incubation period, the cell culture medium was removed, the dye absorbed only by viable cells extracted [with absolute ethyl alcohol/distilled water (1:1) containing 5% acetic acid], and the absorbance measured at 540 nm in a multiwell plate reader (BioTek Instruments, VT, USA). The percentage of NR uptake relative to that of the control cells was used as the cytotoxicity measure [NR uptake (% of control)].</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Data Analysis</h3><div class="NLM_p last">For the enzymatic inhibition studies, the compounds were initially screened at 10 μM. For potent compounds, dose–response curves were plotted and IC<sub>50</sub> values were estimated by nonlinear analysis. For the cytotoxicity assays, MTT reduction for each treatment was calculated as the % of control untreated cells and plotted in column graphs. Statistical comparisons between groups were carried by one-way analysis of variance (ANOVA-1) followed by Dunnett comparison post-test (α = 0.05, 95% confidence intervals). Differences were considered to be significant for <i>p</i> values lower than 0.05. All plots and statistical analysis were performed using GraphPad Prism 5 software.</div></div><div id="sec4_3_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Molecular Modeling</h3><div class="NLM_p last"><i>h</i>MAO-A and <i>h</i>MAO-B receptor models were built following the a consolidated procedure previously reported,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> i.e., starting from the Protein Data Bank (PDB)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> deposited crystallographic structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> respectively. Both experimental structures were submitted to a preliminary pretreatment: (a) the cocrystallized reversible ligands, harmine for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a> and safinamide for <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>, and water molecules were removed; (b) FAD cofactor bond order was fixed, and hydrogen atoms were added. Modified structures were submitted to protein heavy atoms 50 kJ/(mol·Å) constrained energy minimization using 10 000 steps of the Polak–Ribiere conjugate gradient algorithm, as implemented in MacroModel program.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Optimized receptor models were considered for mimicking <i>h</i>MAO-A and <i>h</i>MAO-B, and in both cases, the ligand binding site was represented by an N5 FAD atom centered regular box of 27 000 Å<sup>3</sup>. Inhibitor chemical structures were built and optimized using the Maestro GUI.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Docking simulations were carried out using the standard precision (SP) search algorithms of Glide software.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Ligand structural flexibility was taken into account by means of the corresponding software implementation. A maximum of 10 docking configurations were sampled. Default Glide scoring function (GScore) was applied for poses ranking (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">Table S1</a>). Further analysis and simulations were carried out on compounds <b>20</b> and <b>27</b> MAOs complexes taking into account both the absolutely docking GScore top ranked configuration (TC) and the relative top ranked configuration reporting opposite orientation with respect to TC (SC). For both targets, ligand free (LF), TC, and SC models were explicitly solvated with water molecules included by the impact<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> “soak” method. For all structures a regular box of 64 000 Å<sup>3</sup> centered onto the N5 FAD atom was considered for the solvent positioning (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">Table S2</a>). The resulting structures were submitted for molecular dynamics (MD) simulation carried out using the Desmond software.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The SPC explicit solvent model was applied for generating solvated MD suitable systems. The overall electrostatic net charge of the starting structures was neutralized including 3 Cl<sup>–</sup> ions into the <i>h</i>MAO-A models and 3 Na<sup>+</sup> ions into the <i>h</i>MAO-B ones. The default Desmond protocol was applied for equilibrating solvated systems. The production MD simulation was carried out at 300 K, up to 1.2 ns, using an integration time step equal to 2 fs. MD frames were sampled at regular time intervals equal to 10 ps. The targets’ structural perturbation induced by our inhibitors recognition was evaluated by computing the root-mean-square deviation (rmsd) of TC and SC MD trajectories with respect to the corresponding LF ones. The rmsd data were computed taking into account the targets and not hydrogen atoms.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00527" class="ext-link">10.1021/acs.jmedchem.6b00527</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional molecular docking data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf">jm6b00527_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_002.csv">jm6b00527_si_002.csv (2.28 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00527" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernanda Borges</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d7b1b5b8a5b0b2a497b1b4f9a2a7f9a7a3"><span class="__cf_email__" data-cfemail="1177737e637674625177723f64613f6165">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joana Reis</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Cagide</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Chavarria</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiago Silva</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Fernandes</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra Gaspar</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugenio Uriarte</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Remião</span> - <span class="hlFld-Affiliation affiliation">UCIBIO-REQUIMTE,
Laboratory of Toxicology, Department of Biological Sciences, Faculty
of Pharmacy, University of Porto, 4050-313, Porto, Portugal</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Alcaro</span> - <span class="hlFld-Affiliation affiliation">Department
of “Scienze della Vita”, University
“Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Ortuso</span> - <span class="hlFld-Affiliation affiliation">Department
of “Scienze della Vita”, University
“Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.R., F.C., and F.O. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d656e5971-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This project was supported by Foundation for Science and Technology (FCT) and FEDER/COMPETE2020 (Grants UID/QUI/00081/2015 and POCI-01-0145-FEDER-006980). The authors also thank the COST action CA15135 (Multitarget Paradigm for Innovative Ligand Identification in the Drug Discovery Process MuTaLig) for support. J.R. (Grant SFRH/BD/96033/2013), F.C. (Grant SFRH/BPD/74491/2010), D.C. (Grant SFRH/BD/108119/2015), T.S. (Grant SFRH/BD/79671/2011), C.F. (Grant SFRH/BD/98519/2013), and A.G. (Grant SFRH/BPD/93331/2013) grants are also supported by FCT and FEDER/COMPETE funds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> Abbreviations Used</h2><tr><td class="NLM_term">AEI</td><td class="NLM_def"><p class="first last">ADMET efficiency index</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">IMAO-B</td><td class="NLM_def"><p class="first last">monoamine oxidase B inhibitor</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">log BB</td><td class="NLM_def"><p class="first last">blood (plasma)–brain partitioning</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term"><i>h</i>MAO-A</td><td class="NLM_def"><p class="first last">human monoamine oxidase A</p></td></tr><tr><td class="NLM_term"><i>h</i>MAO-B</td><td class="NLM_def"><p class="first last">human monoamine oxidase B</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">3-amino-7-dimethylamino-2-methylphenazine hydrochloride</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, L. G.</span><span> </span><span class="NLM_article-title">Current approaches to the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.2147/NDT.S2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.2147%2FNDT.S2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=19043519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2mt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=743-757&author=J.+Jankovicauthor=L.+G.+Aguilar&title=Current+approaches+to+the+treatment+of+Parkinson%E2%80%99s+disease&doi=10.2147%2FNDT.S2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to the treatment of Parkinson's disease</span></div><div class="casAuthors">Jankovic, Joseph; Aguilar, L. Giselle</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1176-6328</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Enormous progress has been made in the treatment of Parkinson's disease (PD).  As a result of advances in exptl. therapeutics, many promising therapies for PD are emerging.  Levodopa remains the most potent drug for controlling PD symptoms, yet is assocd. with significant complications such as the "wearing off" effect, levodopa-induced dyskinesias and other motor complications.  Catechol-o-methyl-transferase inhibitors, dopamine agonists and nondopaminergic therapy are alternative modalities in the management of PD and may be used concomitantly with levodopa or one another.  The neurosurgical treatment, focusing on deep brain stimulation, is reviewed briefly.  Although this review has attempted to highlight the most recent advances in the treatment of PD, it is important to note that new treatments are not necessarily better than the established conventional therapy and that the treatment options must be individualized and tailored to the needs of each individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzaZNwdZkoLVg90H21EOLACvtfcHk0lj4PbxfTtDI7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2mt7fK&md5=ff8bd810fa471e018557d36f9ab42795</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2147%2FNDT.S2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S2006%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DAguilar%26aufirst%3DL.%2BG.%26atitle%3DCurrent%2520approaches%2520to%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2008%26volume%3D4%26spage%3D743%26epage%3D757%26doi%3D10.2147%2FNDT.S2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Present and future drug treatment for Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1136/jnnp.2004.035980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1136%2Fjnnp.2004.035980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16227533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BD2MrltFSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=1472-1478&author=A.+H.+V.+Schapira&title=Present+and+future+drug+treatment+for+Parkinson%E2%80%99s+disease&doi=10.1136%2Fjnnp.2004.035980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Present and future drug treatment for Parkinson's disease</span></div><div class="casAuthors">Schapira A H V</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1472-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Considerable advances made in defining the aetiology, pathogenesis, and pathology of Parkinson's disease (PD) have resulted in the development and rapid expansion of the pharmacopoeia available for treatment.  Anticholinergics were used before the introduction of levodopa which is now the drug most commonly used.  Dopamine agonists are effective when used alone or as an adjunct to levodopa, while monoamine oxidase B inhibitors improve motor function in early and advanced PD.  However, treatment mainly addresses the dopaminergic features of the disease and leaves its progressive course unaffected; the drug treatment available for the management of non-motor symptoms is limited.  This article seeks to set current treatment options in context, review emerging and novel drug treatments for PD, and assess the prospects for disease modification.  Surgical therapies are not considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNpmzSqAT4V7BItaL1WaVAfW6udTcc2eYRR7P1Adtudbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrltFSgtA%253D%253D&md5=8230993f22ce63a3207690bb534e7c07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2004.035980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2004.035980%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DPresent%2520and%2520future%2520drug%2520treatment%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2005%26volume%3D76%26spage%3D1472%26epage%3D1478%26doi%3D10.1136%2Fjnnp.2004.035980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Tipton, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span> </span><span class="NLM_article-title">Monoamine oxidases: certainties and uncertainties</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1982</span><span class="refDoi"> DOI: 10.2174/0929867043364810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.2174%2F0929867043364810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=15279561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1965-1982&author=K.+F.+Tiptonauthor=S.+Boyceauthor=J.+O%27Sullivanauthor=G.+P.+Daveyauthor=J.+Healy&title=Monoamine+oxidases%3A+certainties+and+uncertainties&doi=10.2174%2F0929867043364810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidases: Certainties and uncertainties</span></div><div class="casAuthors">Tipton, Keith F.; Boyce, Sinead; O'Sullivan, Jeff; Davey, Gavin P.; Healy, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1965-1982</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Much has been learned about the behavior of monoamine oxidase (MAO) in the 75 yr since it was 1st discovered, but there is still a great deal left to be understood.  This review concs. on the dynamic aspects of the knowledge of the interactions of MAO with substrates and inhibitors and how it may collaborate with other enzymes, with particular emphasis on aspects that remain to be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCOV1QM-ZWXLVg90H21EOLACvtfcHk0lgZwiWRzBxfNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7o%253D&md5=cbcc8214e895614a86010dd5438a149e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F0929867043364810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364810%26sid%3Dliteratum%253Aachs%26aulast%3DTipton%26aufirst%3DK.%2BF.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DO%2527Sullivan%26aufirst%3DJ.%26aulast%3DDavey%26aufirst%3DG.%2BP.%26aulast%3DHealy%26aufirst%3DJ.%26atitle%3DMonoamine%2520oxidases%253A%2520certainties%2520and%2520uncertainties%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1965%26epage%3D1982%26doi%3D10.2174%2F0929867043364810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakhle, Y. S.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S287</span><span class="NLM_x">–</span> <span class="NLM_lpage">S296</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fsj.bjp.0706464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16402116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S287-S296&issue=Suppl.+1&author=M.+B.+Youdimauthor=Y.+S.+Bakhle&title=Monoamine+oxidase%3A+isoforms+and+inhibitors+in+Parkinson%E2%80%99s+disease+and+depressive+illness&doi=10.1038%2Fsj.bjp.0706464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness</span></div><div class="casAuthors">Youdim, Moussa B. H.; Bakhle, Y. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S287-S296</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A few years after the foundation of the British Pharmacol. Society, monoamine oxidase (MAO) was recognized as an enzyme of crucial interest to pharmacologists because it catalyzed the major inactivation pathway for the catecholamine neurotransmitters, noradrenaline, adrenaline and dopamine (and, later, 5-hydroxytryptamine, as well).  Within the next decade, the therapeutic value of inhibitors of MAO in the treatment of depressive illness was established.  Although this first clin. use exposed serious side effects, pharmacol. interest in, and investigation of, MAO continued, resulting in the characterization of two isoforms, MAO-A and -B, and isoform-selective inhibitors.  Selective inhibitors of MAO-B have found a therapeutic role in the treatment of Parkinson's disease and further developments have provided reversible inhibitors of MAO-A, which offer antidepressant activity without the serious side effects of the earlier inhibitors.  Clin. observation and subsequent pharmacol. anal. have also generated the concept of neuroprotection, reflecting the possibility of slowing, halting and maybe reversing, neurodegeneration in Parkinson's or Alzheimer's diseases.  Increased levels of oxidative stress in the brain may be crit. for the initiation and progress of neurodegeneration and selective inhibition of brain MAO could contribute importantly to lowering such stress.  There are complex interactions between free iron levels in brain and MAO, which may have practical outcomes for depressive disorders.  These aspects of MAO and its inhibition and some indication of how this important area of pharmacol. and therapeutics might develop in the future are summarized in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDnikJHT_N0LVg90H21EOLACvtfcHk0lgZwiWRzBxfNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVCltw%253D%253D&md5=0fe90af4656bd06ce1b2266745e1fa98</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706464%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26atitle%3DMonoamine%2520oxidase%253A%2520isoforms%2520and%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520depressive%2520illness%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26issue%3DSuppl.%25201%26spage%3DS287%26epage%3DS296%26doi%3D10.1038%2Fsj.bjp.0706464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s diseases as disease modifying agents</span> <span class="citation_source-journal">Exp. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.5607/en.2010.19.1.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.5607%2Fen.2010.19.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=22110336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FlsFGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1-14&author=M.+B.+H.+Youdim&title=Why+do+we+need+multifunctional+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+and+Alzheimer%E2%80%99s+diseases+as+disease+modifying+agents&doi=10.5607%2Fen.2010.19.1.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents</span></div><div class="casAuthors">Youdim Moussa B H</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parkinson's disease (PD) and Alzheimer's Disease (AD) are severe neurodegenerative disorders, with no drugs that are currently approved to prevent the neuronal cell loss characteristic in brains of patients suffering from PD and AD and all drug treatment are synptomactic.  Due to the complex pathophysiology, including a cascade of neurotoxic molecular events that results in neuronal death and predisposition to depression and eventual dementia and etiology of these disorders, an innovative approach towards neuroprotection or neurorestoration (neurorescue) may be the development and use of multifunctional pharmaceuticals.  Such drugs target an array of pathological pathways, each of which is believed to contribute to the cascades that ultimately lead to neuronal cell death.  In this short review, we discuss examples of novel multifunctional ligands that may have potential as neuroprotective-neurorestorative therapeutics in PD and AD.  The compounds discussed originate from synthetic chemistry as well as from natural sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsSVI6siCAmLHHuJhbyicZfW6udTcc2eZxGlpn0-7_brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FlsFGnsg%253D%253D&md5=b70e8f5f45610f3a28f059c8835b0e44</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.5607%2Fen.2010.19.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2010.19.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DWhy%2520do%2520we%2520need%2520multifunctional%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520and%2520Alzheimer%25E2%2580%2599s%2520diseases%2520as%2520disease%2520modifying%2520agents%26jtitle%3DExp.%2520Neurobiol.%26date%3D2010%26volume%3D19%26spage%3D1%26epage%3D14%26doi%3D10.5607%2Fen.2010.19.1.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">De la Fuente-Fernández, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span> </span><span class="NLM_article-title">Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span><span class="refDoi"> DOI: 10.1093/brain/awh290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1093%2Fbrain%2Fawh290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=2747-2754&author=R.+De+la+Fuente-Fern%C3%A1ndezauthor=V.+Sossiauthor=Z.+Huangauthor=S.+Furtadoauthor=J.-Q.+Luauthor=D.+B.+Calneauthor=T.+J.+Ruthauthor=A.+J.+Stoessl&title=Levodopa-induced+changes+in+synaptic+dopamine+levels+increase+with+progression+of+Parkinson%E2%80%99s+disease%3A+implications+for+dyskinesias&doi=10.1093%2Fbrain%2Fawh290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh290%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BFuente-Fern%25C3%25A1ndez%26aufirst%3DR.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFurtado%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.-Q.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26atitle%3DLevodopa-induced%2520changes%2520in%2520synaptic%2520dopamine%2520levels%2520increase%2520with%2520progression%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520dyskinesias%26jtitle%3DBrain%26date%3D2004%26volume%3D127%26spage%3D2747%26epage%3D2754%26doi%3D10.1093%2Fbrain%2Fawh290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+H.+Youdimauthor=A.+Grossauthor=J.+P.+M.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B&doi=10.1038%2Fsj.bjp.0703826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lgQO1fGc3uQaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506%26doi%3D10.1038%2Fsj.bjp.0703826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span><span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+human+monoamine+oxidase+B+complexes+with+selective+noncovalent+inhibitors%3A+safinamide+and+coumarin+analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lgQO1fGc3uQaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520human%2520monoamine%2520oxidase%2520B%2520complexes%2520with%2520selective%2520noncovalent%2520inhibitors%253A%2520safinamide%2520and%2520coumarin%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ellis, G. P.</span> <span class="citation_source-book">The Chemistry of Heterocyclic Compounds, Chromenes, Chromanones, and Chromones</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">31</span>, p  <span class="NLM_fpage">1085</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1085&author=G.+P.+Ellis&title=The+Chemistry+of+Heterocyclic+Compounds%2C+Chromenes%2C+Chromanones%2C+and+Chromones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BP.%26btitle%3DThe%2520Chemistry%2520of%2520Heterocyclic%2520Compounds%252C%2520Chromenes%252C%2520Chromanones%252C%2520and%2520Chromones%26pub%3DWiley%26date%3D2009%26volume%3D31%26spage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone: a valid scaffold in medicinal chemistry</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4960</span><span class="NLM_x">–</span> <span class="NLM_lpage">4992</span><span class="refDoi"> DOI: 10.1021/cr400265z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400265z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=4960-4992&author=A.+Gasparauthor=M.+J.+Matosauthor=J.+Garridoauthor=E.+Uriarteauthor=F.+Borges&title=Chromone%3A+a+valid+scaffold+in+medicinal+chemistry&doi=10.1021%2Fcr400265z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone: A Valid Scaffold in Medicinal Chemistry</span></div><div class="casAuthors">Gaspar, Alexandra; Matos, Maria Joao; Garrido, Jorge; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4960-4992</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chromones are a group of naturally occurring compds. that are ubiquitous in nature, esp. in plants.  The structural diversity found in chromone family led to their roughly division into different categories: simple chromones and fused chromones (pyrano- and furanchromones).  Until now, simple chromones were an up-and-coming area of exploration, and the literature in the area is diffuse.  So, the purpose of this review is to analyze and summarize aspects related to the medicinal chem. artwork performed with simple chromones to look at their potential therapeutic applications.  In addn., information concerning the development of innovative synthetic strategies and biol. applications, with particular emphasis on structure-activity relationships (SAR) will be also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqpH_RyzLjKbVg90H21EOLACvtfcHk0lh4v40oZDky0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOgs7k%253D&md5=167a2617312956d2aac7b9a3692c6798</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcr400265z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400265z%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%253A%2520a%2520valid%2520scaffold%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D4960%26epage%3D4992%26doi%3D10.1021%2Fcr400265z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2709</span><span class="NLM_x">–</span> <span class="NLM_lpage">2712</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmcl.2010.03.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2709-2712&author=S.+Alcaroauthor=A.+Gasparauthor=F.+Ortusoauthor=N.+Milhazesauthor=F.+Oralloauthor=E.+Uriarteauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Borges&title=Chromone-2-+and+-3-carboxylic+acids+inhibit+differently+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2010.03.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone-2-%2520and%2520-3-carboxylic%2520acids%2520inhibit%2520differently%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2709%26epage%3D2712%26doi%3D10.1016%2Fj.bmcl.2010.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmcl.2010.11.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=707-709&author=A.+Gasparauthor=J.+Reisauthor=A.+Fonsecaauthor=N.+Milhazesauthor=D.+Vi%C3%B1aauthor=E.+Uriarteauthor=F.+Borges&title=Chromone+3-phenylcarboxamides+as+potent+and+selective+MAO-B+inhibitors&doi=10.1016%2Fj.bmcl.2010.11.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.128%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%25203-phenylcarboxamides%2520as%2520potent%2520and%2520selective%2520MAO-B%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D707%26epage%3D709%26doi%3D10.1016%2Fj.bmcl.2010.11.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeiro, M. N. D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Towards the discovery of a novel class of monoamine oxidase inhibitors: structure–property–activity and docking studies on chromone amides</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1002/cmdc.201000452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1002%2Fcmdc.201000452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=628-632&author=A.+Gasparauthor=F.+Teixeiraauthor=E.+Uriarteauthor=N.+Milhazesauthor=A.+Meloauthor=M.+N.+D.+S.+Cordeiroauthor=F.+Ortusoauthor=S.+Alcaroauthor=F.+Borges&title=Towards+the+discovery+of+a+novel+class+of+monoamine+oxidase+inhibitors%3A+structure%E2%80%93property%E2%80%93activity+and+docking+studies+on+chromone+amides&doi=10.1002%2Fcmdc.201000452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000452%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DTeixeira%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DMelo%26aufirst%3DA.%26aulast%3DCordeiro%26aufirst%3DM.%2BN.%2BD.%2BS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DTowards%2520the%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520monoamine%2520oxidase%2520inhibitors%253A%2520structure%25E2%2580%2593property%25E2%2580%2593activity%2520and%2520docking%2520studies%2520on%2520chromone%2520amides%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D628%26epage%3D632%26doi%3D10.1002%2Fcmdc.201000452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5173</span><span class="refDoi"> DOI: 10.1021/jm2004267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5165-5173&author=A.+Gasparauthor=T.+Silvaauthor=M.+Y%C3%A1%C3%B1ezauthor=D.+Vinaauthor=F.+Oralloauthor=F.+Ortusoauthor=E.+Uriarteauthor=S.+Alcaroauthor=F.+Borges&title=Chromone%2C+a+privileged+scaffold+for+the+development+of+monoamine+oxidase+inhibitors&doi=10.1021%2Fjm2004267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span></div><div class="casAuthors">Gaspar, Alexandra; Silva, Tiago; Yanez, Matilde; Vina, Dolores; Orallo, Franscisco; Ortuso, Francesco; Uriarte, Eugenio; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5165-5173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of novel chromone derivs. I and II ( R = Ph, 4-OH-C6H4, 3-OH-4-MeO-C6H3, 3,4-(OH)2-C6H3, 3,4-(MeO)2-C6H3, 4-Cl-C6H4, 4-OCF3-C6H4, 4-CF3-C6H4, 4-NO2-C6H4, cyclohexyl, nPr) were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase.  The SAR data indicate that chromone derivs. with substituents in position 3 of γ-pyrone nucleus act preferably as MAO-B inhibitors, with IC50 values in the nanomolar to micromolar range.  Almost all chromone 3-carboxamides display selectivity toward MAO-B.  Identical substitutions on position 2 of γ-pyrone nucleus result in complete loss of activity in both isoforms (chromones I except R = 4-OH-C6H4 and 3,4-(OH)2-C6H3).  Notably, chromone II(R = 4-Cl-C6H4) exhibits an MAO-B IC50 of 63 nM, greater than 1000-fold selectivity over MAO-A, and behaves as a quasi-reversible inhibitor.  Docking expts. onto the MAO binding of the most active compd. highlight different interaction patterns among the isoforms A and B.  The differential anal. of the solvation effects among the chromone isomers gave addnl. insight about the superior outline of the 3-substituted chromone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKKLGzqjz4yLVg90H21EOLACvtfcHk0lh4v40oZDky0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D&md5=27e7bd37930e26f28fb5b624b2360457</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2004267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004267%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%252C%2520a%2520privileged%2520scaffold%2520for%2520the%2520development%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5165%26epage%3D5173%26doi%3D10.1021%2Fjm2004267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cagide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. N.</span><span> </span><span class="NLM_article-title">Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2832</span><span class="NLM_x">–</span> <span class="NLM_lpage">2835</span><span class="refDoi"> DOI: 10.1039/C4CC08798D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1039%2FC4CC08798D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=2832-2835&author=F.+Cagideauthor=T.+Silvaauthor=J.+Reisauthor=A.+Gasparauthor=F.+Borgesauthor=L.+R.+Gomesauthor=J.+N.+Low&title=Discovery+of+two+new+classes+of+potent+monoamine+oxidase-B+inhibitors+by+tricky+chemistry&doi=10.1039%2FC4CC08798D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2FC4CC08798D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC08798D%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26atitle%3DDiscovery%2520of%2520two%2520new%2520classes%2520of%2520potent%2520monoamine%2520oxidase-B%2520inhibitors%2520by%2520tricky%2520chemistry%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D2832%26epage%3D2835%26doi%3D10.1039%2FC4CC08798D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cagide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Accelerating lead optimization of chromone carboxamide scaffold throughout microwave-assisted organic synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6449</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2011.09.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.tetlet.2011.09.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=6446-6449&author=F.+Cagideauthor=J.+Reisauthor=A.+Gasparauthor=F.+Borges&title=Accelerating+lead+optimization+of+chromone+carboxamide+scaffold+throughout+microwave-assisted+organic+synthesis&doi=10.1016%2Fj.tetlet.2011.09.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.09.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.09.095%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DAccelerating%2520lead%2520optimization%2520of%2520chromone%2520carboxamide%2520scaffold%2520throughout%2520microwave-assisted%2520organic%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D6446%26epage%3D6449%26doi%3D10.1016%2Fj.tetlet.2011.09.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Vedachalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorityala, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.-W.</span><span> </span><span class="NLM_article-title">N-Heterocyclic carbene-catalyzed intramolecular aldehyde–nitrile cross coupling: an easy access to 3- aminochromones</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1021/ol9026232</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9026232" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=352-355&author=S.+Vedachalamauthor=J.+Zengauthor=B.+K.+Gorityalaauthor=M.+Antonioauthor=X.-W.+Liu&title=N-Heterocyclic+carbene-catalyzed+intramolecular+aldehyde%E2%80%93nitrile+cross+coupling%3A+an+easy+access+to+3-+aminochromones&doi=10.1021%2Fol9026232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol9026232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9026232%26sid%3Dliteratum%253Aachs%26aulast%3DVedachalam%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DGorityala%26aufirst%3DB.%2BK.%26aulast%3DAntonio%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.-W.%26atitle%3DN-Heterocyclic%2520carbene-catalyzed%2520intramolecular%2520aldehyde%25E2%2580%2593nitrile%2520cross%2520coupling%253A%2520an%2520easy%2520access%2520to%25203-%2520aminochromones%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D352%26epage%3D355%26doi%3D10.1021%2Fol9026232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lg-2o-JaBhRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Joshi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandhane, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badadhe, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, C. H.</span><span> </span><span class="NLM_article-title">Development of practical methodologies for the synthesis of novel 3(4-oxo-4<i>H</i>-chromen-3-yl)acrylic acid hydrazides</span> <span class="citation_source-journal">Ultrason. Sonochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1016/j.ultsonch.2010.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.ultsonch.2010.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=21112230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ensbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=735-738&author=R.+S.+Joshiauthor=P.+G.+Mandhaneauthor=P.+V.+Badadheauthor=C.+H.+Gill&title=Development+of+practical+methodologies+for+the+synthesis+of+novel+3%284-oxo-4H-chromen-3-yl%29acrylic+acid+hydrazides&doi=10.1016%2Fj.ultsonch.2010.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of practical methodologies for the synthesis of novel 3-(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides</span></div><div class="casAuthors">Joshi, Ratnadeep S.; Mandhane, Priyanka G.; Badadhe, Pravin V.; Gill, Charansingh H.</div><div class="citationInfo"><span class="NLM_cas:title">Ultrasonics Sonochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-738</span>CODEN:
                <span class="NLM_cas:coden">ULSOER</span>;
        ISSN:<span class="NLM_cas:issn">1350-4177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report a new environmentally-benign, convenient and facile methodol. for the synthesis of new series of 3-(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides derivs.I (R1 = H, Me, Cl; R2 = H, Me; R3 = H, Me, Co, Br) designed by exploring the mol. hybridization approach between isoniazide and 3-(4-oxo-4H-chromen-3-yl)acrylic acids by using EDCl/HOBt under ultrasound irradn. in very short reaction time.  Utilization of easy reaction conditions, isolation and purifn. makes this manipulation very interesting from an economic perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI45bfa1M2grVg90H21EOLACvtfcHk0lg-2o-JaBhRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ensbk%253D&md5=158a49ffefd27a8954280acd2afc8a04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ultsonch.2010.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ultsonch.2010.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DR.%2BS.%26aulast%3DMandhane%26aufirst%3DP.%2BG.%26aulast%3DBadadhe%26aufirst%3DP.%2BV.%26aulast%3DGill%26aufirst%3DC.%2BH.%26atitle%3DDevelopment%2520of%2520practical%2520methodologies%2520for%2520the%2520synthesis%2520of%2520novel%25203%25284-oxo-4H-chromen-3-yl%2529acrylic%2520acid%2520hydrazides%26jtitle%3DUltrason.%2520Sonochem.%26date%3D2011%26volume%3D18%26spage%3D735%26epage%3D738%26doi%3D10.1016%2Fj.ultsonch.2010.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">914</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.ejmech.2012.05.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=914-918&author=A.+Gasparauthor=J.+Reisauthor=M.+J.+Matosauthor=E.+Uriarteauthor=F.+Borges&title=In+search+for+new+chemical+entities+as+adenosine+receptor+ligands%3A+development+of+agents+based+on+benzo-%CE%B3-pyrone+skeleton&doi=10.1016%2Fj.ejmech.2012.05.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DIn%2520search%2520for%2520new%2520chemical%2520entities%2520as%2520adenosine%2520receptor%2520ligands%253A%2520development%2520of%2520agents%2520based%2520on%2520benzo-%25CE%25B3-pyrone%2520skeleton%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D914%26epage%3D918%26doi%3D10.1016%2Fj.ejmech.2012.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgKd1YV7fiHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0lgKd1YV7fiHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, R. J.</span><span> </span><span class="NLM_article-title">A new paradigm for navigating compound property related drug attrition</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.drudis.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.drudis.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=26404453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=72-81&author=P.+Bartonauthor=R.+J.+Riley&title=A+new+paradigm+for+navigating+compound+property+related+drug+attrition&doi=10.1016%2Fj.drudis.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for navigating compound property related drug attrition</span></div><div class="casAuthors">Barton Patrick; Riley Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Improving the efficiency of drug discovery remains a major focus for the pharmaceutical industry.  Toxicity accounts for 90% of withdrawals and major early-stage terminations relate to suboptimal efficacy and safety.  Traditional oral drug space is well defined with respect to physicochemical properties and ADMET risks but increased focus on ligand-lipophilicity efficiency, maximizing enthalpy contributions and new target classes challenge this paradigm.  A hybrid space has been identified that combines physical properties and key interactions attributable to drug transporters.  A novel algorithm is proposed that incorporates drug-transporter interactions and its utility evaluated against popular ligand efficiency indices.  Simply reducing the bulk properties of compounds can exchange one problem for another and creates high-risk areas that challenge the successful delivery from a balanced portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw28fh-W5ywlm8bhe6roZYfW6udTcc2eY3I4FwKsspmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D&md5=8f9412912d498680db5bcc2d9880efe2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DA%2520new%2520paradigm%2520for%2520navigating%2520compound%2520property%2520related%2520drug%2520attrition%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.drudis.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0ljcugZd-zQoJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0ljcugZd-zQoJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebHPTZrdDfxW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lguvuh9D_sJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lobner, D.</span><span> </span><span class="NLM_article-title">Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/S0165-0270(99)00193-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2FS0165-0270%2899%2900193-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10720679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslals7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=147-152&author=D.+Lobner&title=Comparison+of+the+LDH+and+MTT+assays+for+quantifying+cell+death%3A+validity+for+neuronal+apoptosis%3F&doi=10.1016%2FS0165-0270%2899%2900193-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?</span></div><div class="casAuthors">Lobner, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Neuronal apoptosis induced in cortical cultures by exposure to serum deprivation, staurosporine, nifedipine, or C2-ceramide was assayed by lactate dehydrogenase (LDH) release or inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) redn.  He protective effects of neurotrophin 4, Z-Val-Ala-Asp-fluoromethylketone (ZVAD), and cycloheximide against each insult were also assayed.  The level of injury for each insult was similar whether detd. by LDH release or inhibition of MTT redn., but the effects of anti-apoptotic agents were assay-dependent.  ZVAD and cycloheximide protected neurons from nifedipine-induced death, when assayed by LDH release, but not MTT redn.  In contrast, only cycloheximide attenuated C2-ceramide-induced LDH release while ZVAD and cycloheximide actually enhanced the C2-ceramide induced inhibition of MTT redn.  Counting of trypan blue-pos. cells provided results consistent with values obtained using the LDH assay.  These results indicate that both LDH release and MTT redn. accurately det. the apoptotic death of neurons.  However, the MTT assay does not always correctly quantify neuroprotective effects and this likely reflects differences in the point of the death pathway that the neuroprotective agents act.  Therefore, while the MTT assay is of limited value in assessing the efficacy of neuroprotective strategies, it may provide information regarding whether specific anti-apoptotic agents act up or downstream of mitochondrial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruv957Ff1DLrVg90H21EOLACvtfcHk0lguvuh9D_sJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslals7c%253D&md5=e674cf3bc4a67d659c3b977255f04692</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0165-0270%2899%2900193-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0270%252899%252900193-4%26sid%3Dliteratum%253Aachs%26aulast%3DLobner%26aufirst%3DD.%26atitle%3DComparison%2520of%2520the%2520LDH%2520and%2520MTT%2520assays%2520for%2520quantifying%2520cell%2520death%253A%2520validity%2520for%2520neuronal%2520apoptosis%253F%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2000%26volume%3D96%26spage%3D147%26epage%3D152%26doi%3D10.1016%2FS0165-0270%2899%2900193-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chimenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span> </span><span class="NLM_article-title">Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5715</span><span class="NLM_x">–</span> <span class="NLM_lpage">5723</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmc.2010.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5715-5723&author=F.+Chimentiauthor=A.+Bolascoauthor=D.+Secciauthor=P.+Chimentiauthor=A.+Graneseauthor=S.+Carradoriauthor=M.+Yanezauthor=F.+Oralloauthor=F.+Ortusoauthor=S.+Alcaro&title=Investigations+on+the+2-thiazolylhydrazyne+scaffold%3A+synthesis+and+molecular+modeling+of+selective+human+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26atitle%3DInvestigations%2520on%2520the%25202-thiazolylhydrazyne%2520scaffold%253A%2520synthesis%2520and%2520molecular%2520modeling%2520of%2520selective%2520human%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5715%26epage%3D5723%26doi%3D10.1016%2Fj.bmc.2010.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lj6IuTYQ39_3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Son, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukihara, T.</span><span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span><span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-A+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lj6IuTYQ39_3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-A%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>MacroModel, version <span class="NLM_edition">10.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%2C+version+10.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Maestro, version <span class="NLM_edition">10.2</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+10.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span>Glide, version <span class="NLM_edition">6.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+6.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span>Impact, version <span class="NLM_edition">6.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+6.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>Desmond Molecular Dynamics System, version <span class="NLM_edition">4.2</span>; <span class="NLM_publisher-name">D. E. Shaw Research</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desmond+Molecular+Dynamics+System%2C+version+4.2%3B+D.+E.+Shaw+Research%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%2520Shaw%2520Research%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 49 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elisa Sassetti, Mads H. Clausen, <span class="NLM_string-name hlFld-ContribAuthor">Luca Laraia</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Reactive Oxygen Species Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5252-5275. <a href="https://doi.org/10.1021/acs.jmedchem.0c01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BReactive%252BOxygen%252BSpecies%252BProduction%26aulast%3DSassetti%26aufirst%3DElisa%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04112020%26date%3D15042021%26volume%3D64%26issue%3D9%26spage%3D5252%26epage%3D5275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chuan-Fei Jin, Zhi-Zheng Wang, Kang-Zhi Chen, Teng-Fei Xu, <span class="NLM_string-name hlFld-ContribAuthor">Ge-Fei Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 15021-15036. <a href="https://doi.org/10.1021/acs.jmedchem.0c01663" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01663%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252BFragment-Based%252BDesign%252BFacilitates%252BDiscovery%252Bof%252BPotent%252Band%252BSelective%252BMonoamine%252BOxidase-B%252B%252528MAO-B%252529%252BInhibitor%26aulast%3DJin%26aufirst%3DChuan-Fei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23092020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D15021%26epage%3D15036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan-Fa Yu, Chen Zhang, Yi-You Huang, Sirui Zhang, Qian Zhou, Xiangmin Li, Zengwei Lai, Zhe Li, Yuqi Gao, Yinuo Wu, Lei Guo, Deyan Wu, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     , 1058-1071. <a href="https://doi.org/10.1021/acschemneuro.0c00024" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BChromone%252BDerivatives%252Bas%252BNovel%252BSelective%252BPhosphodiesterase%252B10%252BInhibitors%26aulast%3DYu%26aufirst%3DYan-Fa%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14012020%26date%3D27022020%26date%3D11032020%26date%3D27022020%26volume%3D11%26issue%3D7%26spage%3D1058%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carina Lemke, Joscha Christmann, Jiafei Yin, José M. Alonso, Estefanía Serrano, Mourad Chioua, Lhassane Ismaili, María Angeles Martínez-Grau, Christopher D. Beadle, Tatiana Vetman, Florian M. Dato, Ulrike Bartz, Paul W. Elsinghorst, Markus Pietsch, Christa E. Müller, Isabel Iriepa, Timo Wille, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Michael Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Chromenones as Multineurotargeting Inhibitors of Human Enzymes. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (26)
                                     , 22161-22168. <a href="https://doi.org/10.1021/acsomega.9b03409" title="DOI URL">https://doi.org/10.1021/acsomega.9b03409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DChromenones%252Bas%252BMultineurotargeting%252BInhibitors%252Bof%252BHuman%252BEnzymes%26aulast%3DLemke%26aufirst%3DCarina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14102019%26date%3D21112019%26date%3D11122019%26volume%3D4%26issue%3D26%26spage%3D22161%26epage%3D22168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlos Fernandes, Cláudia Martins, André Fonseca, Rute Nunes, Maria João Matos, Renata Silva, Jorge Garrido, Bruno Sarmento, Fernando Remião, Francisco J. Otero-Espinar, Eugenio Uriarte, <span class="NLM_string-name hlFld-ContribAuthor">Fernanda Borges</span>. </span><span class="cited-content_cbyCitation_article-title">PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2018,</strong> <em>10 </em>
                                    (46)
                                     , 39557-39569. <a href="https://doi.org/10.1021/acsami.8b17224" title="DOI URL">https://doi.org/10.1021/acsami.8b17224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.8b17224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.8b17224%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DPEGylated%252BPLGA%252BNanoparticles%252BAs%252Ba%252BSmart%252BCarrier%252Bto%252BIncrease%252Bthe%252BCellular%252BUptake%252Bof%252Ba%252BCoumarin-Based%252BMonoamine%252BOxidase%252BB%252BInhibitor%26aulast%3DFernandes%26aufirst%3DCarlos%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05102018%26date%3D23102018%26date%3D09112018%26date%3D23102018%26volume%3D10%26issue%3D46%26spage%3D39557%26epage%3D39569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joana Reis, Nicola Manzella, Fernando Cagide, Jeanne Mialet-Perez, Eugenio Uriarte, Angelo Parini, Fernanda Borges, <span class="NLM_string-name hlFld-ContribAuthor">Claudia Binda</span>. </span><span class="cited-content_cbyCitation_article-title">Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (9)
                                     , 4203-4212. <a href="https://doi.org/10.1021/acs.jmedchem.8b00357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTight-Binding%252BInhibition%252Bof%252BHuman%252BMonoamine%252BOxidase%252BB%252Bby%252BChromone%252BAnalogs%25253A%252BA%252BKinetic%25252C%252BCrystallographic%25252C%252Band%252BBiological%252BAnalysis%26aulast%3DReis%26aufirst%3DJoana%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06032018%26date%3D20042018%26date%3D12042018%26volume%3D61%26issue%3D9%26spage%3D4203%26epage%3D4212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana  Reis</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gaspar</span>, <span class="hlFld-ContribAuthor ">Nuno  Milhazes</span>, and <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>  . </span><span class="cited-content_cbyCitation_article-title">Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 7941-7957. <a href="https://doi.org/10.1021/acs.jmedchem.6b01720" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01720%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D4960%26epage%3D4992%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChromone%252Bas%252Ba%252BPrivileged%252BScaffold%252Bin%252BDrug%252BDiscovery%25253A%252BRecent%252BAdvances%26aulast%3DReis%26aufirst%3DJoana%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D10122016%26date%3D13062017%26date%3D12102017%26date%3D24052017%26volume%3D60%26issue%3D19%26spage%3D7941%26epage%3D7957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Fonseca</span>, <span class="hlFld-ContribAuthor ">Joana  Reis</span>, <span class="hlFld-ContribAuthor ">Tiago  Silva</span>, <span class="hlFld-ContribAuthor ">Maria João  Matos</span>, <span class="hlFld-ContribAuthor ">Donatella  Bagetta</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, and <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>  . </span><span class="cited-content_cbyCitation_article-title">Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 7206-7212. <a href="https://doi.org/10.1021/acs.jmedchem.7b00918" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00918%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCoumarin%252Bversus%252BChromone%252BMonoamine%252BOxidase%252BB%252BInhibitors%25253A%252BQuo%252BVadis%25253F%26aulast%3DFonseca%26aufirst%3DAndr%25C3%25A9%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21062017%26date%3D10082017%26date%3D24082017%26date%3D28072017%26volume%3D60%26issue%3D16%26spage%3D7206%26epage%3D7212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamal  Rafique</span>, <span class="hlFld-ContribAuthor ">Sumbal  Saba</span>, <span class="hlFld-ContribAuthor ">Alex R.  Schneider</span>, <span class="hlFld-ContribAuthor ">Marcelo S.  Franco</span>, <span class="hlFld-ContribAuthor ">Symara M.  Silva</span>, and <span class="hlFld-ContribAuthor ">Antonio L.  Braga</span>  . </span><span class="cited-content_cbyCitation_article-title">Metal- and Solvent-Free Approach to Access 3-Se/S-Chromones from the Cyclization of Enaminones in the Presence of Dichalcogenides Catalyzed by KIO3. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (5)
                                     , 2280-2290. <a href="https://doi.org/10.1021/acsomega.7b00445" title="DOI URL">https://doi.org/10.1021/acsomega.7b00445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b00445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b00445%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DMetal-%252Band%252BSolvent-Free%252BApproach%252Bto%252BAccess%252B3-Se%25252FS-Chromones%252Bfrom%252Bthe%252BCyclization%252Bof%252BEnaminones%252Bin%252Bthe%252BPresence%252Bof%252BDichalcogenides%252BCatalyzed%252Bby%252BKIO3%26aulast%3DRafique%26aufirst%3DJamal%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12042017%26date%3D11052017%26date%3D31052017%26volume%3D2%26issue%3D5%26spage%3D2280%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">Al  Balushi K</span>, <span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">Shah Alam  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1241 </em>, 130618. <a href="https://doi.org/10.1016/j.molstruc.2021.130618" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DCoumarin%252Blinked%252Bheterocyclic%252Bhybrids%25253A%252BA%252Bpromising%252Bapproach%252Bto%252Bdevelop%252Bmulti%252Btarget%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DHusain%26aufirst%3DAsif%26date%3D2021%26volume%3D1241%26spage%3D130618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arzu Özek  Yıldırım</span>, <span class="hlFld-ContribAuthor ">Muhammet Hakkı  Yıldırım</span>, <span class="hlFld-ContribAuthor ">Çiğdem Albayrak  Kaştaş</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Spectroscopic, Conceptual DFT Characterization and Molecular Docking Studies of Two Versatile di-Bromobenzaldehyde Derived Compounds. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>47 </em>, 1-17. <a href="https://doi.org/10.1080/10406638.2021.1946095" title="DOI URL">https://doi.org/10.1080/10406638.2021.1946095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2021.1946095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2021.1946095%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DSynthesis%25252C%252BSpectroscopic%25252C%252BConceptual%252BDFT%252BCharacterization%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BTwo%252BVersatile%252Bdi-Bromobenzaldehyde%252BDerived%252BCompounds%26aulast%3DY%25C4%25B1ld%25C4%25B1r%25C4%25B1m%26aufirst%3DArzu%2B%25C3%2596zek%26date%3D2021%26date%3D2021%26volume%3D47%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohan  Gupta</span>, <span class="hlFld-ContribAuthor ">Devesh  Srivastava</span>, <span class="hlFld-ContribAuthor ">Mehar  Sahu</span>, <span class="hlFld-ContribAuthor ">Swati  Tiwari</span>, <span class="hlFld-ContribAuthor ">Rashmi K.  Ambasta</span>, <span class="hlFld-ContribAuthor ">Pravir  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Artificial intelligence to deep learning: machine intelligence approach for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1007/s11030-021-10217-3" title="DOI URL">https://doi.org/10.1007/s11030-021-10217-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-021-10217-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-021-10217-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DArtificial%252Bintelligence%252Bto%252Bdeep%252Blearning%25253A%252Bmachine%252Bintelligence%252Bapproach%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DGupta%26aufirst%3DRohan%26date%3D2021%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Mesiti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Maruca</span>, <span class="hlFld-ContribAuthor ">Vera  Silva</span>, <span class="hlFld-ContribAuthor ">Roberta  Rocca</span>, <span class="hlFld-ContribAuthor ">Carlos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Fernando  Remião</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Alexandra  Gaspar</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">4-Oxoquinolines and monoamine oxidase: When tautomerism matters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113183. <a href="https://doi.org/10.1016/j.ejmech.2021.113183" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113183%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Oxoquinolines%252Band%252Bmonoamine%252Boxidase%25253A%252BWhen%252Btautomerism%252Bmatters%26aulast%3DMesiti%26aufirst%3DFrancesco%26date%3D2021%26volume%3D213%26spage%3D113183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratibha  Sharma</span>, <span class="hlFld-ContribAuthor ">Manjinder  Singh</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">An Update of Synthetic Approaches and Structure‐Activity Relationships of Various Classes of Human MAO‐B Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (7)
                                     , 1404-1429. <a href="https://doi.org/10.1002/slct.202004188" title="DOI URL">https://doi.org/10.1002/slct.202004188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004188%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAn%252BUpdate%252Bof%252BSynthetic%252BApproaches%252Band%252BStructure%2525E2%252580%252590Activity%252BRelationships%252Bof%252BVarious%252BClasses%252Bof%252BHuman%252BMAO%2525E2%252580%252590B%252BInhibitors%26aulast%3DSharma%26aufirst%3DPratibha%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D7%26spage%3D1404%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanqin  Wang</span>, <span class="hlFld-ContribAuthor ">Biao  Hu</span>, <span class="hlFld-ContribAuthor ">Qiaohe  Zhang</span>, <span class="hlFld-ContribAuthor ">Siyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuxuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Biao  Zhang</span>, <span class="hlFld-ContribAuthor ">Fuchao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Selectfluor-triggered fluorination/cyclization of
              o
              -hydroxyarylenaminones: A facile access to 3-fluoro-chromones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2021,</strong> <em>45 </em>
                                    (1-2)
                                     , 95-101. <a href="https://doi.org/10.1177/1747519820923084" title="DOI URL">https://doi.org/10.1177/1747519820923084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1747519820923084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1747519820923084%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSelectfluor-triggered%252Bfluorination%25252Fcyclization%252Bof%252Bo%252B-hydroxyarylenaminones%25253A%252BA%252Bfacile%252Baccess%252Bto%252B3-fluoro-chromones%26aulast%3DWang%26aufirst%3DYanqin%26date%3D2021%26date%3D2020%26volume%3D45%26issue%3D1-2%26spage%3D95%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammed  Çeçen</span>, <span class="hlFld-ContribAuthor ">Jong Min  Oh</span>, <span class="hlFld-ContribAuthor ">Zeynep  Özdemir</span>, <span class="hlFld-ContribAuthor ">Saliha Ebru  Büyüktuncel</span>, <span class="hlFld-ContribAuthor ">Mehtap  Uysal</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Abdelgawad</span>, <span class="hlFld-ContribAuthor ">Arafa  Musa</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (22)
                                     , 5371. <a href="https://doi.org/10.3390/molecules25225371" title="DOI URL">https://doi.org/10.3390/molecules25225371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25225371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25225371%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BPyridazinones%252BContaining%252Bthe%252B%2525282-Fluorophenyl%252529%252BPiperazine%252BMoiety%252Bas%252BSelective%252BMAO-B%252BInhibitors%26aulast%3D%25C3%2587e%25C3%25A7en%26aufirst%3DMuhammed%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D22%26spage%3D5371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Begüm Nurpelin  Sağlık</span>, <span class="hlFld-ContribAuthor ">Betül  Kaya Çavuşoğlu</span>, <span class="hlFld-ContribAuthor ">Ulviye  Acar Çevik</span>, <span class="hlFld-ContribAuthor ">Derya  Osmaniye</span>, <span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Yusuf  Özkay</span>, <span class="hlFld-ContribAuthor ">Zafer Asım  Kaplancıklı</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors – design, synthesis, biological evaluation and molecular modelling. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1063-1074. <a href="https://doi.org/10.1039/D0MD00150C" title="DOI URL">https://doi.org/10.1039/D0MD00150C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00150C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00150C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B1%25252C3%25252C4-thiadiazole%252Bcompounds%252Bas%252Bpotential%252BMAO-A%252Binhibitors%252B%2525E2%252580%252593%252Bdesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%26aulast%3DSa%25C4%259Fl%25C4%25B1k%26aufirst%3DBeg%25C3%25BCm%2BNurpelin%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D1063%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  He</span>, <span class="hlFld-ContribAuthor ">Wen‐Yong  Han</span>, <span class="hlFld-ContribAuthor ">Bao‐Dong  Cui</span>, <span class="hlFld-ContribAuthor ">Nan‐Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Yong‐Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Assembly of Molecular Complexity Enabled by Palladium‐Catalyzed Heck Coupling/C(
              sp
              2
              )−H Activation/ C(
              sp
              3
              )−H Activation Cascade. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (17)
                                     , 3655-3661. <a href="https://doi.org/10.1002/adsc.202000488" title="DOI URL">https://doi.org/10.1002/adsc.202000488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000488%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BAssembly%252Bof%252BMolecular%252BComplexity%252BEnabled%252Bby%252BPalladium%2525E2%252580%252590Catalyzed%252BHeck%252BCoupling%25252FC%252528%252Bsp%252B2%252B%252529%2525E2%252588%252592H%252BActivation%25252F%252BC%252528%252Bsp%252B3%252B%252529%2525E2%252588%252592H%252BActivation%252BCascade%26aulast%3DHe%26aufirst%3DChen%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D17%26spage%3D3655%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Chunli  Tang</span>, <span class="hlFld-ContribAuthor ">Chengyun  Pang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Yuelian  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Nong</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Maojun  Cheng</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Ningsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112475. <a href="https://doi.org/10.1016/j.ejmech.2020.112475" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112475%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Brasagiline-clorgyline%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidase-B%252Band%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2020%26volume%3D202%26spage%3D112475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jebiti  Haribabu</span>, <span class="hlFld-ContribAuthor ">Chandrasekar  Balachandran</span>, <span class="hlFld-ContribAuthor ">Manoharan Muthu  Tamizh</span>, <span class="hlFld-ContribAuthor ">Yuvaraj  Arun</span>, <span class="hlFld-ContribAuthor ">Nattamai S.P.  Bhuvanesh</span>, <span class="hlFld-ContribAuthor ">Shin  Aoki</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Karvembu</span>. </span><span class="cited-content_cbyCitation_article-title">Unprecedented formation of palladium(II)-pyrazole based thiourea from chromone thiosemicarbazone and [PdCl2(PPh3)2]: Interaction with biomolecules and apoptosis through mitochondrial signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2020,</strong> <em>205 </em>, 110988. <a href="https://doi.org/10.1016/j.jinorgbio.2019.110988" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2019.110988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2019.110988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2019.110988%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DUnprecedented%252Bformation%252Bof%252Bpalladium%252528II%252529-pyrazole%252Bbased%252Bthiourea%252Bfrom%252Bchromone%252Bthiosemicarbazone%252Band%252B%25255BPdCl2%252528PPh3%2525292%25255D%25253A%252BInteraction%252Bwith%252Bbiomolecules%252Band%252Bapoptosis%252Bthrough%252Bmitochondrial%252Bsignaling%252Bpathway%26aulast%3DHaribabu%26aufirst%3DJebiti%26date%3D2020%26volume%3D205%26spage%3D110988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Kong</span>, <span class="hlFld-ContribAuthor ">Demeng  Sun</span>, <span class="hlFld-ContribAuthor ">Yanmei  Jiang</span>, <span class="hlFld-ContribAuthor ">Yun  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1513-1523. <a href="https://doi.org/10.1080/14756366.2020.1797711" title="DOI URL">https://doi.org/10.1080/14756366.2020.1797711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1797711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1797711%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B1%25252C%252B4-benzodioxan-substituted%252Bchalcones%252Bas%252Bselective%252Band%252Breversible%252Binhibitors%252Bof%252Bhuman%252Bmonoamine%252Boxidase%252BB%26aulast%3DKong%26aufirst%3DZhuo%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1513%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Sora  Paik</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of
              N
              -(1-(3-fluorobenzoyl)-1
              H
              -indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1568-1580. <a href="https://doi.org/10.1080/14756366.2020.1800666" title="DOI URL">https://doi.org/10.1080/14756366.2020.1800666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1800666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1800666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN%252B-%2525281-%2525283-fluorobenzoyl%252529-1%252BH%252B-indol-5-yl%252529pyrazine-2-carboxamide%25253A%252Ba%252Bnovel%25252C%252Bselective%25252C%252Band%252Bcompetitive%252Bindole-based%252Blead%252Binhibitor%252Bfor%252Bhuman%252Bmonoamine%252Boxidase%252BB%26aulast%3DElkamhawy%26aufirst%3DAhmed%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1568%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 995-1035. <a href="https://doi.org/10.1080/17460441.2019.1637415" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhuman%252Bmonoamine%252Boxidase-B%252Binhibitors%25253A%252Bis%252Bthere%252Broom%252Bfor%252Bimprovement%25253F%26aulast%3DGuglielmi%26aufirst%3DPaolo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D995%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1603-1706. <a href="https://doi.org/10.1002/med.21561" title="DOI URL">https://doi.org/10.1002/med.21561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21561%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMonoamine%252Boxidase-B%252Binhibitors%252Bas%252Bpotential%252Bneurotherapeutic%252Bagents%25253A%252BAn%252Boverview%252Band%252Bupdate%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1603%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nithya  Murugesh</span>, <span class="hlFld-ContribAuthor ">Jebiti  Haribabu</span>, <span class="hlFld-ContribAuthor ">Krishnamoorthy  Arumugam</span>, <span class="hlFld-ContribAuthor ">Chandrasekar  Balachandran</span>, <span class="hlFld-ContribAuthor ">Rajagopal  Swaathy</span>, <span class="hlFld-ContribAuthor ">Shin  Aoki</span>, <span class="hlFld-ContribAuthor ">Anandaram  Sreekanth</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Karvembu</span>, <span class="hlFld-ContribAuthor ">Seenuvasan  Vedachalam</span>. </span><span class="cited-content_cbyCitation_article-title">NHC-catalyzed green synthesis of functionalized chromones: DFT mechanistic insights and
              in vitro
              activities in cancer cells. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (34)
                                     , 13509-13525. <a href="https://doi.org/10.1039/C9NJ02650A" title="DOI URL">https://doi.org/10.1039/C9NJ02650A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ02650A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ02650A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNHC-catalyzed%252Bgreen%252Bsynthesis%252Bof%252Bfunctionalized%252Bchromones%25253A%252BDFT%252Bmechanistic%252Binsights%252Band%252Bin%252Bvitro%252Bactivities%252Bin%252Bcancer%252Bcells%26aulast%3DMurugesh%26aufirst%3DNithya%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D34%26spage%3D13509%26epage%3D13525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Mellado</span>, <span class="hlFld-ContribAuthor ">Cristian O.  Salas</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Carlos  Jara‐Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Maria J.  Matos</span>, <span class="hlFld-ContribAuthor ">Mauricio  Cuellar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (26)
                                     , 7698-7703. <a href="https://doi.org/10.1002/slct.201901282" title="DOI URL">https://doi.org/10.1002/slct.201901282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201901282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201901282%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BDocking%252BCalculations%252Bof%252BPrenylated%252BChalcones%252Bas%252BSelective%252BMonoamine%252BOxidase%252BB%252BInhibitors%252Bwith%252BAntioxidant%252BActivity%26aulast%3DMellado%26aufirst%3DMarco%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D26%26spage%3D7698%26epage%3D7703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Pinto</span>, <span class="hlFld-ContribAuthor ">Carlos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Eva  Martins</span>, <span class="hlFld-ContribAuthor ">Renata  Silva</span>, <span class="hlFld-ContribAuthor ">Sofia  Benfeito</span>, <span class="hlFld-ContribAuthor ">Fernando  Cagide</span>, <span class="hlFld-ContribAuthor ">Ricardo F.  Mendes</span>, <span class="hlFld-ContribAuthor ">Filipe A.  Almeida Paz</span>, <span class="hlFld-ContribAuthor ">Jorge  Garrido</span>, <span class="hlFld-ContribAuthor ">Fernando  Remião</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2019,</strong> <em>11 </em>
                                    (7)
                                     , 331. <a href="https://doi.org/10.3390/pharmaceutics11070331" title="DOI URL">https://doi.org/10.3390/pharmaceutics11070331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics11070331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics11070331%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DBoosting%252BDrug%252BDiscovery%252Bfor%252BParkinson%2525E2%252580%252599s%25253A%252BEnhancement%252Bof%252Bthe%252BDelivery%252Bof%252Ba%252BMonoamine%252BOxidase-B%252BInhibitor%252Bby%252BBrain-Targeted%252BPEGylated%252BPolycaprolactone-Based%252BNanoparticles%26aulast%3DPinto%26aufirst%3DMiguel%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D7%26spage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Juan  Xiong</span>, <span class="hlFld-ContribAuthor ">Hui-Da  Guan</span>, <span class="hlFld-ContribAuthor ">Chang-Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Xinsheng  Lei</span>, <span class="hlFld-ContribAuthor ">Jin-Feng  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, synthesis, biological evaluation and molecular docking study of (R)-5-methylmellein and its analogs as selective monoamine oxidase A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (10)
                                     , 2027-2040. <a href="https://doi.org/10.1016/j.bmc.2019.03.060" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252B%252528R%252529-5-methylmellein%252Band%252Bits%252Banalogs%252Bas%252Bselective%252Bmonoamine%252Boxidase%252BA%252Binhibitors%26aulast%3DHuang%26aufirst%3DChao%26date%3D2019%26volume%3D27%26issue%3D10%26spage%3D2027%26epage%3D2040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Lv</span>, <span class="hlFld-ContribAuthor ">Yongbin  Tian</span>, <span class="hlFld-ContribAuthor ">Haiyan  Kong</span>, <span class="hlFld-ContribAuthor ">Xufeng  Huang</span>, <span class="hlFld-ContribAuthor ">Yajun  Duan</span>, <span class="hlFld-ContribAuthor ">Jihong  Han</span>, <span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (8)
                                     , 1012-1018. <a href="https://doi.org/10.1016/j.bmcl.2019.02.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bhuman%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bbased%252Bon%252Ba%252Bfragment%252Bin%252Ban%252BX-ray%252Bcrystal%252Bstructure%26aulast%3DCheng%26aufirst%3DKai%26date%3D2019%26volume%3D29%26issue%3D8%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Wang</span>, <span class="hlFld-ContribAuthor ">Bo-Cheng  Tang</span>, <span class="hlFld-ContribAuthor ">Jin-Tian  Ma</span>, <span class="hlFld-ContribAuthor ">Zi-Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Chen  Xiang</span>, <span class="hlFld-ContribAuthor ">Yan-Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Jun-Gang  Wang</span>, <span class="hlFld-ContribAuthor ">An-Xin  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">I
              2
              /DMSO-mediated multicomponent reaction of
              o
              -hydroxyaryl methyl ketones, rongalite, and DMSO: access to C3-sulfenylated chromones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (6)
                                     , 1535-1541. <a href="https://doi.org/10.1039/C8OB02994F" title="DOI URL">https://doi.org/10.1039/C8OB02994F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02994F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02994F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DI%252B2%252B%25252FDMSO-mediated%252Bmulticomponent%252Breaction%252Bof%252Bo%252B-hydroxyaryl%252Bmethyl%252Bketones%25252C%252Brongalite%25252C%252Band%252BDMSO%25253A%252Baccess%252Bto%252BC3-sulfenylated%252Bchromones%26aulast%3DWang%26aufirst%3DMiao%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D6%26spage%3D1535%26epage%3D1541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. A.  Myannik</span>, <span class="hlFld-ContribAuthor ">I. S.  Semenova</span>, <span class="hlFld-ContribAuthor ">V. N.  Yarovenko</span>, <span class="hlFld-ContribAuthor ">M. M.  Krayushkin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-(N-arylcarbamoyl)chromones from 2-hydroxyarylaminoenones and isocyanates. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (1)
                                     , 104-109. <a href="https://doi.org/10.1007/s11172-019-2423-5" title="DOI URL">https://doi.org/10.1007/s11172-019-2423-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2423-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2423-5%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%252Bof%252B3-%252528N-arylcarbamoyl%252529chromones%252Bfrom%252B2-hydroxyarylaminoenones%252Band%252Bisocyanates%26aulast%3DMyannik%26aufirst%3DK.%2BA.%26date%3D2019%26date%3D2019%26volume%3D68%26issue%3D1%26spage%3D104%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex France M.  Monteiro</span>, <span class="hlFld-ContribAuthor ">Jéssika De O.  Viana</span>, <span class="hlFld-ContribAuthor ">Anuraj  Nayarisseri</span>, <span class="hlFld-ContribAuthor ">Ernestine N.  Zondegoumba</span>, <span class="hlFld-ContribAuthor ">Francisco Jaime B.  Mendonça Junior</span>, <span class="hlFld-ContribAuthor ">Marcus Tullius  Scotti</span>, <span class="hlFld-ContribAuthor ">Luciana  Scotti</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2018,</strong> <em>2018 </em>, 1-21. <a href="https://doi.org/10.1155/2018/7912765" title="DOI URL">https://doi.org/10.1155/2018/7912765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/7912765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F7912765%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DComputational%252BStudies%252BApplied%252Bto%252BFlavonoids%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Band%252BParkinson%2525E2%252580%252599s%252BDiseases%26aulast%3DMonteiro%26aufirst%3DAlex%2BFrance%2BM.%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shakeel  Ahmad</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Saquib  Jalil</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Matloob  Ahmad</span>, <span class="hlFld-ContribAuthor ">Sadia  Sultan</span>, <span class="hlFld-ContribAuthor ">Mazhar  Iqbal</span>, <span class="hlFld-ContribAuthor ">Sana  Aslam</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 498-510. <a href="https://doi.org/10.1016/j.bioorg.2018.04.012" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bmonoamine%252Boxidase%252Binhibition%25252C%252Bmolecular%252Bdocking%252Band%252Bdynamic%252Bsimulations%252Bof%252Bnovel%252B2%25252C1-benzothiazine-2%25252C2-dioxide%252Bderivatives%26aulast%3DAhmad%26aufirst%3DShakeel%26date%3D2018%26volume%3D80%26spage%3D498%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rani  Sasidharan</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Manju  Sreedharannair Leelabaiamma</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>106 </em>, 8-13. <a href="https://doi.org/10.1016/j.biopha.2018.06.064" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.06.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.06.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.06.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DImidazole%252Bbearing%252Bchalcones%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bmonoamine%252Boxidase%252Binhibitors%26aulast%3DSasidharan%26aufirst%3DRani%26date%3D2018%26volume%3D106%26spage%3D8%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana  Reis</span>, <span class="hlFld-ContribAuthor ">Fernando  Cagide</span>, <span class="hlFld-ContribAuthor ">Martín Estrada  Valencia</span>, <span class="hlFld-ContribAuthor ">José  Teixeira</span>, <span class="hlFld-ContribAuthor ">Donatella  Bagetta</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Paulo J.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 781-800. <a href="https://doi.org/10.1016/j.ejmech.2018.07.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-target-directed%252Bligands%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252BDiscovery%252Bof%252Bchromone-based%252Bmonoamine%252Boxidase%25252Fcholinesterase%252Binhibitors%26aulast%3DReis%26aufirst%3DJoana%26date%3D2018%26volume%3D158%26spage%3D781%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Takao</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yahagi</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Uesawa</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Sugita</span>. </span><span class="cited-content_cbyCitation_article-title">3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>77 </em>, 436-442. <a href="https://doi.org/10.1016/j.bioorg.2018.01.036" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.01.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.01.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D3-%252528E%252529-Styryl-2H-chromene%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Bmonoamine%252Boxidase%252BB%252Binhibitors%26aulast%3DTakao%26aufirst%3DKoichi%26date%3D2018%26volume%3D77%26spage%3D436%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Xiao</span>, <span class="hlFld-ContribAuthor ">Xing-Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioevalucation of novel 2,3-dihydro-1 H -inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 588-593. <a href="https://doi.org/10.1016/j.ejmech.2018.01.029" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.029%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioevalucation%252Bof%252Bnovel%252B2%25252C3-dihydro-1%252BH%252B-inden-1-amine%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Bhuman%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bbased%252Bon%252Brasagiline%26aulast%3DXiao%26aufirst%3DXuan%26date%3D2018%26volume%3D145%26spage%3D588%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seul Ki  Yeon</span>, <span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ye Rim  Lee</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Su Jeong  Shin</span>, <span class="hlFld-ContribAuthor ">Bo Ko  Jang</span>, <span class="hlFld-ContribAuthor ">Siwon  Kim</span>, <span class="hlFld-ContribAuthor ">Yong-Sun  Bahn</span>, <span class="hlFld-ContribAuthor ">Gyoonhee  Han</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (1)
                                     , 232-244. <a href="https://doi.org/10.1016/j.bmc.2017.11.036" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.11.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.11.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bbiaryl%252Bderivatives%252Bfor%252Bstructural%252Bcharacterization%252Bof%252Bselective%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Btoward%252BParkinson%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3DYeon%26aufirst%3DSeul%2BKi%26date%3D2018%26volume%3D26%26issue%3D1%26spage%3D232%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Sanal  Dev</span>, <span class="hlFld-ContribAuthor ">Monu  Joy</span>, <span class="hlFld-ContribAuthor ">Githa E.  Mathew</span>, <span class="hlFld-ContribAuthor ">Akash  Marathakam</span>, <span class="hlFld-ContribAuthor ">Girish K.  Krishnan</span>. </span><span class="cited-content_cbyCitation_article-title">Refining the Structural Features of Chromones as Selective MAO-B Inhibitors: Exploration of Combined Pharmacophore-Based 3D-QSAR and Quantum Chemical Studies. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (35)
                                     , 11645-11652. <a href="https://doi.org/10.1002/slct.201701213" title="DOI URL">https://doi.org/10.1002/slct.201701213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201701213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201701213%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRefining%252Bthe%252BStructural%252BFeatures%252Bof%252BChromones%252Bas%252BSelective%252BMAO-B%252BInhibitors%25253A%252BExploration%252Bof%252BCombined%252BPharmacophore-Based%252B3D-QSAR%252Band%252BQuantum%252BChemical%252BStudies%26aulast%3DMathew%26aufirst%3DBijo%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D35%26spage%3D11645%26epage%3D11652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Carmen  Costas-Lago</span>, <span class="hlFld-ContribAuthor ">Pedro  Besada</span>, <span class="hlFld-ContribAuthor ">Fernanda  Rodríguez-Enríquez</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Santiago  Vilar</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Carmen  Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 1-11. <a href="https://doi.org/10.1016/j.ejmech.2017.07.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252B3-heteroarylcoumarins%252Bbased%252Bon%252Bpyridazine%252Bscaffold%252Bas%252Bselective%252BMAO-B%252Binhibitors%26aulast%3DCostas-Lago%26aufirst%3DMar%25C3%25ADa%2BCarmen%26date%3D2017%26volume%3D139%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Maccioni</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Colombo</span>, <span class="hlFld-ContribAuthor ">Irene  Lorrai</span>, <span class="hlFld-ContribAuthor ">Alessandro  Zaru</span>, <span class="hlFld-ContribAuthor ">Mauro A. M.  Carai</span>, <span class="hlFld-ContribAuthor ">Gian Luigi  Gessa</span>, <span class="hlFld-ContribAuthor ">Antonella  Brizzi</span>, <span class="hlFld-ContribAuthor ">Claudia  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Federico  Corelli</span>. </span><span class="cited-content_cbyCitation_article-title">Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2017,</strong> <em>234 </em>
                                    (17)
                                     , 2525-2543. <a href="https://doi.org/10.1007/s00213-017-4644-3" title="DOI URL">https://doi.org/10.1007/s00213-017-4644-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-017-4644-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-017-4644-3%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DSuppressing%252Beffect%252Bof%252BCOR659%252Bon%252Balcohol%25252C%252Bsucrose%25252C%252Band%252Bchocolate%252Bself-administration%252Bin%252Brats%25253A%252Binvolvement%252Bof%252Bthe%252BGABAB%252Band%252Bcannabinoid%252BCB1%252Breceptors%26aulast%3DMaccioni%26aufirst%3DPaola%26date%3D2017%26date%3D2017%26volume%3D234%26issue%3D17%26spage%3D2525%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gagandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Naman  Gupta</span>, <span class="hlFld-ContribAuthor ">Vivek  Gupta</span>, <span class="hlFld-ContribAuthor ">Mohan Paul Singh  Ishar</span>. </span><span class="cited-content_cbyCitation_article-title">Reduction of chromano–piperidine-fused isoxazolidines: Tandem intramolecular rearrangements leading to 2-(methylamino)-4-oxo- N -phenyl- N -propyl-4 H -chromene-3-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (25)
                                     , 2456-2459. <a href="https://doi.org/10.1016/j.tetlet.2017.05.032" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.032%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DReduction%252Bof%252Bchromano%2525E2%252580%252593piperidine-fused%252Bisoxazolidines%25253A%252BTandem%252Bintramolecular%252Brearrangements%252Bleading%252Bto%252B2-%252528methylamino%252529-4-oxo-%252BN%252B-phenyl-%252BN%252B-propyl-4%252BH%252B-chromene-3-carboxamide%26aulast%3DSingh%26aufirst%3DGagandeep%26date%3D2017%26volume%3D58%26issue%3D25%26spage%3D2456%26epage%3D2459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Domenico  Gadaleta</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Gianluca  Lattanzi</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">A rational approach to elucidate human monoamine oxidase molecular selectivity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>101 </em>, 90-99. <a href="https://doi.org/10.1016/j.ejps.2017.02.008" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DA%252Brational%252Bapproach%252Bto%252Belucidate%252Bhuman%252Bmonoamine%252Boxidase%252Bmolecular%252Bselectivity%26aulast%3DMangiatordi%26aufirst%3DGiuseppe%2BFelice%26date%3D2017%26volume%3D101%26spage%3D90%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naeem  Abbas</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Syeda Mahwish  Bakht</span>, <span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Sadaf  Batool</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Symmetrical aryl linked bis-iminothiazolidinones as new chemical entities for the inhibition of monoamine oxidases: Synthesis, in vitro biological evaluation and molecular modelling analysis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>70 </em>, 17-26. <a href="https://doi.org/10.1016/j.bioorg.2016.11.004" title="DOI URL">https://doi.org/10.1016/j.bioorg.2016.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2016.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSymmetrical%252Baryl%252Blinked%252Bbis-iminothiazolidinones%252Bas%252Bnew%252Bchemical%252Bentities%252Bfor%252Bthe%252Binhibition%252Bof%252Bmonoamine%252Boxidases%25253A%252BSynthesis%25252C%252Bin%252Bvitro%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Banalysis%26aulast%3DAbbas%26aufirst%3DNaeem%26date%3D2017%26volume%3D70%26spage%3D17%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Stammler</span>, <span class="hlFld-ContribAuthor ">Beate  Neumann</span>, <span class="hlFld-ContribAuthor ">Silvia  Hristova</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>, <span class="hlFld-ContribAuthor ">Marcus  Gastreich</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures, binding interactions, and ADME evaluation of brain penetrant  N -substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 470-492. <a href="https://doi.org/10.1016/j.ejmech.2017.01.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructures%25252C%252Bbinding%252Binteractions%25252C%252Band%252BADME%252Bevaluation%252Bof%252Bbrain%252Bpenetrant%252BN%252B-substituted%252Bindazole-5-carboxamides%252Bas%252Bsubnanomolar%25252C%252Bselective%252Bmonoamine%252Boxidase%252BB%252Band%252Bdual%252BMAO-A%25252FB%252Binhibitors%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2017%26volume%3D127%26spage%3D470%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Mobasher Ali  Abid</span>, <span class="hlFld-ContribAuthor ">Sana  Aslam</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Syeda Mahwish  Bakht</span>, <span class="hlFld-ContribAuthor ">Matloob  Ahmad</span>, <span class="hlFld-ContribAuthor ">Muhammad Makshoof  Athar</span>, <span class="hlFld-ContribAuthor ">John M.  Gardiner</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, in vitro bioevaluation and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 452-464. <a href="https://doi.org/10.1039/C6MD00570E" title="DOI URL">https://doi.org/10.1039/C6MD00570E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00570E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00570E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DPyrazolobenzothiazine-based%252Bcarbothioamides%252Bas%252Bnew%252Bstructural%252Bleads%252Bfor%252Bthe%252Binhibition%252Bof%252Bmonoamine%252Boxidases%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Bbioevaluation%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DAbid%26aufirst%3DSyed%2BMobasher%2BAli%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D452%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Gülberk  Uçar</span>, <span class="hlFld-ContribAuthor ">Githa Elizabeth  Mathew</span>, <span class="hlFld-ContribAuthor ">Sincy  Mathew</span>, <span class="hlFld-ContribAuthor ">Praseedha  Kalatharakkal Purapurath</span>, <span class="hlFld-ContribAuthor ">Fasil  Moolayil</span>, <span class="hlFld-ContribAuthor ">Smrithy  Mohan</span>, <span class="hlFld-ContribAuthor ">Sheeba  Varghese Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Monoamine Oxidase Inhibitory Activity: Methyl- versus Chlorochalcone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (24)
                                     , 2649-2655. <a href="https://doi.org/10.1002/cmdc.201600497" title="DOI URL">https://doi.org/10.1002/cmdc.201600497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600497%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMonoamine%252BOxidase%252BInhibitory%252BActivity%25253A%252BMethyl-%252Bversus%252BChlorochalcone%252BDerivatives%26aulast%3DMathew%26aufirst%3DBijo%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D24%26spage%3D2649%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Takao</span>, <span class="hlFld-ContribAuthor ">Takayuki  Saito</span>, <span class="hlFld-ContribAuthor ">Daisuke  Chikuda</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Sugita</span>. </span><span class="cited-content_cbyCitation_article-title">2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2016,</strong> <em>64 </em>
                                    (10)
                                     , 1499-1504. <a href="https://doi.org/10.1248/cpb.c16-00527" title="DOI URL">https://doi.org/10.1248/cpb.c16-00527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00527%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3D2-Azolylchromone%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BMonoamine%252BOxidases%252BA%252Band%252BB%26aulast%3DTakao%26aufirst%3DKoichi%26date%3D2016%26volume%3D64%26issue%3D10%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of known MAO-B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of the lead compound described in previous work<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and rational design strategy followed for lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Strategy Followed for the Synthesis of Chromone-3-phenylcarboxamide Derivatives (<b>2</b>–<b>31</b>) from Chromone-3-carboxylic Acid (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, appropriate arylamine (a<sub>1</sub>), <i>N</i>-methylaniline (a<sub>2</sub>), 4-methylphenol (a<sub>3</sub>), or 4-methylbenzenethiol (a<sub>4</sub>), rt, 1–5 h; (b) TFA, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Strategy Followed for the Synthesis of Chromone Derivative <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 5-(2-hydroxyethyl)-3,4-dimethylthiazolium iodide, DBU, rt, 5 h; (b) POCl<sub>3</sub>, DMF, DIPEA, 4-methylbenzoic acid, rt, 2 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Strategy Followed for the Synthesis of Chromone Derivatives (<b>36</b>–<b>41</b>) from 3-Formylchromone (<b>35</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-methylaniline, Na(AcO)<sub>3</sub>BH, rt, 15 min; (b) malonic acid, pyridine, rt, 1.5 h; (c) PyBOP, appropriate arylamine, DMF, DIPEA, rt, 6 h.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Kinetic studies on the mechanism of <i>h</i>MAO-B inhibition by chromones <b>20</b> (A) and <b>27</b> (B). The effect of the inhibitors on the enzyme was determined from the double reciprocal plot of 1/rate (1/<i>V</i>) versus 1/substrate concentration in the presence of varying concentrations of the inhibitors. The <i>K</i><sub>i</sub> values were calculated by the intersection of the curves obtained by plotting 1/<i>V</i> versus the inhibitor concentration for each substrate concentration (Dixon plots insets in the top left).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent inhibition of recombinant human MAO-B by standard compounds (<i>R</i>)-(−)-deprenyl (50 nM), safinamide (40 nM), and rasagiline (200 nM) (A) and test compounds <b>20</b> (0.7 nM) and compound <b>27</b> (2 nM) (B). The remaining activity was expressed as % of activity. Data are the mean ± SD of three different experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Last MD trajectory frames of <b>20</b> and <b>27</b> interacting with <i>h</i>MAO-A and <i>h</i>MAO-B. Ligands are depicted in polytube. FAD cofactor is depicted in spacefill, and ligand interacting residues are in wireframe and water molecules in ball and sticks notation. Chemical structures are CPK color compliant. Cyan, purple, or yellow dotted lines represent stacking contacts, halogen bonds, or hydrogen bonds, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/medium/jm-2016-00527m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0007.jpeg" id="rightTab-GRAPHIC-d656e2303-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell viability of human neuroblastoma SH-SY5Y cells after a 24 h exposure to chromones <b>20</b> and <b>27</b> at 1 and 10 μM as determined in the MTT reduction (A) and the NR uptake (B) assays. Untreated cells were used as control: (∗∗) <i>p</i> < 0.01 and (∗∗∗) <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-12/acs.jmedchem.6b00527/20160617/images/large/jm-2016-00527m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00527&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, L. G.</span><span> </span><span class="NLM_article-title">Current approaches to the treatment of Parkinson’s disease</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span><span class="refDoi"> DOI: 10.2147/NDT.S2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.2147%2FNDT.S2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=19043519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2mt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=743-757&author=J.+Jankovicauthor=L.+G.+Aguilar&title=Current+approaches+to+the+treatment+of+Parkinson%E2%80%99s+disease&doi=10.2147%2FNDT.S2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to the treatment of Parkinson's disease</span></div><div class="casAuthors">Jankovic, Joseph; Aguilar, L. Giselle</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1176-6328</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Enormous progress has been made in the treatment of Parkinson's disease (PD).  As a result of advances in exptl. therapeutics, many promising therapies for PD are emerging.  Levodopa remains the most potent drug for controlling PD symptoms, yet is assocd. with significant complications such as the "wearing off" effect, levodopa-induced dyskinesias and other motor complications.  Catechol-o-methyl-transferase inhibitors, dopamine agonists and nondopaminergic therapy are alternative modalities in the management of PD and may be used concomitantly with levodopa or one another.  The neurosurgical treatment, focusing on deep brain stimulation, is reviewed briefly.  Although this review has attempted to highlight the most recent advances in the treatment of PD, it is important to note that new treatments are not necessarily better than the established conventional therapy and that the treatment options must be individualized and tailored to the needs of each individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzaZNwdZkoLVg90H21EOLACvtfcHk0lisdrSJOlIcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2mt7fK&md5=ff8bd810fa471e018557d36f9ab42795</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2147%2FNDT.S2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S2006%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DAguilar%26aufirst%3DL.%2BG.%26atitle%3DCurrent%2520approaches%2520to%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2008%26volume%3D4%26spage%3D743%26epage%3D757%26doi%3D10.2147%2FNDT.S2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Present and future drug treatment for Parkinson’s disease</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1472</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span><span class="refDoi"> DOI: 10.1136/jnnp.2004.035980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1136%2Fjnnp.2004.035980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16227533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BD2MrltFSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2005&pages=1472-1478&author=A.+H.+V.+Schapira&title=Present+and+future+drug+treatment+for+Parkinson%E2%80%99s+disease&doi=10.1136%2Fjnnp.2004.035980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Present and future drug treatment for Parkinson's disease</span></div><div class="casAuthors">Schapira A H V</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1472-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Considerable advances made in defining the aetiology, pathogenesis, and pathology of Parkinson's disease (PD) have resulted in the development and rapid expansion of the pharmacopoeia available for treatment.  Anticholinergics were used before the introduction of levodopa which is now the drug most commonly used.  Dopamine agonists are effective when used alone or as an adjunct to levodopa, while monoamine oxidase B inhibitors improve motor function in early and advanced PD.  However, treatment mainly addresses the dopaminergic features of the disease and leaves its progressive course unaffected; the drug treatment available for the management of non-motor symptoms is limited.  This article seeks to set current treatment options in context, review emerging and novel drug treatments for PD, and assess the prospects for disease modification.  Surgical therapies are not considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNpmzSqAT4V7BItaL1WaVAfW6udTcc2ebrO0bPvY1xgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrltFSgtA%253D%253D&md5=8230993f22ce63a3207690bb534e7c07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2004.035980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2004.035980%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DPresent%2520and%2520future%2520drug%2520treatment%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2005%26volume%3D76%26spage%3D1472%26epage%3D1478%26doi%3D10.1136%2Fjnnp.2004.035980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Tipton, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span> </span><span class="NLM_article-title">Monoamine oxidases: certainties and uncertainties</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1982</span><span class="refDoi"> DOI: 10.2174/0929867043364810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.2174%2F0929867043364810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=15279561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1965-1982&author=K.+F.+Tiptonauthor=S.+Boyceauthor=J.+O%27Sullivanauthor=G.+P.+Daveyauthor=J.+Healy&title=Monoamine+oxidases%3A+certainties+and+uncertainties&doi=10.2174%2F0929867043364810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidases: Certainties and uncertainties</span></div><div class="casAuthors">Tipton, Keith F.; Boyce, Sinead; O'Sullivan, Jeff; Davey, Gavin P.; Healy, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1965-1982</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Much has been learned about the behavior of monoamine oxidase (MAO) in the 75 yr since it was 1st discovered, but there is still a great deal left to be understood.  This review concs. on the dynamic aspects of the knowledge of the interactions of MAO with substrates and inhibitors and how it may collaborate with other enzymes, with particular emphasis on aspects that remain to be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCOV1QM-ZWXLVg90H21EOLACvtfcHk0lisdrSJOlIcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7o%253D&md5=cbcc8214e895614a86010dd5438a149e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F0929867043364810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364810%26sid%3Dliteratum%253Aachs%26aulast%3DTipton%26aufirst%3DK.%2BF.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DO%2527Sullivan%26aufirst%3DJ.%26aulast%3DDavey%26aufirst%3DG.%2BP.%26aulast%3DHealy%26aufirst%3DJ.%26atitle%3DMonoamine%2520oxidases%253A%2520certainties%2520and%2520uncertainties%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1965%26epage%3D1982%26doi%3D10.2174%2F0929867043364810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakhle, Y. S.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S287</span><span class="NLM_x">–</span> <span class="NLM_lpage">S296</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fsj.bjp.0706464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16402116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S287-S296&issue=Suppl.+1&author=M.+B.+Youdimauthor=Y.+S.+Bakhle&title=Monoamine+oxidase%3A+isoforms+and+inhibitors+in+Parkinson%E2%80%99s+disease+and+depressive+illness&doi=10.1038%2Fsj.bjp.0706464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness</span></div><div class="casAuthors">Youdim, Moussa B. H.; Bakhle, Y. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S287-S296</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A few years after the foundation of the British Pharmacol. Society, monoamine oxidase (MAO) was recognized as an enzyme of crucial interest to pharmacologists because it catalyzed the major inactivation pathway for the catecholamine neurotransmitters, noradrenaline, adrenaline and dopamine (and, later, 5-hydroxytryptamine, as well).  Within the next decade, the therapeutic value of inhibitors of MAO in the treatment of depressive illness was established.  Although this first clin. use exposed serious side effects, pharmacol. interest in, and investigation of, MAO continued, resulting in the characterization of two isoforms, MAO-A and -B, and isoform-selective inhibitors.  Selective inhibitors of MAO-B have found a therapeutic role in the treatment of Parkinson's disease and further developments have provided reversible inhibitors of MAO-A, which offer antidepressant activity without the serious side effects of the earlier inhibitors.  Clin. observation and subsequent pharmacol. anal. have also generated the concept of neuroprotection, reflecting the possibility of slowing, halting and maybe reversing, neurodegeneration in Parkinson's or Alzheimer's diseases.  Increased levels of oxidative stress in the brain may be crit. for the initiation and progress of neurodegeneration and selective inhibition of brain MAO could contribute importantly to lowering such stress.  There are complex interactions between free iron levels in brain and MAO, which may have practical outcomes for depressive disorders.  These aspects of MAO and its inhibition and some indication of how this important area of pharmacol. and therapeutics might develop in the future are summarized in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDnikJHT_N0LVg90H21EOLACvtfcHk0lisdrSJOlIcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVCltw%253D%253D&md5=0fe90af4656bd06ce1b2266745e1fa98</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706464%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26atitle%3DMonoamine%2520oxidase%253A%2520isoforms%2520and%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520depressive%2520illness%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26issue%3DSuppl.%25201%26spage%3DS287%26epage%3DS296%26doi%3D10.1038%2Fsj.bjp.0706464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s diseases as disease modifying agents</span> <span class="citation_source-journal">Exp. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.5607/en.2010.19.1.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.5607%2Fen.2010.19.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=22110336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FlsFGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1-14&author=M.+B.+H.+Youdim&title=Why+do+we+need+multifunctional+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+and+Alzheimer%E2%80%99s+diseases+as+disease+modifying+agents&doi=10.5607%2Fen.2010.19.1.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents</span></div><div class="casAuthors">Youdim Moussa B H</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parkinson's disease (PD) and Alzheimer's Disease (AD) are severe neurodegenerative disorders, with no drugs that are currently approved to prevent the neuronal cell loss characteristic in brains of patients suffering from PD and AD and all drug treatment are synptomactic.  Due to the complex pathophysiology, including a cascade of neurotoxic molecular events that results in neuronal death and predisposition to depression and eventual dementia and etiology of these disorders, an innovative approach towards neuroprotection or neurorestoration (neurorescue) may be the development and use of multifunctional pharmaceuticals.  Such drugs target an array of pathological pathways, each of which is believed to contribute to the cascades that ultimately lead to neuronal cell death.  In this short review, we discuss examples of novel multifunctional ligands that may have potential as neuroprotective-neurorestorative therapeutics in PD and AD.  The compounds discussed originate from synthetic chemistry as well as from natural sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsSVI6siCAmLHHuJhbyicZfW6udTcc2eZ7DgZVk0DTC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FlsFGnsg%253D%253D&md5=b70e8f5f45610f3a28f059c8835b0e44</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.5607%2Fen.2010.19.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2010.19.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DWhy%2520do%2520we%2520need%2520multifunctional%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520and%2520Alzheimer%25E2%2580%2599s%2520diseases%2520as%2520disease%2520modifying%2520agents%26jtitle%3DExp.%2520Neurobiol.%26date%3D2010%26volume%3D19%26spage%3D1%26epage%3D14%26doi%3D10.5607%2Fen.2010.19.1.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">De la Fuente-Fernández, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtado, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span> </span><span class="NLM_article-title">Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">2747</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span><span class="refDoi"> DOI: 10.1093/brain/awh290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1093%2Fbrain%2Fawh290" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=2747-2754&author=R.+De+la+Fuente-Fern%C3%A1ndezauthor=V.+Sossiauthor=Z.+Huangauthor=S.+Furtadoauthor=J.-Q.+Luauthor=D.+B.+Calneauthor=T.+J.+Ruthauthor=A.+J.+Stoessl&title=Levodopa-induced+changes+in+synaptic+dopamine+levels+increase+with+progression+of+Parkinson%E2%80%99s+disease%3A+implications+for+dyskinesias&doi=10.1093%2Fbrain%2Fawh290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh290%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2Bla%2BFuente-Fern%25C3%25A1ndez%26aufirst%3DR.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DFurtado%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DJ.-Q.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26atitle%3DLevodopa-induced%2520changes%2520in%2520synaptic%2520dopamine%2520levels%2520increase%2520with%2520progression%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520dyskinesias%26jtitle%3DBrain%26date%3D2004%26volume%3D127%26spage%3D2747%26epage%3D2754%26doi%3D10.1093%2Fbrain%2Fawh290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+H.+Youdimauthor=A.+Grossauthor=J.+P.+M.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B&doi=10.1038%2Fsj.bjp.0703826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lhvzHzOakAtkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506%26doi%3D10.1038%2Fsj.bjp.0703826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span><span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+human+monoamine+oxidase+B+complexes+with+selective+noncovalent+inhibitors%3A+safinamide+and+coumarin+analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lhCdeQnPdndxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520human%2520monoamine%2520oxidase%2520B%2520complexes%2520with%2520selective%2520noncovalent%2520inhibitors%253A%2520safinamide%2520and%2520coumarin%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ellis, G. P.</span> <span class="citation_source-book">The Chemistry of Heterocyclic Compounds, Chromenes, Chromanones, and Chromones</span>; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">31</span>, p  <span class="NLM_fpage">1085</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1085&author=G.+P.+Ellis&title=The+Chemistry+of+Heterocyclic+Compounds%2C+Chromenes%2C+Chromanones%2C+and+Chromones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BP.%26btitle%3DThe%2520Chemistry%2520of%2520Heterocyclic%2520Compounds%252C%2520Chromenes%252C%2520Chromanones%252C%2520and%2520Chromones%26pub%3DWiley%26date%3D2009%26volume%3D31%26spage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone: a valid scaffold in medicinal chemistry</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4960</span><span class="NLM_x">–</span> <span class="NLM_lpage">4992</span><span class="refDoi"> DOI: 10.1021/cr400265z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400265z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFOgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=4960-4992&author=A.+Gasparauthor=M.+J.+Matosauthor=J.+Garridoauthor=E.+Uriarteauthor=F.+Borges&title=Chromone%3A+a+valid+scaffold+in+medicinal+chemistry&doi=10.1021%2Fcr400265z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone: A Valid Scaffold in Medicinal Chemistry</span></div><div class="casAuthors">Gaspar, Alexandra; Matos, Maria Joao; Garrido, Jorge; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4960-4992</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chromones are a group of naturally occurring compds. that are ubiquitous in nature, esp. in plants.  The structural diversity found in chromone family led to their roughly division into different categories: simple chromones and fused chromones (pyrano- and furanchromones).  Until now, simple chromones were an up-and-coming area of exploration, and the literature in the area is diffuse.  So, the purpose of this review is to analyze and summarize aspects related to the medicinal chem. artwork performed with simple chromones to look at their potential therapeutic applications.  In addn., information concerning the development of innovative synthetic strategies and biol. applications, with particular emphasis on structure-activity relationships (SAR) will be also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqpH_RyzLjKbVg90H21EOLACvtfcHk0lhCdeQnPdndxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFOgs7k%253D&md5=167a2617312956d2aac7b9a3692c6798</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcr400265z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400265z%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%253A%2520a%2520valid%2520scaffold%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D4960%26epage%3D4992%26doi%3D10.1021%2Fcr400265z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2709</span><span class="NLM_x">–</span> <span class="NLM_lpage">2712</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmcl.2010.03.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2709-2712&author=S.+Alcaroauthor=A.+Gasparauthor=F.+Ortusoauthor=N.+Milhazesauthor=F.+Oralloauthor=E.+Uriarteauthor=M.+Y%C3%A1%C3%B1ezauthor=F.+Borges&title=Chromone-2-+and+-3-carboxylic+acids+inhibit+differently+monoamine+oxidases+A+and+B&doi=10.1016%2Fj.bmcl.2010.03.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.081%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone-2-%2520and%2520-3-carboxylic%2520acids%2520inhibit%2520differently%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2709%26epage%3D2712%26doi%3D10.1016%2Fj.bmcl.2010.03.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viña, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmcl.2010.11.128" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=707-709&author=A.+Gasparauthor=J.+Reisauthor=A.+Fonsecaauthor=N.+Milhazesauthor=D.+Vi%C3%B1aauthor=E.+Uriarteauthor=F.+Borges&title=Chromone+3-phenylcarboxamides+as+potent+and+selective+MAO-B+inhibitors&doi=10.1016%2Fj.bmcl.2010.11.128"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.128%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%25203-phenylcarboxamides%2520as%2520potent%2520and%2520selective%2520MAO-B%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D707%26epage%3D709%26doi%3D10.1016%2Fj.bmcl.2010.11.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhazes, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordeiro, M. N. D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Towards the discovery of a novel class of monoamine oxidase inhibitors: structure–property–activity and docking studies on chromone amides</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1002/cmdc.201000452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1002%2Fcmdc.201000452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=628-632&author=A.+Gasparauthor=F.+Teixeiraauthor=E.+Uriarteauthor=N.+Milhazesauthor=A.+Meloauthor=M.+N.+D.+S.+Cordeiroauthor=F.+Ortusoauthor=S.+Alcaroauthor=F.+Borges&title=Towards+the+discovery+of+a+novel+class+of+monoamine+oxidase+inhibitors%3A+structure%E2%80%93property%E2%80%93activity+and+docking+studies+on+chromone+amides&doi=10.1002%2Fcmdc.201000452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000452%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DTeixeira%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DMilhazes%26aufirst%3DN.%26aulast%3DMelo%26aufirst%3DA.%26aulast%3DCordeiro%26aufirst%3DM.%2BN.%2BD.%2BS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DTowards%2520the%2520discovery%2520of%2520a%2520novel%2520class%2520of%2520monoamine%2520oxidase%2520inhibitors%253A%2520structure%25E2%2580%2593property%25E2%2580%2593activity%2520and%2520docking%2520studies%2520on%2520chromone%2520amides%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D628%26epage%3D632%26doi%3D10.1002%2Fcmdc.201000452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5173</span><span class="refDoi"> DOI: 10.1021/jm2004267</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2004267" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5165-5173&author=A.+Gasparauthor=T.+Silvaauthor=M.+Y%C3%A1%C3%B1ezauthor=D.+Vinaauthor=F.+Oralloauthor=F.+Ortusoauthor=E.+Uriarteauthor=S.+Alcaroauthor=F.+Borges&title=Chromone%2C+a+privileged+scaffold+for+the+development+of+monoamine+oxidase+inhibitors&doi=10.1021%2Fjm2004267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors</span></div><div class="casAuthors">Gaspar, Alexandra; Silva, Tiago; Yanez, Matilde; Vina, Dolores; Orallo, Franscisco; Ortuso, Francesco; Uriarte, Eugenio; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5165-5173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two series of novel chromone derivs. I and II ( R = Ph, 4-OH-C6H4, 3-OH-4-MeO-C6H3, 3,4-(OH)2-C6H3, 3,4-(MeO)2-C6H3, 4-Cl-C6H4, 4-OCF3-C6H4, 4-CF3-C6H4, 4-NO2-C6H4, cyclohexyl, nPr) were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase.  The SAR data indicate that chromone derivs. with substituents in position 3 of γ-pyrone nucleus act preferably as MAO-B inhibitors, with IC50 values in the nanomolar to micromolar range.  Almost all chromone 3-carboxamides display selectivity toward MAO-B.  Identical substitutions on position 2 of γ-pyrone nucleus result in complete loss of activity in both isoforms (chromones I except R = 4-OH-C6H4 and 3,4-(OH)2-C6H3).  Notably, chromone II(R = 4-Cl-C6H4) exhibits an MAO-B IC50 of 63 nM, greater than 1000-fold selectivity over MAO-A, and behaves as a quasi-reversible inhibitor.  Docking expts. onto the MAO binding of the most active compd. highlight different interaction patterns among the isoforms A and B.  The differential anal. of the solvation effects among the chromone isomers gave addnl. insight about the superior outline of the 3-substituted chromone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKKLGzqjz4yLVg90H21EOLACvtfcHk0lhxelhb1LLN1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlaisb0%253D&md5=27e7bd37930e26f28fb5b624b2360457</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm2004267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004267%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DChromone%252C%2520a%2520privileged%2520scaffold%2520for%2520the%2520development%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5165%26epage%3D5173%26doi%3D10.1021%2Fjm2004267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cagide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomes, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. N.</span><span> </span><span class="NLM_article-title">Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2832</span><span class="NLM_x">–</span> <span class="NLM_lpage">2835</span><span class="refDoi"> DOI: 10.1039/C4CC08798D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1039%2FC4CC08798D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=2832-2835&author=F.+Cagideauthor=T.+Silvaauthor=J.+Reisauthor=A.+Gasparauthor=F.+Borgesauthor=L.+R.+Gomesauthor=J.+N.+Low&title=Discovery+of+two+new+classes+of+potent+monoamine+oxidase-B+inhibitors+by+tricky+chemistry&doi=10.1039%2FC4CC08798D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1039%2FC4CC08798D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC08798D%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DT.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DGomes%26aufirst%3DL.%2BR.%26aulast%3DLow%26aufirst%3DJ.%2BN.%26atitle%3DDiscovery%2520of%2520two%2520new%2520classes%2520of%2520potent%2520monoamine%2520oxidase-B%2520inhibitors%2520by%2520tricky%2520chemistry%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D2832%26epage%3D2835%26doi%3D10.1039%2FC4CC08798D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cagide, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">Accelerating lead optimization of chromone carboxamide scaffold throughout microwave-assisted organic synthesis</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6449</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2011.09.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.tetlet.2011.09.095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=6446-6449&author=F.+Cagideauthor=J.+Reisauthor=A.+Gasparauthor=F.+Borges&title=Accelerating+lead+optimization+of+chromone+carboxamide+scaffold+throughout+microwave-assisted+organic+synthesis&doi=10.1016%2Fj.tetlet.2011.09.095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.09.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.09.095%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DAccelerating%2520lead%2520optimization%2520of%2520chromone%2520carboxamide%2520scaffold%2520throughout%2520microwave-assisted%2520organic%2520synthesis%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D6446%26epage%3D6449%26doi%3D10.1016%2Fj.tetlet.2011.09.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Vedachalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorityala, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.-W.</span><span> </span><span class="NLM_article-title">N-Heterocyclic carbene-catalyzed intramolecular aldehyde–nitrile cross coupling: an easy access to 3- aminochromones</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span><span class="refDoi"> DOI: 10.1021/ol9026232</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9026232" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=352-355&author=S.+Vedachalamauthor=J.+Zengauthor=B.+K.+Gorityalaauthor=M.+Antonioauthor=X.-W.+Liu&title=N-Heterocyclic+carbene-catalyzed+intramolecular+aldehyde%E2%80%93nitrile+cross+coupling%3A+an+easy+access+to+3-+aminochromones&doi=10.1021%2Fol9026232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fol9026232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9026232%26sid%3Dliteratum%253Aachs%26aulast%3DVedachalam%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DGorityala%26aufirst%3DB.%2BK.%26aulast%3DAntonio%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.-W.%26atitle%3DN-Heterocyclic%2520carbene-catalyzed%2520intramolecular%2520aldehyde%25E2%2580%2593nitrile%2520cross%2520coupling%253A%2520an%2520easy%2520access%2520to%25203-%2520aminochromones%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D352%26epage%3D355%26doi%3D10.1021%2Fol9026232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span><span class="refDoi"> DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lgGAQ4G153zug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Joshi, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandhane, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badadhe, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, C. H.</span><span> </span><span class="NLM_article-title">Development of practical methodologies for the synthesis of novel 3(4-oxo-4<i>H</i>-chromen-3-yl)acrylic acid hydrazides</span> <span class="citation_source-journal">Ultrason. Sonochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1016/j.ultsonch.2010.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.ultsonch.2010.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=21112230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ensbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=735-738&author=R.+S.+Joshiauthor=P.+G.+Mandhaneauthor=P.+V.+Badadheauthor=C.+H.+Gill&title=Development+of+practical+methodologies+for+the+synthesis+of+novel+3%284-oxo-4H-chromen-3-yl%29acrylic+acid+hydrazides&doi=10.1016%2Fj.ultsonch.2010.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of practical methodologies for the synthesis of novel 3-(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides</span></div><div class="casAuthors">Joshi, Ratnadeep S.; Mandhane, Priyanka G.; Badadhe, Pravin V.; Gill, Charansingh H.</div><div class="citationInfo"><span class="NLM_cas:title">Ultrasonics Sonochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-738</span>CODEN:
                <span class="NLM_cas:coden">ULSOER</span>;
        ISSN:<span class="NLM_cas:issn">1350-4177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report a new environmentally-benign, convenient and facile methodol. for the synthesis of new series of 3-(4-oxo-4H-chromen-3-yl)acrylic acid hydrazides derivs.I (R1 = H, Me, Cl; R2 = H, Me; R3 = H, Me, Co, Br) designed by exploring the mol. hybridization approach between isoniazide and 3-(4-oxo-4H-chromen-3-yl)acrylic acids by using EDCl/HOBt under ultrasound irradn. in very short reaction time.  Utilization of easy reaction conditions, isolation and purifn. makes this manipulation very interesting from an economic perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI45bfa1M2grVg90H21EOLACvtfcHk0lgGAQ4G153zug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ensbk%253D&md5=158a49ffefd27a8954280acd2afc8a04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ultsonch.2010.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ultsonch.2010.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DJoshi%26aufirst%3DR.%2BS.%26aulast%3DMandhane%26aufirst%3DP.%2BG.%26aulast%3DBadadhe%26aufirst%3DP.%2BV.%26aulast%3DGill%26aufirst%3DC.%2BH.%26atitle%3DDevelopment%2520of%2520practical%2520methodologies%2520for%2520the%2520synthesis%2520of%2520novel%25203%25284-oxo-4H-chromen-3-yl%2529acrylic%2520acid%2520hydrazides%26jtitle%3DUltrason.%2520Sonochem.%26date%3D2011%26volume%3D18%26spage%3D735%26epage%3D738%26doi%3D10.1016%2Fj.ultsonch.2010.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gaspar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span> </span><span class="NLM_article-title">In search for new chemical entities as adenosine receptor ligands: development of agents based on benzo-γ-pyrone skeleton</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">914</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.ejmech.2012.05.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=914-918&author=A.+Gasparauthor=J.+Reisauthor=M.+J.+Matosauthor=E.+Uriarteauthor=F.+Borges&title=In+search+for+new+chemical+entities+as+adenosine+receptor+ligands%3A+development+of+agents+based+on+benzo-%CE%B3-pyrone+skeleton&doi=10.1016%2Fj.ejmech.2012.05.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DIn%2520search%2520for%2520new%2520chemical%2520entities%2520as%2520adenosine%2520receptor%2520ligands%253A%2520development%2520of%2520agents%2520based%2520on%2520benzo-%25CE%25B3-pyrone%2520skeleton%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D914%26epage%3D918%26doi%3D10.1016%2Fj.ejmech.2012.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgGAQ4G153zug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span><span class="refDoi"> DOI: 10.1021/js980402t</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1021%2Fjs980402t" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10430548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood-brain+barrier+penetration&doi=10.1021%2Fjs980402t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Clark, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes the derivation of a simple QSAR model for the prediction of log BB from a set of 55 diverse org. compds.  The model contains two variables: polar surface area (PSA) and calcd. logP, both of which can be rapidly computed.  It therefore permits the prediction of log BB for large compd. sets, such as virtual combinatorial libraries.  The performance of this QSAR on two test sets taken from the literature is illustrated and compared with results from other reported computational approaches to log BB prediction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHa3ieLzy0RbVg90H21EOLACvtfcHk0li1u1Y8Ig_M0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFGitbk%253D&md5=949f8bf41525d8d04694e1288f24b626</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjs980402t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjs980402t%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood-brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821%26doi%3D10.1021%2Fjs980402t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, R. J.</span><span> </span><span class="NLM_article-title">A new paradigm for navigating compound property related drug attrition</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.drudis.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.drudis.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=26404453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=72-81&author=P.+Bartonauthor=R.+J.+Riley&title=A+new+paradigm+for+navigating+compound+property+related+drug+attrition&doi=10.1016%2Fj.drudis.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A new paradigm for navigating compound property related drug attrition</span></div><div class="casAuthors">Barton Patrick; Riley Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Improving the efficiency of drug discovery remains a major focus for the pharmaceutical industry.  Toxicity accounts for 90% of withdrawals and major early-stage terminations relate to suboptimal efficacy and safety.  Traditional oral drug space is well defined with respect to physicochemical properties and ADMET risks but increased focus on ligand-lipophilicity efficiency, maximizing enthalpy contributions and new target classes challenge this paradigm.  A hybrid space has been identified that combines physical properties and key interactions attributable to drug transporters.  A novel algorithm is proposed that incorporates drug-transporter interactions and its utility evaluated against popular ligand efficiency indices.  Simply reducing the bulk properties of compounds can exchange one problem for another and creates high-risk areas that challenge the successful delivery from a balanced portfolio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw28fh-W5ywlm8bhe6roZYfW6udTcc2eah-xDkMorF_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ltl2rtg%253D%253D&md5=8f9412912d498680db5bcc2d9880efe2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DA%2520new%2520paradigm%2520for%2520navigating%2520compound%2520property%2520related%2520drug%2520attrition%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.drudis.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0li1u1Y8Ig_M0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0li1u1Y8Ig_M0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span><span class="refDoi"> DOI: 10.1602/neurorx.2.4.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs&doi=10.1602%2Fneurorx.2.4.541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZsXrCWcBCDVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553%26doi%3D10.1602%2Fneurorx.2.4.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhr63ZoVTcaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lobner, D.</span><span> </span><span class="NLM_article-title">Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/S0165-0270(99)00193-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2FS0165-0270%2899%2900193-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10720679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslals7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2000&pages=147-152&author=D.+Lobner&title=Comparison+of+the+LDH+and+MTT+assays+for+quantifying+cell+death%3A+validity+for+neuronal+apoptosis%3F&doi=10.1016%2FS0165-0270%2899%2900193-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?</span></div><div class="casAuthors">Lobner, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Neuronal apoptosis induced in cortical cultures by exposure to serum deprivation, staurosporine, nifedipine, or C2-ceramide was assayed by lactate dehydrogenase (LDH) release or inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) redn.  He protective effects of neurotrophin 4, Z-Val-Ala-Asp-fluoromethylketone (ZVAD), and cycloheximide against each insult were also assayed.  The level of injury for each insult was similar whether detd. by LDH release or inhibition of MTT redn., but the effects of anti-apoptotic agents were assay-dependent.  ZVAD and cycloheximide protected neurons from nifedipine-induced death, when assayed by LDH release, but not MTT redn.  In contrast, only cycloheximide attenuated C2-ceramide-induced LDH release while ZVAD and cycloheximide actually enhanced the C2-ceramide induced inhibition of MTT redn.  Counting of trypan blue-pos. cells provided results consistent with values obtained using the LDH assay.  These results indicate that both LDH release and MTT redn. accurately det. the apoptotic death of neurons.  However, the MTT assay does not always correctly quantify neuroprotective effects and this likely reflects differences in the point of the death pathway that the neuroprotective agents act.  Therefore, while the MTT assay is of limited value in assessing the efficacy of neuroprotective strategies, it may provide information regarding whether specific anti-apoptotic agents act up or downstream of mitochondrial dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruv957Ff1DLrVg90H21EOLACvtfcHk0lhr63ZoVTcaqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslals7c%253D&md5=e674cf3bc4a67d659c3b977255f04692</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0165-0270%2899%2900193-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0270%252899%252900193-4%26sid%3Dliteratum%253Aachs%26aulast%3DLobner%26aufirst%3DD.%26atitle%3DComparison%2520of%2520the%2520LDH%2520and%2520MTT%2520assays%2520for%2520quantifying%2520cell%2520death%253A%2520validity%2520for%2520neuronal%2520apoptosis%253F%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2000%26volume%3D96%26spage%3D147%26epage%3D152%26doi%3D10.1016%2FS0165-0270%2899%2900193-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chimenti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carradori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span> </span><span class="NLM_article-title">Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5715</span><span class="NLM_x">–</span> <span class="NLM_lpage">5723</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1016%2Fj.bmc.2010.06.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5715-5723&author=F.+Chimentiauthor=A.+Bolascoauthor=D.+Secciauthor=P.+Chimentiauthor=A.+Graneseauthor=S.+Carradoriauthor=M.+Yanezauthor=F.+Oralloauthor=F.+Ortusoauthor=S.+Alcaro&title=Investigations+on+the+2-thiazolylhydrazyne+scaffold%3A+synthesis+and+molecular+modeling+of+selective+human+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.06.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DChimenti%26aufirst%3DF.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DGranese%26aufirst%3DA.%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DOrallo%26aufirst%3DF.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DAlcaro%26aufirst%3DS.%26atitle%3DInvestigations%2520on%2520the%25202-thiazolylhydrazyne%2520scaffold%253A%2520synthesis%2520and%2520molecular%2520modeling%2520of%2520selective%2520human%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5715%26epage%3D5723%26doi%3D10.1016%2Fj.bmc.2010.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lgQqPWYgHDdqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Son, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukihara, T.</span><span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span><span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.+Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-A+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lhED_EJNjGBNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.%2BY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-A%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>MacroModel, version <span class="NLM_edition">10.8</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel%2C+version+10.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Maestro, version <span class="NLM_edition">10.2</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+10.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span>Glide, version <span class="NLM_edition">6.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+6.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span>Impact, version <span class="NLM_edition">6.7</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+6.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>Desmond Molecular Dynamics System, version <span class="NLM_edition">4.2</span>; <span class="NLM_publisher-name">D. E. Shaw Research</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desmond+Molecular+Dynamics+System%2C+version+4.2%3B+D.+E.+Shaw+Research%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%2520Shaw%2520Research%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X','PDB','2Z5X'); return false;">PDB: 2Z5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z','PDB','2V5Z'); return false;">PDB: 2V5Z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i68"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61625"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00527">10.1021/acs.jmedchem.6b00527</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional molecular docking data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_001.pdf">jm6b00527_si_001.pdf (0.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00527/suppl_file/jm6b00527_si_002.csv">jm6b00527_si_002.csv (2.28 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00527&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00527%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-12%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00527" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991c3a8b46221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
